false --09-30 2023 FY 0001884072 0

 2024-08-08

 jewl: LiabilitiesAdjustmentRelatedToLoanDefaultMember

 2022-01-01
 2022-03-31

 2022-07-01

 jewl: LiabilitiesAdjustmentRelatedToLoanDefaultMember

 jewl: LiabilitiesAdjustmentRelatedToLoanDefaultMember

 2023-10-01
 2023-10-01

 jewl: LiabilitiesAdjustmentRelatedToLoanDefaultMember

 2023-10-01

 jewl: ScioDiamondTechnologyCorporationMember

 2020-02-03
 2020-02-03

 jewl: ScioDiamondTechnologyCorporationMember

 2020-02-03
 2020-02-03

 jewl: ScioDiamondTechnologyCorporationMember

 2019-10-17

 us-gaap: MachineryAndEquipmentMember
 srt: MinimumMember

 us-gaap: MachineryAndEquipmentMember
 srt: MaximumMember

 us-gaap: FurnitureAndFixturesMember
 srt: MinimumMember

 us-gaap: FurnitureAndFixturesMember
 srt: MaximumMember

 us-gaap: OtherMachineryAndEquipmentMember
 srt: MinimumMember

 us-gaap: OtherMachineryAndEquipmentMember
 srt: MaximumMember

 us-gaap: PatentsMember

 jewl: ResearchAndDevelopmentMember

 jewl: TechnologyMember

 jewl: ScioDiamondTechnologyCorporationMember

 2019-08-07

 jewl: InUseMember

 jewl: InUseMember

 us-gaap: InProcessResearchAndDevelopmentMember

 us-gaap: InProcessResearchAndDevelopmentMember

 srt: ChiefExecutiveOfficerMember

 srt: ChiefExecutiveOfficerMember

 srt: ChiefFinancialOfficerMember

 srt: ChiefFinancialOfficerMember

 srt: ChiefOperatingOfficerMember

 srt: ChiefOperatingOfficerMember

 us-gaap: EmploymentContractsMember
 jewl: Year2024Member

 us-gaap: EmploymentContractsMember
 jewl: Year2025Member

 us-gaap: EmploymentContractsMember

 jewl: Year2024Member

 jewl: Year2025Member

 jewl: Year2026Member

 us-gaap: SubsequentEventMember

 2024-03-31

 us-gaap: SubsequentEventMember

 2024-01-01
 2024-03-31

 us-gaap: SubsequentEventMember

 2023-10-01

 jewl: Integer

 UNITED
STATES

SECURITIES AND EXCHANGE COMMISSION

 WASHINGTON, D.C. 20549

 FORM

 x

 ANNUAL
 REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For
the fiscal year ended September 30, 2023

 OR

 o

 TRANSITION
 REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For
the transition period from ________ to ________

 ADAMAS ONE CORP.

 (Exact Name of Registrant as Specified in its Charter)

 Nevada

 001-41560

 83-1833607

 (State
 of incorporation)

 (Commission
 File No.)

 (I.R.S.
Identification Number)

 17767 N. Perimeter Drive, Suite B115, Scottsdale, AZ 85255
 (Address of Principal Executive Offices) (Zip Code)

 Registrant's
telephone number including area code: (480) 356-8798

 Securities
registered pursuant to Section 12(b) of the Act:

 Title
 of each class

 Trading
 Symbol(s)

 Name
 of each exchange on which registered

 Common Stock, $0.001 par value

 JEWL

 The
 Nasdaq Stock Market LLC (Nasdaq

 Capital Market)

 Securities
registered pursuant to Section 12(g) of the Act: None

by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o
 No x

by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o
 No x

by check mark whether the issuer (1) filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of
1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days. Yes x No
o

by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes x No
o

by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer,"
"smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 Large
 accelerated filer o

 Accelerated
 filer o

 Non-accelerated filer x

 Smaller
 reporting company x

 Emerging
 growth company x

 If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of
its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public
accounting firm that prepared or issued its audit report. o

by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). o Yes
x No

 As
of September 30, 2023, the aggregate market value of the voting common stock held by non-affiliates of the registrant, based on the closing
price of the Registrants common stock was N/A.

 As
of August 08, 2024, there were 37,972,648
shares of $0.001 par value Common Stock issued and outstanding.

 DOCUMENTS
INCORPORATED BY REFERENCE: one.

 EXPLANATORY
NOTE

 The Company is restating
in this 10K, the opening balance of retained earnings and the opening balance of accrued interest. This is a "little
r" restatement and previously issued 10Qs and 10Ks will not be amended. Under this approach, the Company will correct the
error in the current period comparative financial statements by adjusting the prior period and posting this notice. Correcting
the prior period financial statements through a "little r" restatement is referred to as an "adjustment" or "revision"
of prior period financial statements. As previously reported financial information has changed, we believe clear and transparent
disclosure about the nature and impact on the financial statements should be included within the financial statement footnotes.
As the effect of the error corrections on the prior periods is by definition, immaterial, column headings are not required to be labeled.
Moreover, the auditor's opinion is generally not revised to include an explanatory paragraph in a "little r" restatement
scenario.

 At September 30, 2022, accrued
interest was determined to be overstated by $255,403, resulting in the overstatement of interest expense and net loss for the year ended
September 30, 2022 by the amount of the overstatement.

 As the prior period financial
statements are not determined to be materially misstated, Adamas One Corp is not required to notify users that they can no longer rely
on the prior period financial statements.

 TABLE
OF CONTENTS

 ITEM 1:

 BUSINESS

 ITEM 1A:

 RISK FACTORS

 ITEM 1B:

 UNRESOLVED STAFF COMMENTS

 ITEM 2:

 PROPERTIES

 ITEM 3:

 LEGAL PROCEEDINGS

 ITEM 4:

 MINE SAFETY DISCLOSURE

 ITEM 5:

 MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND PURCHASES OF EQUITY SECURITIES

 ITEM 6:

 RESERVED

 ITEM 7:

 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

 ITEM 7A:

 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 ITEM 8:

 FINANCIAL STATEMENTS

 ITEM 9:

 CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 ITEM 9A:

 CONTROLS AND PROCEDURES

 ITEM 9B:

 OTHER INFORMATION

 ITEM 9C:

 DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 ITEM 10:

 DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE

 ITEM 11:

 EXECUTIVE COMPENSATION

 ITEM 12:

 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 ITEM 13:

 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 ITEM 14:

 PRINCIPAL ACCOUNTING FEES AND SERVICES

 ITEM 15:

 EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 SIGNATURES

 ADDITIONAL
INFORMATION

 Descriptions
of agreements or other documents contained in this report are intended as summaries and are not necessarily complete. Please refer to
the agreements or other documents filed or incorporated herein by reference as exhibits. Please see the exhibit index at the end of this
report for a complete list of those exhibits.

 SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS

 This
document contains certain "forward-looking statements". All statements other than statements of historical fact are "forward-looking
statements" for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue
or other financial items; any statements of the plans, strategies, goals and objectives of management for future operations; any statements
concerning proposed new products and services or developments thereof; any statements regarding future economic conditions or performance;
any statements or belief; and any statements of assumptions underlying any of the foregoing.

 Forward
looking statements may include the words "may," "could," "estimate," "intend," "continue,"
"believe," "expect" or "anticipate" or other similar words, or the negative thereof. These forward-looking
statements present our estimates and assumptions only as of the date of this report. Accordingly, readers are cautioned not to place
undue reliance on forward-looking statements, which speak only as of the dates on which they are made. We do not undertake to update
forward-looking statements to reflect the impact of circumstances or events that arise after the dates they are made. You should, however,
consult further disclosures and risk factors we include in Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports
filed on Form 8-K.

 As
used in this report, the term "Adamas" and such terms as "the company," "the corporation," "our,"
"we," "us" and "its" may refer to Adamas One Corp. All of these terms are used for convenience only and
are not intended as a precise description of any of the separate companies.

 PART
I

 ITEM
1. BUSINESS.

 Introduction

 We
are a high-tech diamond company that uses our proprietary technology to produce high-quality, single crystal laboratory grown diamonds
(lab-grown diamonds or LGD) and diamond materials through a Chemical Vapor Deposition (CVD) process, which we refer to as our "Diamond
Technology." Our Lab-grown diamonds have the exact physical, chemical, and optical properties of the best mined diamonds.
Lab-grown diamonds are composed of a pure carbon lattice, just like mined diamonds, and are not considered synthetic or simulant diamonds
like cubic zirconia and moissanite. Simulants are other chemical compounds that resemble diamonds but do not possess the same hardness,
thermal characteristics, band gap energy (an important property of semiconductor substrates), and light reflectivity as diamond, whether
mined or lab-grown.

 We
use our Diamond Technology to produce finished diamond gemstones that we sell wholesale and intend to sell at retail for jewelry and
rough unfinished diamond materials that we intend to sell at wholesale and retail for industrial uses. We are in the initial phases of
commercializing diamonds and diamond materials. Our primary mission is the development of a profitable and sustainable commercial
production for the manufacture and sale of diamonds and diamond materials which are suitable for known, emerging, and anticipated industrial,
technology, and consumer applications.

 We
intend to bring to market a line of fine jewelry featuring lab-grown diamonds. During this fiscal year 2023, we expended considerable
effort to prepare this jewelry line for launch in 2024.

 We
also intend to vertically integrate our lab-grown diamond manufacturing. During the fiscal year 2023, we identified acquisition
target companies in the diamond cutting and polishing arena. We believe that integrating diamond cutting will help improve our
product time to market performance, overall manufacturing costs, increase the company's management bandwidth and provide
increased capacity for the company.

 Our
Growth Strategy

 Our
goal is to become one of the leading suppliers of high-quality lab-grown diamonds to both the diamond jewelry industry and industrial
markets. We believe that we will be able to gain a share in chosen industrial markets where our quality, consistency, and scalability
will give our customers a competitive advantage. The following are our strategies to achieve our goal:

 Create
 the highest quality lab-grown diamond materials. Our Diamond Technology is proprietary
 and unique in our industry. It enables us to precisely control all diamond growth parameters,
 thereby creating the ideal environment within our growing chamber to grow and deliver high-
 quality diamonds for gemstones and diamond materials for industry in large batches and with
 high yield. We believe our proprietary Diamond Technology will, in the future, allow us to
 consistently deliver superior goods to the industry standard at very competitive pricing.

 Expand
 our production capabilities. Our diamond growing machines are the heart of our Diamond Technology. Scalability is achieved in
 two ways: first, through increasing the number of machines; and second, through expanding the batch size within each machine. We
 recently leased and began building an expanded factory near our current factory.

 Vertically
 integrate our diamond gemstone production. We believe that there is both margin and revenue
 opportunity by integrating the diamond grown with diamond cutting and polishing. We see this
 integration as also improving out time-to-market velocity, decrease learning-cycle times
 on experiments involving gemstone color, and assure high quality offerings to the market.

 Promote
 and brand lab-grown diamonds and lab-grown diamond jewelry. For diamond consumers, awareness
 of the lab-grown category is rapidly rising with leading jewelry chains now selling lab-grown
 diamonds. The product category is on-trend socially and ecologically, and we believe further
 consumer education will drive more awareness and preference for lab-grown over mined diamonds.
 We anticipate working with social media influencers and utilizing our marketing abilities
 to create further awareness and drive demand for our diamond gemstones and lab-grown diamond
 jewelry.

 Strategically
 partner with innovators in promising new applications. The physical properties of diamond hardness,
 band gap energy, and thermal conductivity are the best of any material on Earth and immensely
 valuable to several leading-edge applications. Our lab-grown diamonds are identical optically,
 physically, and chemically to the best mined diamonds. Our Diamond Technology allows us to
 manufacture diamond materials of the specific size and composition for each specific application.
 As this is a manufacturing process, we will be able to deliver products repeatedly at attractive
 price points. The high cost and lack of atomic level consistency of mined diamonds has hampered
 the use of diamond in various semiconductor, quantum computing and other leading-edge applications.
 Our Diamond Technology should provide a path for success in those applications.

 Our
Competitive Strengths

 We
believe we are uniquely positioned to capture a share of the lab-grown diamond industry.

 CVD
 Diamond Growth. Our Diamond Technology is based on a proprietary CVD diamond growth system. Large single crystal diamonds produced
 through this specific CVD process have been shown to be exceptionally pure and possess very low levels of structural defects. Diamonds
 produced by this process include highly desirable Type-IIa diamonds, which contain negligible levels of nitrogen impurities
 and are the most known for precious white diamond gemstones. Similarly, the low impurities of these diamonds make them ideally suited
 for industrial applications, including electronics.

 Proprietary
 Diamond Technology. CVD diamond technologies offer significant advantages versus other
 growth technologies, and our Diamond Technology offers significant advantages over other
 available CVD technology. One key element in CVD systems is the plasma formation, a cloud
 of carefully controlled ionized gases. Our plasma cloud is ignited and controlled in a manner
 that is different than conventional microwave CVD systems and gives the advantage of a more
 consistent temperature across the growth surface and larger plasma volume. What this means
 is more consistent diamond growth over a larger area. This translates to a larger batches
 and more consistent output.

 Patents
 and Proprietary Knowledge. Our Diamond Technology provides a materials production platform and is supported by intellectual property,
 including trade secrets, recipes, and is based on a foundation of 36 issued patents (28 in the United States and 8 in foreign
 jurisdictions). In addition to our patents, we have acquired through processes and key individuals, a large body of know-how in the
 areas of diamond crystal growth, diamond recipes, diamond lasering, diamond annealing, gemstone production, and industrial diamond
 production.

 Scalability.
 We believe that our Diamond Technology can be scaled through larger capacity diamond growing
 platforms within the growing chamber. Through further research and development, we believe
 we will be able to increase production by almost 100% over the current process. This results
 in a doubling of the batch size in each diamond growing machine.

 Products

 We
currently have limited available commercial products and have only recently commenced selling diamonds or diamond materials to consumers
or commercial buyers. Our current operations have been primarily dedicated to the research and development of our Diamond Technology,
the design or our fine jewelry line for launch in 2024, and the exploration of markets that we may enter in the future. While we
are unable to predict the timing of our entry into any market in the future, we will strive to produce on a large scale high-quality
finished diamonds and raw diamond materials and to pursue related commercial opportunities. In addition to opportunities in the diamond
gemstone market and precision cutting market, we will continue to explore other opportunities for our diamond materials through applications
where the unique properties of diamond may be desirable and advantageous, including alternative energy, optoelectronics, communications,
biotechnology, water treatment, quantum computing, and the diamond device industries.

 Diamond
Gemstones

 Within
the gemstone industry, our single-crystal diamond can be used in jewelry products requiring the highest quality gemstones and can be
consistently grown in matched color sets ranging in polished sizes from 0.05 carats to well over 2 carats. Our diamonds are well suited
for jewelry featuring matching diamonds of various sizes, clarities, and colors, as well as diamond engagement rings and fashion jewelry.
Our lab-grown diamonds are graded in the same manner as mined diamonds using the familiar 4Cs (color, clarity, cut, and carat
weight). Our intention is to deliver high-quality diamonds to the jewelry market, with "excellent or ideal" cuts and high clarity
in near colorless, colorless, and fancy color stones.

 The
consistency and other characteristics of lab-grown diamond gemstones using our Diamond Technology may provide advantages over their mined
counterparts in areas that matter to jewelers, jewelry manufacturers, and consumers, with characteristics such as the following:

 quality
 and brilliance of our lab-grown diamonds equal to that of mined diamonds;

 matched
 sizes, colors, and clarities (particularly in lab-grown diamonds ranging in sizes from 0.5
 to 2 carats);

 opportunity
 for color palette of diamond gemstones; and

 environmentally
 friendly and socially conscious alternative to mined diamonds.

 We
will seek to establish and maintain market acceptance through consumer education and industry cooperation. We intend to educate retailers
and consumers on the physical properties and quality of our lab-grown diamonds as compared to mined diamonds.

 Diamond
Materials for Commercial, Industrial, and Semiconductor Technological Applications

 Diamonds
have exceptional unique qualities, such as hardness, clarity, and thermal characteristics, for use in advanced electronics and optics
applications, but to date, development progress has been slow because of, among other things, mined diamond's relative scarcity,
mined diamond's low uniformity, and high cost. We believe that our patented technology and production approach will give us the
ability to improve the quality and lower the cost of producing diamond materials, creating the opportunity for use in a wider range of
applications.

 The
demand for computing and communications products has increased significantly. As devices become more intelligent and ubiquitous, we believe
the need for connectivity at extremely high speeds, data intensive storage needs, and ever-faster computer processors are pushing the
limits of conventional silicon-based devices. The physical properties of diamond provide the opportunity for significant improvement
in high-speed and high-power electronic devices due to diamond's superlative thermal, lattice mobility, and band gap energy properties.
These properties can remove heat more quickly, allow electrons to flow freely with low resistance, and show promise for high-power high-speed
circuits over traditional semiconductor materials. Diamond may enable these technologies to move past their current limitations and may
be able to facilitate the development of next-generation devices in key areas such as wireless networking, optical storage, and high-speed
computing.

 We
anticipate several opportunities to monetize our Diamond Technology and production approach in various technological applications. Pursuit
of these opportunities is expected to be directed, in part, in concert with strategic partners that we hope to engage in the future.

 Industrial
diamond materials already comprise a multiple billion dollar per year market but largely consist of small and lower quality diamonds
that have primarily been utilized in rudimentary cutting and polishing devices. These diamond materials are largely in the form of diamond
grit and diamond dust. Higher-quality, single crystal diamond materials are gaining traction in the precision milling and machining subsegments.
We anticipate substantial growth for these industrial diamond market segments. Tools equipped with single-crystal diamond can both improve
surface quality and reduce the number of manufacturing passes on precision milled hard materials like high-tech alloys.

 The
diamond materials historically used in the development of many non-gem applications has been impeded by cost, size, and lack of uniformity
of mined diamonds. As our production commences, and as volume increases and manufacturing costs continue to decrease due to our capacity
expansion, we anticipate that our diamond materials will provide a viable and potentially economically preferred alternative for many
non-gemstone applications, including electronic, optical, and industrial applications.

 To
more fully explore the opportunities discussed above, we intend to acquire other companies involved in the production of high-quality
diamond materials and to pursue related commercial opportunities. Currently, we intend to continue to explore opportunities in the precision
cutting devices market while concurrently seeking distribution opportunities for our lab-grown diamond gemstones. However, we do not
have agreements or commitments for any specific acquisitions or investments at this time.

 Marketing

 We
plan to market our products to consumers through distributors, dealers, mass market and specialty retailers, and direct to consumer through
e-commerce. We plan to maintain consumer-focused product marketing and promotional campaigns, which include print and digital advertising
campaigns; social and electronic media; product demonstrations; point-of-sales materials; in-store training, and in-store retail merchandising.
Our use of social media includes Instagram, Facebook, Twitter, and You Tube.

 Manufacturing

 We are obligated under a triple-net
operating lease for our 6,475 square foot manufacturing facility located in Greenville, South Carolina, which is classified as an operating
lease. The terms of the lease require a payment of approximately $13,000 per month, which includes an estimate for taxes and repairs.
This lease expires in August 2028.

 We believe this facility will
be adequate to meet our current needs based on the property and equipment currently owned. However, our business plan may require additional
space, and we will be making plans to expand our building footprint at possible new or additional locations to accommodate additional
manufacturing equipment. We added a lease for 3,414 square feet of office space in Scottsdale, Arizona, expiring in September 2024, to
facilitate the administration and marketing of expanding the manufacturing aspect of our company as well as to administer increased management
anticipated in areas of human resources, finance, accounting, and financial analysis as well as sales and marketing to manage the expected
growth in the production output in our manufacturing efforts. We intend to pay for new lease space and related improvements using a combination
of working capital, new debt financing, and equity offerings.

and Development

 Since
acquiring the Scio assets in 2019, we have focused our efforts on research and development of improvements to the fundamental CVD process.
Our development efforts have focused on commercialization of the diamonds and diamond materials we produce, improvements in our white
diamond process, improvements in our diamond seed processes, automation in our machine operation, expansion of our capacity with our
existing machines, and improvements in our laser cutting procedures. In the future, our research and development projects will include
further improvements in the CVD process, primarily around capacity expansion per diamond growing machine. We are planning to
invest in other parts of the manufacturing chain as well to develop our own diamond seeds, which are thin slices of diamond upon which
our diamonds are grown; add color enhancement; and add additional laser capabilities.

 Suppliers

 We
believe we have reliable sources of supply for all our raw material and component needs, but from time-to-time raw materials and components
are subject to shortages and price increases. Most of our suppliers are U.S.-based and provide us the materials and components at competitive
rates. We plan to continue to broaden our supplier base and secure multiple sources for all the raw materials and components we require.

 Customers

 Customers for our diamond gemstones
will include diamond brokers, diamond cutters, diamond wholesalers' jewelry manufacturers and retailers, both domestic and foreign.
Diamond cutters take deliveries of diamonds in a rough form, known as cores or whole crystals, where they will employ a variety of industry
standard techniques of laser cutting and polishing diamonds and resell the cut diamonds in both the wholesale and retail markets. These
techniques are identical to the techniques that are used in the production of mined gems. Diamond brokers and wholesalers will also take
delivery of our diamonds in the rough form but will also purchase diamond gems that we have cut and polished by our third-party contractors
and will resell the cut diamonds in both the wholesale and retail markets. It is also our intention to "finish" gemstones
for the jewelry market, meaning that we will use third-party contractors to cut and polish our rough diamonds into gemstones to our specifications.
As described, we intend to integrate diamond cutters and polishers into the Company during 2024. These finished diamond gemstones will
allow us to expand our customer base by selling directly to consumers, beyond the diamond middle market and supply diamond wholesalers
and retailers.

 Industrial
diamond materials are sold in a business-to-business arrangement. Many industrial customers expect diamonds to be cut in specific ways
along certain diamond crystal planes. For example, precise milling applications require that the hardest surface is presented and is
often flat polished. These customers will work directly with us on the shapes and cuts needed. Once samples are approved, production
orders will follow.

 If
we begin to reliably manufacture diamond products and are successful in expanding our manufacturing capacity, we anticipate that we will
experience increased demand for our products both domestically and internationally, given the potential demand for diamond, the variety
of potential uses for these products in gemstone, high-tech applications, alternative energy technologies, and defense technologies.

 Market and Competition

 Over recent years, the lab-grown
diamond market share has been growing steadily within the entire diamond market. The global lab-grown diamond market is estimated to have
reached $24 billion in 2022 (per Allied Market Research Report: "Global Lab Grown Diamonds Market; Opportunity Analysis and Industry
Forecast 2023 - 2032), growing at a CAGR of 9.6% during 2022 to 2032. Market revenue is expected to reach $59 billion in 2032, according
to Allied Market Research. In 2022, the largest share of revenue came from North America at 9.5B with Asia Pacific at 9.0B, again per
Allied Market Research.

 On the Manufacturing side as
of 2019, China was by far the world's largest producer, accounting for a 56% share of lab-grown diamond production worldwide. India
was the world's second largest producer, having produced a distant share of 15% of the lab-grown diamond industry. The United States
followed closely in third place at 13%. In 2020, the worldwide lab-grown diamond production grew to around seven million carats according
to the BBC. While at the same time, the production of mined diamonds fell to 111 million carats after reaching a peak of 152 million
carats in 2017 according to a report by the Antwerp World Diamond Centre and Bain & Company. De Beers, the largest diamond producer,
reported a 14% decrease in production in its 2020 annual report. They attributed this major downturn to the COVID-19 pandemic but indicated
that the market is beginning to recover.

 Sales
of lab-grown diamonds into the diamond jewelry market are aggressively growing because of awareness, acceptability, social factors, and
pricing. The industrial market for lab-grown diamond materials is more developed in some applications (like precision milling and
grinding) but it is diffused across geography and a wide variety of industrial application segments. The rapid growth of the construction
and automotive sectors is a major factor in boosting the market. In the construction industry, lab- grown diamond materials are used
for drilling, cutting, grinding, and polishing purposes. Increasing urbanization is driving the growth of the construction industry as
the government is focusing on infrastructure development, such as transportation, water supply, telecommunication, and energy networks.
As a result, the rising construction activities, especially in the Asia Pacific, such as 'Smart City Mission' and Housing
for All,' are likely to fuel the product demand for diamond materials. High Tech and electronic applications are beginning to
emerge as LGDs have hit price points and manufacturing volumes to support electronic applications in EVs, quantum computers and other
high-speed electronics.

 Competitive
factors that influence the market for our products include product quality, consistency of supply, and price. There are two main methods
for producing lab-grown diamonds.

 The
first method, called high pressure high temperature, or HPHT, is the first method invented for the creation of lab-grown diamonds, originating
in the 1950s in the laboratories of the General Electric Company. The HPHT process employs large hydraulic presses, which exert
enormous amounts of pressure on a small cell containing graphite material and a catalyst. Over time, that cell is heated and pressed
causing diamond to nucleate and grow. HPHT is most often used in the creation of small diamonds and grit for industrial abrasives and
for small stones in jewelry. There are some companies that use HPHT to grow larger single crystal diamonds and some companies that use
HPHT equipment with a different method to enhance the color of mined and lab-grown diamonds.

 The
second method, chemical vapor deposition, or CVD is the method on which our Diamond Technology is based. This method is very different
than HPHT as it uses low pressure and heated carbon rich gases. A plasma is formed, a hot cloud of precisely mixed ionized carbon
rich gases; these carbon ions are forced onto a small sliver of diamond seed, extending or growing the diamond crystal.

 We
believe that we will be able to compete against HPHT diamonds based on batch size cost, color quality, and clarity. We believe that we
will be able to efficiently produce lab-grown diamonds possessing identical qualities and characteristics of their mined diamond counterparts.

 Lab-grown
diamond gemstones and diamond materials for use in industrial applications face competition from established producers and sellers of
mined diamonds, including companies such as De Beers, and other current and potential future manufacturers of lab-grown diamonds. At
wholesale and retail levels, lab-grown diamonds are in general less expensive than mined diamonds. In addition to being less expensive,
lab-grown diamonds are considered by many to be a more environmentally friendly and a more socially ethical alternative to mined diamonds.
This is due to lab-grown diamonds being made in a laboratory rather than requiring large amounts of earth to be moved, invariably damaging
our ecosystem. Because lab-grown diamonds are produced in a safe environment, our diamonds are completely conflict free, and we do not
encounter the "blood diamond" issues associated with mined diamonds.

 Our
competitors include large multi-national gemstone diamond and diamond materials companies as well as start-up and development-stage gemstone
diamond companies, some of whom we may not be aware. Many of our competitors have significantly greater financial, technical, manufacturing,
and marketing resources and greater access to distribution channels than we do. Many of our competitors may be able to devote substantially
greater resources to promotion and systems development than we can. Barriers to developing competitive technology in our market may not
be sufficient to prevent competitors from entering the industry, and current and new competitors may be able to develop competing diamonds
at a relatively low cost. We believe that our success will depend heavily upon whether we can achieve significant market acceptance before
our competitors are able to introduce universally accepted competitive products.

 Several
of our competitors offer material in different sizes and classes of diamond, including diamond films, diamond grit, diamond bort, and
polycrystalline diamond. Our products, large single crystal diamonds, have fewer competitors. However, industrial diamond manufacturers
may in the future attempt to develop large single crystal diamonds similar to ours.

 Companies that produce lab-grown
diamonds and who may compete with us in one or more markets include Element Six UK Ltd., a privately held subsidiary of De Beers Group,
Pure Grown Diamonds, Inc./IIA Technologies Pte. Ltd. (USA, Singapore, and Malaysia), WDAT an industrial diamond company formed from the
assets of WD Lab-grown Diamonds, GreenLab lab-grown diamonds, Mittal Diamonds, India., Diamond Foundry Inc., Applied Diamond, Inc., and
CORNES Technologies Limited (Japan). Other companies could seek to introduce lab-grown diamonds or to develop competing processes for
production of lab-grown diamonds and diamond materials. We believe that competition will increase as demand for diamond materials increases
for use in industrial and technology applications and as lab-grown diamonds for gemstones continue to gain market acceptance.

 Employees

 As
of September 30, 2023, we had a total of 12 employees. Of these employees, 6 were engaged in manufacturing, 1 in sales, marketing and
customer service, 1 in research and development, manufacturing engineering, and software engineering, and 4 in various corporate and
administrative functions (information technology, accounting, executives, etc.). None of our employees are represented by a union in
collective bargaining with us. We believe that our employee relations are good.

 Seasonality

 Our
sales to the jewelry industry may be higher in periods leading up to special dates, occasions and seasons that are historically and traditionally
highly jewelry gift giving occasions. We expect to encounter seasonality in sales leading up to those traditional sales opportunities
including the holiday season running from Thanksgiving to Christmas and the New Year's Day celebration. Valentine's Day, Mother's
Day and certain periods of engagement ring purchases, bridal shows and wedding season are anticipated to be part of our seasonality sales
forecasts.

 Intellectual
Property

 Our
Diamond Technology is based on a CVD diamond growth system, a process by which large, single-crystal diamonds are grown in a controlled
laboratory environment. Diamond wafers produced through our Diamond Technology CVD process that have been tested have been shown to be
exceptionally pure and possess low levels of structural defects. Advances in this technology have dramatically improved the quality and
lowered the cost of high-quality diamonds.

 One
of our proprietary methods, which is part of our Diamond Technology, is a method of growing diamond crystals from diamond seeds in our
proprietary diamond growing machines. Specifically, we place a group of seeds inside our diamond growing machines. Diamond seeds are
thin slices of mined or lab-grown diamond. We then apply a vacuum to evacuate the growing chamber. Then refill the chamber with a mixture
of several ultra-pure, laboratory grade gases. At least one of those gases is rich in carbon. We stabilize the chamber at a specific
pressure, and at that point we apply power to the chamber to create a plasma. That plasma is a glowing hot ball of the gas mixture and
contains carbon ions, other ions, and non-ionized gases. Those carbon ions are the key to crystal growth as they become bonded through
a chemical reaction to the diamond seed and add a diamond bonded carbon (chemists call this an SP3 bond) layer to the seed. Layer after
layer of carbon is added to the seed, which grows to eventually reach the desired height. The plasma is then extinguished, gases are
turned off, and the chamber is refilled with air. The process of growing the diamonds can take as long as 45 days, depending upon the
size of the diamonds. We can then open the chamber and remove all the diamond crystals, which are further cleaned and cut into gemstones
or industrial shapes. Our industrial grade diamond materials are grown using a similar method to the above-described process. As industrial
diamond materials are used in a wide variety of applications, including, among others, precision milling and grinding, laser light guides,
optical windows, and medical scalpels, our products are grown to various color grades and sizes. These diamonds are then laser cut to
match the specific shape required by each application.

 Our
Diamond Technology provides a materials production platform and is supported by intellectual property, including trade secrets, recipes,
and 36 issued patents (28 in the United States and 8 in foreign jurisdictions).

 Specifically,
our Diamond Technology utilizes proprietary equipment, which we refer to as our diamond growing machines, that control many environmental
and chemical parameters to grow pure diamond crystals. The diamond crystals are grown on thin slices of diamond called "seeds."
These seeds provide the blueprint for atomic connections between carbon atoms. Inside the diamond growing machines, carbon rich gases
are ionized into a plasma (a very high energy state). These high energy gases will then deposit carbon atoms on top of the diamond seeds.
The carbon atoms from the gas plasma bond to the seed, extending the solid diamond crystal. This process is repeated over and over, depositing
several atomic layers per second. Over a period of a few weeks, the diamond crystals grow inside the machines vertically into sizes that
can be subsequently cut and polished into gemstones or fashioned into industrial pieces.

 Our
diamonds are grown in batches inside the diamond growing machines. Our proprietary diamond growing machines can maintain a large stable
plasma of carbon rich gases for long periods of time. The large size of the plasma and its management is unique to our Diamond Technology
and enables the growth of large batches of diamonds.

 We
are seeking to commercialize our Diamond Technology and are preparing to produce diamonds in volume. We believe that our Diamond Technology
can be scaled through larger capacity diamond growing platforms. Our Diamond Technology supports larger plasmas for depositing diamonds
on larger batches. Through further research and development, we believe we will be able to increase production by almost 100% over the
current process with modifications to our existing diamond growing machines.

 Our
diamond growing machines are situated in a factory with specific infrastructure that includes a distribution mechanism for high purity
laboratory- grade gases, specific environmental control, precisely controlled electricity with backup, and cooling systems that allow
the diamond reactions to occur at specific controlled temperatures. We believe that the factory infrastructure and the diamond growing
machines will enhance efficiency and produce diamonds at commercial volumes.

 Our
produced diamonds for use in jewelry are cut and polished using third-party contract resources, similar to how most companies produce
gemstones. The diamonds will then be sold through various diamond merchants, diamond brokers, and diamond retailers. Our produced diamond
material for use in industrial applications is laser cut by our company and will be sold business-to-business. Certain of our employees
have deep experience in the lab-grown diamond field as well as related semiconductor related fields.

 Environmental
Matters

 Our
operations are subject to local, state, and federal laws and regulations governing environmental quality and pollution control. To date,
our compliance with these regulations has had no material effect on our operations, capital, earnings, or competitive position, and the
cost of such compliance has not been material. We are unable to assess or predict at this time what effect additional regulations or
legislation could have on our activities.

 Regulatory
Matters

 Certain
federal and state laws and regulations govern the testing, creation, and sale of the types of diamonds we intend to produce. The FTC
and other comparable regulatory authorities in the United States and in foreign countries may extensively and rigorously regulate our
lab-grown diamonds, product development activities, manufacturing processes, advertising, and sales. In the United States, the FTC regulates
the introduction and labeling of gemstone diamonds. We may be required to:

 obtain
clearance before we can market and sell our lab-grown diamond gemstones;

 describe
our products consistent with the FTC guidelines in marketing and sales material;

 satisfy
content requirements applicable to our labeling, sales, and promotional materials;

 comply
with manufacturing and reporting requirements; and

 undergo
rigorous inspections.

 Further,
we may be subject to regulatory requirements in the future. Government authorities can withdraw marketing clearance due to our failure
to comply with regulatory standards or due to the occurrence of unforeseen problems following initial clearance. Ongoing regulatory requirements
are wide- ranging and govern, among other things:

manufacturing;

 annual
inspections related to International Organization for Standardization, or ISO, certification of our quality system;

 supplier
substitution;

changes;

 process
modifications;

 the
process of assuring origin of mine and/or production of diamonds;

 lab-grown
diamond gemstone reporting and disclosure; and

sales and distribution.

 Various
government agencies may inspect our facilities from time to time to determine whether we comply with applicable laws and regulations.
Additionally, if we fail to comply or maintain compliance with laws and regulations pertaining to diamond gemstones, regulatory authorities
may fine us and bar us from selling our lab-grown diamond gemstones. If a regulatory agency believes we are not in compliance with such
laws or regulations, it may be able to:

 seize
our lab-grown diamond gemstones;

 require
a recall;

 withdraw
previously granted market clearances;

 implement
procedures to stop future violations; and/or

 seek
civil and criminal penalties against us.

 Available
Information

 You
will be able to find reports on our company including our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports
on Form 8-K, and amendments to those reports on our website www.adamasone.com under the "Investor Relations" heading.
These reports are free of charge and are available as soon as reasonably practicable after they have been filed with, or furnished to,
the U.S. Securities and Exchange Commission (SEC). We are providing the address to our website solely for the information of investors
and the information on our website is not a part of this or any report that we file with the SEC.

 Our
History

 We were incorporated on September
6, 2018, in the state of Nevada for the purpose of acquiring existing technology that would efficiently and effectively produce lab-grown,
environmentally friendly, ethically sourced diamonds. On January 31, 2019, we entered into an Amended Asset Purchase Agreement with Scio
Diamond Technology Corporation, or Scio, which was subsequently amended February 3, 2020, pursuant to which we acquired substantially
all of the assets of Scio, which assets consisted primarily of proprietary diamond growing chemical reactors, which we refer to as diamond
growing machines, patents, and all intellectual property related thereto, for an aggregate of 1,500,000 shares of our common stock and
payment to certain lenders of Scio of an aggregate of $2.1 million in cash. In addition, we agreed to pay one-half of certain other unsecured
operational liabilities of Scio. The transaction was approved by a majority of the Scio stockholders voting in person or by proxy at
a special meeting of stockholders held commencing on June 30, 2019, and reconvening on August 6, 2019. The transaction closed on October
17, 2019. We recorded the fair value of the assets purchased and liabilities assumed at $8.65 million.

 The
assets and liabilities were valued using ASC 805, the fair value of assets acquired and liabilities assumed in a business combination,
which requires the measurement of assets acquired and liabilities assumed to be recognized at their acquisition-date fair values.

 Since acquiring
the assets of Scio, we have continued to further develop the technologies acquired from Scio, and we have begun producing diamonds for
fine jewelry and diamond material for industrial uses. We have also further improved on the acquired proprietary diamond recipes for
pink and white diamond gemstones to the point where they are commercially competitive. We have added new capabilities in diamond planning
and laser cutting, which allows for commercially acceptable preforms to be efficiently cut and polished into gemstones. We plan to continue
to further refine and improve our technology with respect to lab-grown diamond development, growth, and commercialization.

 We
are currently a developmental stage company with minimal revenue and a nominal operating history. While we are now able to go-to-market
based on our current operations, it is currently on a very small scale. It will take additional time to ramp up our operations as we
bring all of the diamond growing machines acquired in the Scio acquisition into operation and increase our production scale through the
preparation of additional factory space and the purchase, commissioning, and operation of additional diamond growing machines. Increasing
our production scale, the number of diamond crystals grown per month, is our current challenge. For us to increase our production, we
must be able to secure the necessary financing and distribution chain. If we are unable to secure adequate financing, we may not be able
to fully increase our operations to scale.

 We
completed our Initial Public Offering (IPO) on December 14, 2022.

 Our
Common Stock began trading on the Nasdaq Capital Market under the symbol JEWL on December 9, 2022.

 ITEM
1A. RISK FACTORS

 Purchasing
our Common Stock involves a high degree of risk. You should carefully consider the following risk factors, together with all of the information
included in this Form 10-K Report, before you decide to purchase shares of our Common Stock. We believe the risks and uncertainties described
below are the most significant we face. Additional risks and uncertainties of which we are unaware, or that we currently deem immaterial,
also may become important factors that affect us. If any of the following risks occur, our business, operating results, and financial
condition could be materially and adversely affected. In that case, the trading price of our Common Stock could decline, and you may
lose all or part of your investment.

 Risks
Related to Our Business

 Because
we have recently commenced business operations, we face a risk of business failure.

 We
were formed on September 6, 2018. Most of our efforts to date have been related to executing our business plan, raising capital, negotiating
the acquisition transaction with Scio, and commencing business operations. The prior businesses that utilized our Diamond Technology
have failed. From inception through December 31, 2021, we have had no revenue, and we have had revenue through September 30, 2023. We
face a risk of business failure. Our likelihood of success must be considered in light of the expenses, complications, and delays frequently
encountered in connection with the establishment and expansion of new business and the competitive environment in which we will operate.
There can be no assurance that future revenue from sales of our intended products or services will occur or be significant enough or
that we will be able to sell at a profit, if at all. Future revenue or profits, if any, will depend on many factors, including initial
(and continued) market acceptance of our products or services and the successful implementation of the planned strategy.

 We
only recently formed our Company and acquired our operating assets through the Scio acquisition. From the asset acquisition date, we
continue our efforts to ramp up our operations as we bring all of the diamond growing machines acquired in the Scio acquisition into
operation and increase our production scale through the preparation of additional factory space and the purchase, commissioning, and
operation of additional diamond growing machines. Increasing our production scale, the number of diamond crystals grown per month, is
our current challenge. For us to increase our production, we must be able to secure the necessary financing and distribution channels.
If we are unable to secure adequate financing, we may not be able to fully increase our operations to scale.

 Our
future profitability, if any, could be materially and adversely impacted if we are unable to produce marketable diamonds or diamond materials
on a large scale. Our ability to achieve profitability will be dependent on the ability of our future products or services to generate
sufficient operating cash flow to fund the continuation of our business and future growth or acquisitions. There can be no assurance
that our future results of operations will be profitable or that our strategy will be successful or even begin to generate any substantial
revenue.

 There
is substantial doubt about our ability to continue as a going concern.

 For
the year ended September 30, 2023, we incurred a net loss of $22.5 million and used approximately $6.8 million of cash in operations.
For the year ended September 30, 2022, we incurred a net loss of $11.1 million and used approximately $3.2 million of cash in operations.
As of September 30, 2023, we had an accumulated deficit of $63.6 million. These conditions raise substantial doubt about our ability
to continue as a going concern. Turner, Stone & Company, LLP, our independent registered public accounting firm, included an explanatory
paragraph in its report on our financial statements as of, and for the year ended, September 30, 2023, describing the existence of substantial
doubt about our ability to continue as a going concern.

 We
will need additional financing to implement our full business plan and to service our ongoing operations. There can be no assurance that
we will be able to secure any needed funding, or that if such funding is available, the terms or conditions would be acceptable to us.
If we are unable to obtain additional financing when it is needed, we will need to restructure our operations and possibly divest all
or a portion of our business. We may seek additional capital through a combination of private and public equity offerings and debt financing.
Debt financing, if obtained, may involve agreements that include covenants limiting or restricting our ability to take specific actions,
such as incurring additional debt, and could increase our expenses, require that our assets secure such debt, or provide for high interest
rates, discounted conversion prices, or other unfavorable terms. Equity financing, if obtained, could result in dilution to our then-existing
stockholders and/or require such stockholders to waive certain rights and preferences. The financial statements do not include any adjustments
relating to the recoverability and classification of recorded asset amounts or the amount and classification of liabilities or any other
adjustment that might be necessary should we be unable to continue as a going concern. We may be required to cease operations which could
result in our stockholders losing all or almost all of their investment.

 Loss
of key members of management or our inability to attract and retain qualified personnel could adversely affect our business.

 Our
success depends substantially on the efforts and abilities of our senior management and key personnel. The competition for qualified
management and key personnel is intense. Although we maintain noncompetition and nondisclosure covenants with many of our key personnel,
and we have employment agreements with the key personnel, all our employees are "employees at will." The loss of services of
one or more of our key employees or the inability to hire, train, and retain additional key personnel could delay the development and
sale of our products, disrupt our business, and interfere with our ability to execute our business plan.

 In
addition, our ability to maintain our competitive position is dependent to a large degree on the efforts and skills of our senior management
team, including Mr. John G. Grdina, our President and Chief Executive Officer. The loss of the services of one or more of our key personnel
could materially and adversely affect our operations.

 The
inability of our senior management and board of directors to ensure the timely filing of our periodic reports pursuant to Section 13
or 15(d) of the Exchange Act could result in the termination of our registration status or revocation by the SEC of the registration
of our securities pursuant to Section 12(j) of the Exchange Act.

 Our
future survival as a public company will largely depend on the ability of our senior management and board of directors to ensure the
timely filing of our periodic reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange
Act. Pursuant to the list set forth below at the end of this risk factor, while each of our named executive officers and one of our directors
were executive officers and/or directors of certain other public companies in the past, such companies in certain instances did not timely
file their respective periodic reports in accordance with the rules of the SEC. As a result, such companies were required to terminate
their registration status pursuant to the filing of a Form 15 or had their securities registration revoked by the SEC pursuant to Section
12(j) of the Exchange Act. Such companies may also have been delisted from their respective national securities exchanges.

 The
potential failure to timely file such information for our company would result in stockholders and/or prospective investors not having
complete current business and financial information about our company. Therefore, the potential occurrence of such an event could cause
the existence of inadequate public information available about our company to properly evaluate our common stock or the general status
of our company.

 Mr.
John G. Grdina, our President and Chief Executive Officer and Chairman of the Board, served as Chief Executive Officer and a director
of NOHO, Inc., and Mr. Staehr, our Chief Financial Officer, served as Chief Financial Officer of NOHO, Inc. from October 2013 to May
2015. During their respective tenures, NOHO, Inc. filed Forms 12b-25 notifying the public of the late filings of its (a) Form 10-K on
March 31, 2015; and (b) Forms 10-Q on the following dates: March 19, 2013; August 14, 2013; November 14, 2013; May 15, 2014; and November
14, 2014. NOHO, Inc. failed to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2014 and on May 19, 2015, NOHO,
Inc. filed a Form 15 to terminate its registration under Section 12(g) of the Exchange Act.

 Mr.
Staehr, our Chief Financial Officer, served as Chief Financial Officer for Mix 1 Life, Inc. from October 2016 to August 2018 and served
as the sole officer and director from February 2017 to August 2018. During his tenure, Mix 1 Life, Inc. filed Forms 12b-25 notifying
the public of the late filings of its (a) Form 10-K on November 30, 2016; and (b) Form 10-Q on January 17, 2017. Mix 1 Life, Inc. failed
to file its (a) Annual Report on Form 10-K for the fiscal year ended August 31, 2016; (b) Quarterly Reports on Form 10-Q for the quarterly
periods ended November 30, 2016, February 28, 2017, and May 31, 2017; (c) Annual Report on Form 10-K for the fiscal year ended August
31, 2017; (d) Quarterly Reports on Form 10-Q for the quarterly periods ended November 30, 2017, February 28, 2017, and May 31, 2017;
and (e) Annual Report on Form 10-K for the fiscal year ended August 31, 2018. On August 6, 2018, Mix 1 Life, Inc. filed a Form 15 to
terminate its registration under Section 12(g) of the Exchange Act.

 Mr.
McGuire, our Chief Operating Officer, served as President and Chief Executive Officer of Scio Diamond Technology Corporation from
June 14 until its acquisition by our company in September 2019. During his tenure, Scio Diamond Technology Corporation filed Forms
12b-25 notifying the public of the late filings of its (a) Forms 10-K on July 12, 2017; and (b) Forms 10-Q
on the following dates: November 14, 2016; August 14, 2017; November 15, 2017; and February 15, 2018. Scio Diamond Technology
Corporation failed to file its (a) Annual Report on Form 10-K for the fiscal year ended March 31, 2017; (b) Quarterly Reports on
Form 10-Q for the quarterly periods ended July 12, 2017, September 30, 2017, and December 31, 2017; (c) Annual Report on Form
10-K for the fiscal year ended March 31, 2018; (d) Quarterly Reports on Form 10-Q for the quarterly periods ended July 12,
2018, September 30, 2018, and December 31, 2018; and (e) Annual Report on Form 10-K for the fiscal year ended March 31, 2019.
Effective August 9, 2019, pursuant to Section 12(j) of the Exchange Act, the registration of each class of Scio Diamond Technology
Corporation's securities registered pursuant to Section 12 of the Exchange Act were revoked by the SEC.

 Mr.
Vassilakos, a director of our company, served on the Board of Directors of Cross Border Resources, Inc. from April 2012 to February 2016.
During his tenure, Cross Border Resources, Inc. filed Forms 12b-25 notifying the public of the late filings of its Forms 10-Q on November
15, 2013 and November 17, 2014. On August 14, 2015, Cross Border Resources, Inc. filed a Form 15 to terminate its registration under
Section 12(g) of the Exchange Act.

 Mr.
Vassilakos, a director of our company, served as interim President and Chief Executive Officer of Red Mountain Resources, Inc. from February
2011 to March 2011 and also served on the Board of Directors of Red Mountain Resources, Inc. from October 2011 to February 2016. During
his tenure, Red Mountain Resources, Inc. filed Forms 12b-25 notifying the public of the late filings of its Forms 10-Q on October 14,
2011 and November 12, 2014. On November 13, 2015, Red Mountain Resources, Inc. filed a Form 15 to terminate its registration under Section
12(g) of the Exchange Act.

 Our
Chairman of the Board, President and Chief Executive Officer has limited experience in the diamond gemstone and diamond industrial market.
and is not required to devote his full time and attention to our business, and there are significant potential conflicts of interest.

 Our
Chairman of the Board, President, and Chief Executive Officer, John G. Grdina, has spent most of his prior career in various aspects
of manufacturing, production, distribution, and marketing multiple products and categories. Mr. Grdina has limited experience in the
diamond gemstone or diamond industrial market.

 We
have a limited operating history and have incurred losses to date. We have only recently begun to generate revenue, and therefore it
is difficult to evaluate our business and prospects.

 Our
company is in its early stages of operation, is not a profitable enterprise, and may incur substantial losses for the foreseeable future.
As a company in the early stages of operation, our business is subject to all the risks inherent in a new business enterprise. We have
no substantial operating history for investors to consider in evaluating our business and prospects. When making the decision to invest
in our common stock, investors should consider the risks, expenses, and difficulties that we may encounter as a young company in a new
market with the assets of a company that has failed in the past. These risks include the following:

 our
need to fund and manage our rapidly developing and changing operations;

 our
need to expand our sales and marketing activities;

 our
 need to quickly hire and integrate new personnel, including various levels of senior management
 who have been hired relatively recently;

 our
ability to develop additional applications and markets for our lab-grown diamond gemstones and diamond materials;

 our
ability to produce lab-grown diamonds sufficient to meet anticipated demand in the gemstone marketplace;

 acceptance
of our lab-grown diamonds in the gemstone marketplace; and

 the
 need to further refine and improve our technology with respect to lab-grown diamond development,
 growing, and commercialization, including the need to make the diamond growing process commercially
 viable, acceptable (by our own and third-party measures), and economical, and our intellectual
 property and product offerings, and the need to respond to changing technologies and consumer
 preferences.

 The
lab-grown diamond gemstone and diamond materials market is a rapidly growing segment of the overall diamond market. Our business is subject
to the risks inherent in the transition of this market segment from early commercial production to mainstream alternative to mined diamonds.

 Our
failure to complete and integrate commercial development of our diamonds and to distribute them in sufficient quantities to meet market
demand would have a material adverse effect on our business, results of operations, financial condition, and prospects. Accordingly,
our prospects must be considered in light of the risks, expenses, and difficulties frequently encountered by companies in their early
stage of development, particularly technology-based companies operating with developing and unproven manufacturing processes.

 To
address these risks, we must, among other things, respond to competitive developments, attract and motivate qualified personnel, develop
market acceptance for our diamonds and diamond materials, establish effective distribution channels, effectively manage any growth that
may occur, and continue to upgrade and successfully commercialize our Diamond Technology and our products incorporating such technology.

 We
will require additional funding to support our current and future expanded operations.

 We
currently have limited cash and working capital to support our operations. Our future continuing operations will require additional funding,
and we may not be able to obtain such funding on acceptable terms or at all. We likely will require additional capital to be able to
fund continued development and improvement of the process for growing diamonds and to fund our expansion of manufacturing capacity to
meet projected growth of the market for our diamonds. There can be no assurance that such efforts for raising capital will not involve
substantial dilution with respect to our existing or future stockholders.

 Our
future capital requirements will depend on many factors, including the speed at which our production process can be scaled-up for high-yield
production, market acceptance of and demand for our diamonds, and the timing of our expansion into new diamond markets. Our future capital
requirements depend upon many factors, including, but not limited to:

 the
rate at which we increase our production capacity;

 the
rate at which we expand our sales and marketing operations;

 the
rate at which we attract consumers, distributors, and strategic relationships;

 the
extent to which we can develop and upgrade our technology and infrastructure; and

 the
response of competitors to our product offerings.

 We
expect significant additional financing to be required to meet these challenges and there can be no assurance that additional equity
or debt financing, if required, will be available on acceptable terms or at all. If we raise additional funds by selling stock, the percentage
ownership of our then current stockholders will be reduced, and we may raise these funds with securities that have rights, preferences,
or privileges equal or superior to the rights of investors owning our common stock. If we cannot raise adequate funds to satisfy our
capital requirements, we may have to limit our operations significantly, or we could terminate operations entirely, resulting in a complete
loss of investment for our stockholders. Our inability to obtain financing on acceptable terms when needed would have a material adverse
effect on our business, results of operations, financial condition, and prospects.

 Our
predecessors have attempted to commercialize our technology and have, for various reasons, failed, and our current business model has
only recently been implemented.

 We
produce lab-grown diamonds for retail gemstone consumption and diamond materials for specific industrial applications. Our predecessors
have attempted to commercialize our technology and have for various reasons (including lack of funding), failed. Although other companies
are selling lab-grown diamond gemstones, we believe that the market for such lab-grown diamonds has not been fully developed. Accordingly,
our business model may not be successful, and we may need to make substantial changes thereto. Our ability to generate significant revenue
will depend, in large part, on our ability to successfully market our product to consumers, distributors, and commercial customers. We
intend to continue to develop our business model as the market for our products evolves.

 We
are wholly dependent on our Diamond Technology, which has not been commercially proven.

 Our
diamond supply depends entirely on our ability to manufacture diamonds using our Diamond Technology. Although we have been able to produce
limited quantities of high-quality lab-grown diamond gemstones, we have yet to prove that we can transfer such success into a mass production
process that will yield high-quality gemstones and material suitable for retail gemstone distribution and commercial/industrial applications.
The inability or difficulty to transfer our Diamond Technology into a high-yield production facility would have a material adverse effect
on our business, results of operations, financial condition, and prospects. Our inability to produce high-quality lab-grown diamonds
would have a significant material adverse effect on our business, results of operations, financial condition, and prospects that would
likely result in our insolvency and the loss of your entire investment.

 Our
business is exposed to the risk of facility and equipment failures.

 Like
any manufacturing process, our business relies upon properly and efficiently run equipment and facilities. Over time, our facilities
and equipment may depreciate and degrade. Although we have a preventative maintenance program, we attempt to maintain our facilities
and equipment in proper working order and according to our equipment manufacturer's standards, and we attempt to mitigate risks
through redundancies where possible, there is still a risk of a potential failure in our facilities or equipment. Potential failures
may also arise from outside sources such as utility companies from whom we receive electricity, natural gas and water, all of which are
essential to our manufacturing processes. Such a failure could interrupt our production and have a significant material adverse effect
on our business, results of operations, financial condition, and prospects.

 Our
future revenue is unpredictable, and we expect the results of operations to fluctuate from period to period.

 Our
lack of long-term operating history and the emerging nature of the markets in which we expect to compete make it difficult for us to
accurately forecast revenue in any given period. As such, revenue could fall short of our expectations if we experience production delays
or difficulties. Likewise, revenue could fall short of expectations should our product not be met with the demand we anticipate from
the marketplace. We have limited experience in manufacturing diamonds and in financial planning for our business on which to base our
planned operating expenses.

 Our
results of operations are likely to fluctuate substantially from period to period because of a number of factors, many of which are beyond
our control. These factors include, but are not limited to, the following:

 our
ability to manufacture diamonds at all or that meet customer specifications or expectations;

 outside
market influences beyond our control, including extended periods of decreased demand for diamonds;

 our
ability to enter successful strategic relationships;

 our
ability to attract purchasers and/or distributors;

 the
amount and timing of operating costs and capital expenditures relating to expansion of production operations;

 the
rate at which individuals and organizations accept our diamonds;

 an
announcement or introduction of new or enhanced diamonds or services by our competitors;

 our
ability to attract and retain qualified personnel; and

 pricing
policies instituted by our current and possible future competitors.

 We
have generated minimal revenue to date, and consequently, our operations are subject to all risks inherent in the establishment of a
new business enterprise. We are currently generating minimal revenue and expect to begin generating revenue in the future, but there
can be no assurances that we will ever generate sufficient revenue to achieve profitability. If we do achieve profitability, there can
be no assurances that we can sustain or increase profitability.

 We
may not be able to establish effective distribution channels.

 We
initially intend to sell our diamonds in selected markets in the United States and internationally. We expect that we will be required
to enter into formal distribution agreements with, and will be dependent upon, several third parties for distribution and sales of our
diamonds. We have only begun to sell our diamonds directly to customers and have not yet entered into any formal distribution agreements.
Our initial sales for the twelve months ended September 30, 2023, have been primarily to a few customers. There can be no assurance that
we will be able to broaden our customer base and enter into distribution agreements with distributors or that our distribution strategy
will prove to be successful. Additionally, there can be no assurance that distributors will devote the efforts needed for successful
distribution of our diamonds. Our inability to enter into favorable arrangements with distributors or to achieve the desired distribution
of our diamonds would have a material adverse effect on our business, results of operations, financial condition, and prospects.

 Sales
of diamonds for industrial applications are dependent upon our ability to enter profitable relationships with businesses best able to
utilize the unique characteristics of diamonds. There is no assurance that we will be able to initiate and maintain these relationships.

 Our
Diamond Technology may be vulnerable to failure due to potential interruptions in the manufacturing process.

 Our
success depends, in part, on the performance, reliability, and availability of our Diamond Technology and the diamonds we ultimately
produce. Our Diamond Technology and the diamonds produced thereby may be vulnerable to failure or interruption. The failure of our Diamond
Technology or the diamonds produced thereby could adversely affect our business. The process for manufacturing diamonds using our Diamond
Technology is vulnerable to disruptions due to a variety of factors, including availability of stable power, availability of lab-grade
purity gases, availability of diamond seeds, availability of proprietary diamond growing machine parts that wear out over time, and failure
of factory systems like cooling, which may lead to interruptions, delays, and losses of opportunities or inability to consistently market
and sell our lab-grown diamonds. The occurrence of any of the foregoing could have a material adverse effect on our business, results
of operations, financial condition, and prospects.

 We
may need to effectively manage the rapid growth of our operations.

 Our
ability to successfully offer diamonds and to implement our business plan in new markets requires an effective planning and management
process. We are in the process of increasing our operations and anticipate having to increase our headcount as well. Increasing our operations
and potentially experiencing rapid growth would place a significant strain on our management systems, infrastructure, and resources.
We will need to continue to improve our financial and managerial controls and reporting systems and procedures, and will need to continue
to expand, train, and manage our workforce.

 Furthermore,
we may be required to manage an increasing number of relationships with various diamond industry companies, customers, and other third
parties. Any failure to expand any of the foregoing areas efficiently and effectively could cause our business to suffer. We could experience
a period of rapid and significant growth, which could continue over several years. We believe rapid growth would place a significant
strain on our resources. Our ability to manage growth effectively will require us to implement and improve operational and financial
systems and to expand, train, and manage our employee base. We also may be required to manage multiple relationships with various suppliers,
customers, and other third parties. Our future results of operations will also depend on our ability to expand sales and marketing, research
and development, and administrative support organizations. If we were unable to manage growth effectively, our business, financial condition,
results of operations, and prospects would be materially adversely affected.

 We
may not be successful in hiring additional personnel because of the competitive market for qualified people.

 Our
future success depends on our ability to identify, attract, hire, train, retain, and motivate highly skilled and qualified executives,
technical, managerial, sales and marketing, and business development personnel. We intend to hire a number of executives, technical,
sales and marketing, business development, and administrative personnel during the next one or two years. Competition for qualified personnel
may prove intense. If we fail to successfully attract, assimilate, and retain a sufficient number of qualified executives, technical,
sales and marketing, business development and administrative personnel, our business could suffer.

 Our
future success also depends on our ability to identify, attract, hire, train, retain, and motivate highly skilled and qualified personnel
to develop and manufacture our products. Competition for such personnel may be intense. There can be no assurance that we will be successful
in attracting and retaining the specific personnel we will require to conduct and expand our operations successfully or to differentiate
us from our competitors. The results of operations and growth prospects could be materially adversely affected if we were unable to identify,
attract, hire, retain, and motivate such qualified personnel.

 Our
success depends upon achieving a critical mass of customers and strategic relationships.

 Our
success is largely dependent upon achieving significant market acceptance for our diamonds. The market for our diamonds is at an early
stage of development. Lab-grown diamonds as a category is just beginning to be accepted at a mass market level in jewelry. We need to
build market awareness and acceptance for our diamonds in that segment. In the industrial segment, we need to also build awareness and
acceptance for our particular products in various applications. Although we believe that our diamonds will ultimately achieve broad market
acceptance, our existing and potential competitors may offer diamonds that could negatively affect the market acceptance of our product
and damage our business prospects.

 Our
success is also dependent upon attracting significant numbers of distributors and forming strategic relationships to market our diamonds.
Our ability to enter into beneficial distribution partnerships will depend in large part upon our success in convincing diamond gemstone
consumers that our lab- grown diamond gemstones are of a desired quality. Failure to achieve and maintain a critical mass of market acceptance
will seriously harm our business in the diamond gemstone industry.

 Our
insurance policies may not cover all potential losses.

 We
maintain insurance coverage for general liability, property, directors' and officers' liability coverage, and other risks with
respect to business operations. While we have comprehensive property and liability insurance policies with coverage features and insured
limits that we believe are customary, market forces beyond our control may limit the scope of the insurance coverage we can obtain or
our ability to obtain coverage at reasonable rates. The cost of our insurance may increase, and our coverage levels may decrease, which
may affect our ability to maintain customary insurance coverage and deductibles at acceptable costs. There is a limit as well as various
sub-limits on the amount of insurance proceeds we will receive in excess of applicable deductibles. If an insurable event occurs that
affects more than one of our properties, the claims from each affected property may be considered together to determine whether the per
occurrence limit, annual aggregate limit, or sub-limits, depending on the type of claim, have been reached. If the limits or sub-limits
are exceeded, each affected property may only receive a proportional share of the amount of insurance proceeds provided for under the
policy. Further, certain types of losses, generally of a catastrophic nature, such as earthquakes, hurricanes and floods, war, terrorist
acts, such as biological or chemical terrorism, political risks, some environmental hazards, and/or natural or manmade disasters, may
be outside the general coverage limits of our policy, subject to large deductibles, deemed uninsurable, or too cost-prohibitive to justify
insuring against. In addition, in the event of a substantial loss, the insurance coverage we carry may not be sufficient to pay the full
market value or replacement cost of the affected property or in some cases may not provide a recovery for any part of a loss. As a result,
we could lose some or all the capital we have invested in a property.

 We
are currently operating in a period of economic uncertainty and capital markets disruption, which has been significantly impacted by
geopolitical instability due to the ongoing invasion of Ukraine by Russia.

 U.S.
and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions and Russia's launch
of a full-scale military invasion of Ukraine in February 2022. Although the length and impact of the ongoing military conflict is highly
unpredictable, the war in Ukraine has led to market disruptions, including significant volatility in commodity prices, credit, and capital
markets. Additionally, Russia's prior annexation of Crimea, recent recognition of two separatist republics in the Donetsk and Luhansk
regions of Ukraine, and subsequent military invasion in Ukraine have led to sanctions and other penalties being levied by the United
States, the European Union, and other countries against Russia, Belarus, the Crimea Region of Ukraine, the so-called Donetsk People's
Republic, and the so-called Luhansk People's Republic, including the agreement by the U.S. and the EU to remove certain Russian
financial institutions from the Society for Worldwide Interbank Financial Telecommunication (SWIFT) payment system. Additional potential
sanctions and penalties have also been proposed and/or threatened. Russian military actions and the resulting sanctions could adversely
affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets, potentially making
it more difficult for us to obtain additional equity or debt funding. Any of the abovementioned factors could affect our business, prospects,
financial condition, and operating results. The extent and duration of the war, sanctions, and resulting market disruptions are impossible
to predict, but could be substantial. Any such disruptions may also magnify the impact of other risks described herein.

 In
addition, as a result of the ongoing conflict between Russia and Ukraine, we may experience other risks, difficulties and challenges
in the way we conduct our business and operations generally. For example, there may be an increased risk of cybersecurity attacks due
to the current conflict between Russia and Ukraine, including cybersecurity attacks perpetrated by Russia or others at its direction
in response to economic sanctions and other actions taken against Russia as a result of its invasion of Ukraine. Any increase in such
attacks on us or our third-party providers or other systems could adversely affect our network systems or other operations. At this time,
to the best of our knowledge, we do not believe we have experienced any cyberattacks that are related to the conflict between Russia
and Ukraine. Although we have taken steps to enhance our protections against such attacks, including removing internet connectivity from
our diamond growing machines and laser machines and using fully encrypted file share facilities, we may not be able to address these
cybersecurity threats proactively or implement adequate preventative measures and there can be no assurance that we will promptly detect
and address any such disruption or security breach, if at all.

 A
protracted conflict between Ukraine and Russia, any escalation of that conflict, and the financial and economic sanctions and import
and/or export controls imposed on Russia by the United States, the UK, the EU, Canada and others, and the above-mentioned adverse effect
on our operations (both in this region and generally) and on the wider global economy and market conditions could, in turn, have a material
adverse impact on our business, financial condition, cash flows and results of operations and could cause the market value of our common
shares to decline.

 The
current and future state of the global economy may curtail our operations and our anticipated revenue.

 Our
business may be adversely affected by changes in domestic and international economic conditions, including inflation, changes in consumer
preferences and changes in consumer spending rates, personal bankruptcy, and the ability to collect our accounts receivable. Changes
in global economic conditions may adversely affect the demand for our products and make it more difficult to collect accounts receivable,
thereby negatively affecting our business, results of operations, financial condition, and prospects. The recent disruptions in credit
and other financial markets and deterioration of national and global economic conditions could, among other things, impair the financial
condition of some of our customers and suppliers, thereby increasing customer bad debts, decreasing customers' ability to spend
disposable income on luxury items such as jewelry, or non-performance by suppliers. Additionally, consumers may significantly prefer
mined diamonds over our lab-grown diamonds, which would significantly diminish anticipated sales.

 Acts
of war, terrorism, or other unknown and unexpected events could disrupt our business and we could be required to cease our operations.

 Involvement
in a war or other military action or acts of terrorism may cause significant disruption to commerce throughout the world. To the extent
that such disruptions result in (i) delays or cancellations of customer orders, (ii) a general decrease in consumer spending, (iii) our
inability to effectively market and distribute our products, or (iv) our inability to access capital markets, our business, results of
operations, financial condition, and prospects could be materially and adversely affected. We are unable to predict whether the involvement
in a war or other military action will result in any long-term commercial disruptions or if such involvement or responses will have any
long-term material adverse effect on our business, results of operations, financial condition, or prospects.

 Changes
to accounting rules or regulations may adversely affect our reported financial condition and results of operations.

 New
accounting rules or regulations and varying interpretations of existing accounting rules or regulations have occurred and may occur in
the future. A change in accounting rules or regulations may require retrospective application and affect our reporting of transactions
completed before the change is effective, and future changes to accounting rules or regulations may adversely affect our reported financial
condition and results of operations.

 We
may incur impairment charges related to the fair value of our assets.

 Changes
to estimates or projections used to assess the fair value of our assets or results of operations that are lower than our current estimates
may cause us to incur impairment losses and require us to write-off all or a portion of the remaining value of our goodwill or other
tangible and intangible assets.

 Our
total assets include goodwill and other intangible assets. As of September 30, 2023, of our total assets, approximately 44.6%
is goodwill and other intangible assets. We evaluate our goodwill and other intangible assets for impairment on an annual basis or at
other times during the year if events or circumstances indicate that it is more likely than not that the fair value is below the carrying
value. We may be required to record a significant non-cash impairment charge in our financial statements during the period in which any
impairment of our goodwill, other intangible assets or other assets is determined, negatively impacting our results of operations and
stockholders' equity.

 Use
of social media and influencers may materially and adversely affect our reputation or subject us to fines or other penalties.

 We
plan to expand our use of third-party social media platforms as marketing tools for our diamond gemstones. For example, we plan to further
establish and maintain Instagram, Snapchat, Facebook, Twitter, TikTok, and Pinterest accounts, as well as our channel on YouTube and
Spotify. We also plan to establish and maintain relationships with social media influencers. As existing e-commerce and social media
platforms continue to rapidly evolve and new platforms develop, we must continue to maintain a presence on these platforms and establish
presences on new or emerging popular social media platforms. If we are unable to cost-effectively use social media platforms as marketing
tools or if the social media platforms, we use do not evolve quickly enough for us to fully optimize such platforms, our ability to acquire
new consumers and our financial condition may suffer. Furthermore, as laws and regulations rapidly evolve to govern the use of these
platforms and devices, the failure by us, our employees, our network of social media influencers, our sponsors, or third parties acting
at our direction to abide by applicable laws and regulations in the use of these platforms and devices or otherwise could subject us
to regulatory investigations, class action lawsuits, liability, fines, or other penalties and have a material adverse effect on our business,
financial condition, results of operations, and prospects.

 In
addition, an increase in the use of social media for marketing may cause an increase in the burden on us to monitor compliance of such
materials and increase the risk that such materials could contain problematic product or marketing claims in violation of applicable
regulations. For example, in some cases, the United States Federal Trade Commission, or the FTC, has sought enforcement action where
an endorsement has failed to clearly and conspicuously disclose a material relationship between an influencer and an advertiser. While
we will ask influencers to comply with the FTC regulations, we may not be able to regularly monitor what our influencers post, and if
we were held responsible for the content of their posts, we could be forced to alter our practices, which could have material adverse
effect on our business, financial condition, results of operations, and prospects.

 We
are subject to risks related to corporate social responsibility.

 Many
factors influence our reputation and the value of our brand, including the perception held by our stakeholders and the industries in
which we do business. Our business faces increasing scrutiny related to environmental, social, and governance activities and risk of
damage to our reputation and the value of our brands if we fail to act responsibly or comply with regulatory requirements in several
areas, such as safety and security, environmental stewardship and sustainability, supply chain management, climate change, diversity,
human rights, philanthropy, and support for local communities.

 The
costs of being a public company could result in us being unable to continue as a going concern.

 As
a public company, we will be required to comply with numerous financial reporting and legal requirements, including those pertaining
to audits and internal control. The costs of maintaining all public company reporting requirements could be significant and may preclude
us from seeking financing or equity investment on terms acceptable to us and our stockholders. If our revenue is insufficient or non-existent,
and/or we cannot satisfy many of these costs through the issuance of shares or debt, we may be unable to satisfy these costs in the normal
course of business. This would certainly result in our being unable to continue as a going concern.

 We
may not have or ever have the resources or ability to implement and manage our growth strategy.

 Although
we expect to experience growth based on the ability to implement and execute our business strategy, significant operations may never
occur because the business plan may never be fully implemented because of the lack of funds to do so. If our growth strategy is implemented,
of which no assurances can be provided, a significant strain on management, operating systems, or financial resources may be imposed.
Failure by our management to manage this expected growth, if it occurs, or unexpected difficulties encountered during this growth, could
have a material adverse impact on the results of operations or financial condition.

 Our
ability to operate profitable revenue generating products (if we are able to establish any product lines at all) will depend upon a number
of factors, including (i) identifying appropriate and satisfactory sales channels; (ii) generating sufficient funds from our then-existing
operations or obtaining third-party financing or additional capital to develop new product lines; (iii) our management team and our financial
and accounting controls; and (iv) staffing, training, and retention of skilled personnel, if any at all. These factors most likely will
be beyond our control and may be adversely affected by the economy or actions taken by competing businesses. There can be no assurance
that we will be able to execute and manage a growth strategy effectively or at all.

 Our
internal controls may be inadequate, which could cause our financial reporting to be unreliable and lead to misinformation being disseminated
to the public.

 Our
management is responsible for establishing and maintaining adequate internal control over our financial reporting. As defined in Rule
13a-15(f) of the Exchange Act, internal control over financial reporting is a process designed by, or under the supervision of, the principal
executive and principal financial officer and effected by our Board of Directors, management, and other personnel, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles, or GAAP, and includes those policies and procedures that:

 pertain
to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;

 provide
reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP,
and that our receipts and expenditures are being made only in accordance with authorizations of our management and/or directors; and

 provide
reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could
have a material effect on the financial statements.

 Our
internal controls may be inadequate or ineffective, which could cause financial reporting to be unreliable and lead to misinformation
being disseminated to the public. Investors relying upon this misinformation may make an uninformed investment decision.

 Failure
to achieve and maintain an effective internal control environment could cause us to face regulatory action and also cause investors to
lose confidence in our reported financial information, either of which could have a material adverse effect on our business, financial
condition, results of operations, and prospects.

 Regulatory
Risks

 Our
business is extensively regulated, and any failure to comply with applicable laws could materially adversely affect our business.

 Certain
federal and state laws and regulations govern the testing, creation, and sale of the types of diamonds we intend to produce. The FTC
and other comparable regulatory authorities in the United States and in foreign countries may extensively and rigorously regulate our
lab-grown diamonds, product development activities, manufacturing processes, advertising, and sales. In the United States, the FTC regulates
the introduction and labeling of gemstone diamonds. We may be required to:

 obtain
clearance before we can market and sell our lab-grown diamond gemstones;

 describe
our products consistent with the FTC guidelines in marketing and sales material;

 satisfy
content requirements applicable to our labeling, sales, and promotional materials;

 comply
with manufacturing and reporting requirements; and

 undergo
rigorous inspections.

 Further,
we may be subject to regulatory requirements in the future. Government authorities can withdraw marketing clearance due to our failure
to comply with regulatory standards or due to the occurrence of unforeseen problems following initial clearance. Ongoing regulatory requirements
are wide- ranging and govern, among other things:

manufacturing;

 annual
inspections related to International Organization for Standardization, or ISO, certification of our quality system;

 supplier
substitution;

changes;

 process
modifications;

 the
process of assuring origin of mine and/or production of diamonds;

 lab-grown
diamond gemstone reporting and disclosure; and

sales and distribution.

 Various
government agencies may inspect our facilities from time to time to determine whether we comply with applicable laws and regulations.
Additionally, if we fail to comply or maintain compliance with laws and regulations pertaining to diamond gemstones, regulatory authorities
may fine us and bar us from selling our lab-grown diamond gemstones. If a regulatory agency believes we are not in compliance with such
laws or regulations, it may be able to:

 seize
our lab-grown diamond gemstones;

 require
a recall;

 withdraw
previously granted market clearances;

 implement
procedures to stop future violations; and/or

 seek
civil and criminal penalties against us.

 The former stockholders of Scio have brought
a suit against the former directors of Scio and current management of Adamas.

 On January 10, 2023, the Company
was joined as a defendant to an existing lawsuit in the United States District Court for the District of Nevada (case no. 2:22-cv-00256)
between Theodorus Strous, a shareholder of Scio Diamond Technology Corp. ("Scio"), and Scio executives, brought as a proposed
derivative shareholder class action. The second amended complaint added the Company and John G. Grdina as defendants, expanding the claim
to assert a proposed derivative shareholder class action against the Company as well as Scio.

 The Company retained outside counsel
and filed a motion to dismiss and joined in Scio's motion to dismiss on February 17, 2023. Specifically, the Company believes it
was mis-joined to the lawsuit and that no claims are adequately pled against it. The Company further contends that the court lacks subject
matter jurisdiction. The case was re-assigned to Hon. Cristina D. Silva. Judge Silva's on July 5, 2023. After a long period of delay,
on June 14, 2024, the court ordered additional briefing on the argument based on the Company's motion to dismiss for lack of subject
matter jurisdiction, signaling we believe the court was inclined to dismiss the entire case for lack of subject matter jurisdiction. The
briefing was to commence on June 28, 2024. Largely, as a result of the court's inclination to dismiss, on June 28, 2024, the Plaintiff
stipulated to dismiss the claims against the Company, Mr. Grdina, and Scio's management and filed a voluntary dismissal of all of
the claims.

 Future
litigation against us, which may arise in the ordinary course of our business, could be costly and time- consuming to defend.

 We
are subject to claims that arise in the ordinary course of business, such as claims brought in connection with commercial disputes, employment
claims made by our current or former employees, or claims brought by third parties for product liability. Third parties may in the future
assert intellectual property rights to technologies that are important to our business and demand back royalties or demand that we license
their technology. Litigation may result in substantial costs and may divert management's attention and resources, which may seriously
harm our business, overall financial condition, and operating results. Insurance may not cover such claims, may not be sufficient for
one or more of such claims, and may not continue to be available on terms acceptable to us. A claim brought against us that is uninsured
or underinsured could result in unanticipated costs, negatively affecting our business, results of operations, financial condition, and
prospects.

 Risks
Related to our Common Stock

 Claims
for indemnification by our directors and officers may reduce our available funds to satisfy successful stockholder claims against us
and may reduce the amount of money available to us.

 As
permitted by Section 78.7502 of Chapter 78 of the Nevada Revised Statutes, or the NRS, our amended and restated articles of incorporation
limit the liability of our directors to the fullest extent permitted by law. In addition, as permitted by Section 78.7502 of the NRS,
our amended and restated articles of incorporation and amended and restated bylaws provide that we shall indemnify, to the fullest extent
authorized by the NRS, any person who is involved in any litigation or other proceeding because such person is or was a director or officer
of ours or is or was serving as an officer or director of another entity at our request, against all expense, loss, or liability reasonably
incurred or suffered in connection therewith. Our amended and restated articles of incorporation provide that indemnification includes
the right to be paid expenses incurred in defending any proceeding in advance of its final disposition; provided, however, that such
advance payment will only be made upon delivery to us of an undertaking, by or on behalf of the director or officer, to repay all amounts
so advanced if it is ultimately determined that such director is not entitled to indemnification. Section 78.7502 of the NRS permits
a corporation to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending, or completed
action, suit, or proceeding, whether civil, criminal, administrative, or investigative, except an action by or in the right of us, by
reason of the fact that the person is or was a director, officer, employee, or agent of ours, or is or was serving at our request as
a director, officer, employee, or agent of another company, partnership, joint venture, trust, or other enterprise, against expenses,
including attorneys' fees, judgment, fines, and amounts paid in settlement actually and reasonably incurred by the person in connection
with the action, suit, or proceeding if the person is not liable under Section 78.138 of the NRS, or acted in good faith and in a manner
which he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal
action or proceeding, had no reasonable cause to believe the conduct was unlawful.

 The
above limitations on liability and our indemnification obligations limit the personal liability of our directors and officers for monetary
damages for breach of their fiduciary duty as directors by shifting the burden of such losses and expenses to us. Certain liabilities
or expenses covered by our indemnification obligations may not be covered by our directors' and officers' insurance policy
or the coverage limitation amounts may be exceeded. As a result, we may need to use a significant amount of our funds to satisfy our
indemnification obligations, which could severely harm our business and financial condition and limit the funds available to stockholders
who may choose to bring a claim against us.

 We
may be unable to maintain our listing, and an active trading market may not be sustained.

 Our
common stock began trading on the Nasdaq Capital Market on December 9, 2022. There can be no assurance that we will meet the listing
requirements in the future or maintain an active public trading market for our common stock. In the absence maintaining our Nasdaq listing
or an active trading market:

 investors
may have difficulty buying and selling or obtaining market quotations;

 market
visibility for shares of our common stock may be limited; and

 a
lack of visibility for shares of our common stock may have a depressive effect on any market price for our shares of common stock that
might develop.

 We
currently trade our common stock on the Nasdaq Capital Market. There can be no assurance that we will be able to maintain the listing
of our shares on the Nasdaq Capital Market.

 The
lack of an active market would impair your ability to sell your shares at the time you wish to sell them or at a price that you consider
reasonable. The lack of an active market may also reduce the fair market value of your shares. An inactive market may also impair our
ability to raise capital to continue to fund operations by selling shares of our common stock and may impair our ability to acquire additional
intellectual property assets by using our shares of common stock as consideration.

 Our
stock price may be volatile, and you may not be able to sell shares of our common stock at or above the price you paid.

 The
trading price of our common stock is likely to be highly volatile and could be subject to wide fluctuations in response to various factors,
some of which are beyond our control. Such factors include the following:

 actual
or anticipated fluctuations in our results of operations;

 announcements
by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, collaborations, or capital commitments;

 failure
to meet or exceed financial estimates and projections of the investment community or that we provide to the public;

 issuance
of new or updated research or reports by securities analysts or changed recommendations for our stock;

 our
focus on long-term goals over short-term results;

 the
timing of our investments in the growth of our business;

 actual
or anticipated changes in regulatory oversight of our business;

 additions
or departures of key management or other personnel;

 disputes
or other developments related to our intellectual property or other proprietary rights, including litigation; and

 general
economic and market conditions.

 In
addition, the stock market in general has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate
to the operating performance of those companies. Broad market and industry factors may seriously affect the market price of our common
stock, regardless of our actual operating performance. These fluctuations may be even more pronounced in the trading market for our stock
shortly following this offering. In addition, in the past, following periods of volatility in the overall market and the market price
of a particular company's securities, securities class action litigation has often been instituted against these companies. This
litigation, if instituted against us, could result in substantial costs and a diversion of our management's attention and resources.

 If
securities or industry analysts do not publish research or publish unfavorable or inaccurate research about our business, our common
stock price and trading volume could decline.

 Our
stock price and trading volume will be heavily influenced by the way analysts and investors interpret our financial information and other
disclosures. If securities or industry analysts do not publish research or reports about our business, delay publishing reports about
our business, or publish negative reports about our business, regardless of accuracy, our common stock price and trading volume could
decline.

 The
trading market for our common stock will depend, in part, on the research and reports that securities or industry analysts publish about
us or our business. We do not have any control over these analysts. We expect that only a limited number of analysts will cover our company
following our initial public offering. If the number of analysts that cover us declines, demand for our common stock could decrease and
our common stock price and trading volume may decline.

 Even
if our common stock is actively covered by analysts, we do not have any control over the analysts or the measures that analysts or investors
may rely upon to forecast our future results. Over-reliance by analysts or investors on any particular metric to forecast our future
results may result in forecasts that differ significantly from our own.

 Regardless
of accuracy, unfavorable interpretations of our financial information and other public disclosures could have a negative impact on our
stock price. If our financial performance fails to meet analyst estimates, for any of the reasons discussed above or otherwise, or one
or more of the analysts who cover us downgrade our common stock or change their opinion of our common stock, our stock price would likely
decline.

 We
will continue to incur significantly increased costs as a result of operating as a public company, and our management will be required
to devote substantial time to new compliance initiatives.

 As
a public company, we incur significant legal, accounting, insurance, and other expenses that we did not incur as a private company.
For example, we incur increased legal and accounting costs as a result of being subject to the information and reporting
requirements of the Exchange Act and other federal securities laws. The costs of preparing and filing periodic and other reports,
proxy statements, and other information with the SEC and furnishing audited reports to stockholders will cause a significant
increase in our expenses than if we remained privately held. The cost of being a public company will divert continue resources that
might otherwise have been used to develop our business, which could have a material adverse effect on our company.

 As
a public company, we are required to comply with certain corporate governance and financial reporting practices and policies required
of a public reporting company. We are required to file with the SEC annual and quarterly information and other reports pursuant to the
Exchange Act. We are also required to ensure that we have the ability to prepare financial statements that are fully compliant with all
SEC reporting requirements on a timely basis. In addition, we will be subject to other reporting and corporate governance requirements,
including the requirements of the Nasdaq exchange on which our common stock is listed., and certain provisions of the Sarbanes-Oxley
Act and the regulations promulgated thereunder, which will impose significant compliance obligations upon us. As a public company, we,
among other things, were required to do the following:

 prepare
and distribute periodic public reports and other stockholder communications;

 comply
with our obligations under the federal securities laws and applicable listing rules;

 create
or expand the roles and duties of our board of directors and committees of the board of directors;

 institute
more comprehensive financial reporting and disclosure compliance functions;

 enhance
our investor relations function;

 establish
new internal policies, including those relating to disclosure controls and procedures; and

 involve
and retain to a greater degree outside counsel and accountants in the activities listed above.

 We
may not be successful in complying with these obligations, and the significant commitment of resources required for complying with them
could have a material adverse effect on our business, results of operations, financial condition, and prospects. These laws and regulations
could also make it more difficult or costly for us to obtain certain types of insurance, including director and officer liability insurance,
and we may be forced to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage.
These laws and regulations could also make it more difficult for us to attract and retain qualified people to serve on our board of directors,
on the committees of our board of directors, or as our executive officers.

 In
addition, if we fail to implement the requirements with respect to our internal accounting and audit functions, our ability to report
our results of operations on a timely and accurate basis could be impaired and we could suffer adverse regulatory consequences or violate
applicable listing standards. There could also be a negative reaction to our stock price due to a loss of investor confidence in us and
the reliability of our financial statements, which could have a material adverse effect on our business, results of operations, financial
condition, and prospects.

 These
changes require a significant commitment of resources and management supervision that has increased and may continue to increase our
costs and might place a strain on our management, systems, and resources. As a result, our management's attention might be diverted
from other business concerns. If we fail to maintain an effective internal control environment or to comply with the numerous legal and
regulatory requirements imposed on public companies, we could make material errors in, and be required to restate, our financial statements.
Any such restatement could result in a loss of public confidence in the reliability of our financial statements and sanctions imposed
on us by the SEC. We cannot predict or estimate the amount of additional costs we may incur in the future or the timing of such costs.
If we are unable to satisfy our obligations as a public company, we could be subject to delisting of our common stock, fines, sanctions,
and other regulatory action and potentially civil litigation.

 Provisions
in our corporate charter documents and under Nevada law could make acquiring us more difficult and may prevent attempts by our stockholders
to replace or remove our current management.

 Provisions
in our amended and restated articles of incorporation and amended and restated bylaws may discourage, delay or prevent a merger, acquisition
or other change in control of us that stockholders may consider favorable, including transactions in which stockholders might otherwise
receive a premium for their shares. These provisions could also limit the price that investors might be willing to pay in the future
for shares of our common stock, thereby reducing the market price of our common stock. In addition, these provisions may frustrate or
prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to
replace members of our Board of Directors. Because our Board of Directors is responsible for appointing the members of our management
team, these provisions could in turn affect any attempt by our stockholders to replace current members of our management team. Among
others, these provisions include the following:

 our
 Board of Directors has the right to elect directors to fill a vacancy created by the expansion
 of our Board of Directors or the resignation, death, or removal of a director, which will
 prevent stockholders from being able to fill vacancies on our Board of Directors;

 our
 amended and restated articles of incorporation prohibit cumulative voting in the election
 of directors, which limits the ability of minority stockholders to elect director candidates;
 and

 our
 Board of Directors can issue, without stockholder approval, shares of undesignated preferred
 stock, which makes it possible for our Board of Directors to issue preferred stock with voting
 or other rights or preferences that could impede the success of any attempt to acquire us.

 These
provisions may also frustrate or prevent any attempts by our stockholders to replace or remove our current management or members of our
Board of Directors.

 In
addition, we are subject to Nevada's statute on combinations with interested stockholders (Sections 78.411—78.444 of the NRS),
which prohibits us from entering into a "combination" with an "interested stockholder" for up to four years, unless
certain conditions are met (such as, in some circumstances, approval by our Board of Directors before such person became an interested
stockholder, or by both our Board of Directors and a supermajority of the disinterested stockholders). Under the statute, an interested
stockholder is a person who beneficially owns (or, if one of our affiliates or associates did, within the prior two years, beneficially
own) stock with 10% or more of the corporation's voting power. The inability of an interested stockholder to pursue the types of
combinations restricted by the statute could discourage, delay or prevent a merger, acquisition or other change in control of our company.

 Finally,
a person acquiring a significant proportion of our voting stock could be precluded from voting all or a portion of such shares under
Nevada's "control share" statute (Sections 78.378—78.3793 of the NRS), which prohibits an acquirer of stock, under
certain circumstances, from voting its "control shares" of stock acquired up to 90 days prior to crossing certain ownership
threshold percentages, unless the acquirer obtains approval of the disinterested stockholders or unless the issuing corporation amends
its articles of incorporation or bylaws within 10 days of the acquisition to provide that the "control share" statute does
not apply to the corporation or the types of existing or future stockholders. If the voting rights are not approved, the statute would
allow us to call all of such control shares for redemption at the average price paid for such shares.

 We
do not expect to pay cash dividends in the foreseeable future.

 We
have never paid cash dividends on our common stock. We do not expect to pay cash dividends on our common stock at any time in the foreseeable
future. The future payment of dividends directly depends upon our future earnings, capital requirements, financial requirements, and
other factors that our Board of Directors will consider. Accordingly, your only opportunity to achieve a return on your investment in
our company may be if the market price of our common stock appreciates and you sell your shares at a profit. The market price for our
common stock may never exceed, and may fall below, the price that you pay for such common stock.

 We
may require additional capital in the future and such additional capital may not be available to us, or only available to us on unfavorable
terms.

 To
the extent that the funds generated by our ongoing operations and capital remaining at our company are insufficient to fund future operating
requirements, we may need to raise additional funds through financings or curtail our growth. We cannot be sure that we will be able
to raise equity or debt financing on terms favorable to us and our stockholders in the amounts that we require, or at all. If we cannot
obtain adequate capital, our business, financial condition, results of operations and prospects could be materially and adversely affected.

 In
addition, the terms of a capital raising transaction could require us to agree to stringent financial and operating covenants and to
grant security interests on our assets to lenders or holders of our debt securities that could limit our flexibility in operating our
business or our ability to pay dividends on our common stock and could make it more difficult for us to obtain capital in the future.

 Future
sales and issuances of our capital stock or rights to purchase capital stock could result in additional dilution of the percentage ownership
of our stockholders and could cause the price of our common stock to decline.

 We
may issue additional securities. Future sales and issuances of our capital stock or rights to purchase our capital stock could result
in substantial dilution to our existing stockholders. We may sell common stock, convertible securities, and other equity securities in
one or more transactions at prices and in a manner as we may determine from time to time. If we sell any such securities in subsequent
transactions, investors may be materially diluted. New investors in such subsequent transactions could gain rights, preferences, and
privileges senior to those of holders of our common stock.

 The
concentration of ownership of our common stock among our executive officers and directors will prevent new investors from influencing
significant corporate decisions.

 Based
on our common stock outstanding as of September 30, 2023, our executive officers and directors will, in the aggregate, beneficially own
approximately 27.5% of our outstanding common stock. Mr. Grdina, our President, Chief Executive Officer, and Chairman of the Board,
beneficially owns approximately 21.76% of our outstanding common stock is able to significantly influence all matters requiring
stockholder approval, including the election and removal of directors and any merger or other significant corporate transactions. The
interests of Mr. Grdina may not coincide with the interests of other stockholders, and he may vote in a way with which you disagree and
that may be adverse to your interests.

 In
addition, Mr. Grdina's concentration of ownership could have the effect of delaying or preventing a change in control or otherwise
discouraging a potential acquirer from attempting to obtain control of us, which could cause the market price of our common stock to
decline or prevent our other stockholders from realizing a premium over the market price for their common stock. In addition, because
our principal stockholders acquired their shares at prices substantially below the price at which shares are being sold in this offering
and have held their shares for a longer period, they may want us to pursue strategies that deviate from the interests of other stockholders.
Moreover, while Mr. Grdina has committed to devote his full time and attention to our business for a minimum of 40 hours per week, his
employment agreement does not expressly require him to do so. Due to the lack of restrictions in his employment agreement and because
he has other investments, he may pursue other employment or business opportunities, including acquisitions, which may be directly or
indirectly competitive with our business. Investors should consider that the interests of Mr. Grdina may differ from their interests
in material respects.

 We
are both an "emerging growth company" and a "smaller reporting company," and our compliance with the reduced reporting
and disclosure requirements applicable to "emerging growth companies" and "smaller reporting companies" may make
our common stock less attractive to investors.

 We
are an "emerging growth company," as defined in the JOBS Act, and we have elected to take advantage of certain exemptions and
relief from various reporting requirements that are applicable to other public companies that are not emerging growth companies. These
provisions include being permitted to have only two years of audited financial statements and management's discussion and analysis
of financial condition and results of operations disclosures in this 10K; being exempt from compliance with the auditor attestation requirements
of Section 404(b) of the Sarbanes-Oxley Act; being exempt from any rules that could be adopted by the Public Company Accounting Oversight
Board requiring mandatory audit firm rotations or a supplement to the auditor's report on financial statements; being subject to
reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements; and not being required
to hold nonbinding advisory votes on executive compensation or on any golden parachute payments not previously approved.

 We
may remain an emerging growth company until as late as September 30, 2026, the fiscal year-end following the fifth anniversary of the
completion of this offering, though we may cease to be an emerging growth company earlier under certain circumstances, including if (i)
we have more than $1.235 billion in annual revenues in any fiscal year, (ii) we become a "large accelerated filer," with at
least $700.0 million of equity securities held by non-affiliates as of the end of the second quarter of that fiscal year, or (iii) we
issue more than $1.0 billion of non-convertible debt securities over a three-year period. If some investors find our common stock less
attractive as a result of us utilizing some or all of these exemptions or forms of relief, there may be a less active trading market
for our common stock, and our stock price may decline or become more volatile.

 Under
the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards
apply to private companies. We have elected to take advantage of the extended transition period to comply with new or revised accounting
standards. As a result of the accounting standards election, we will not be subject to the same implementation timing for new or revised
accounting standards as other public companies that are not emerging growth companies, which may make comparison of our financials to
those of other public companies more difficult.

 We
are also a "smaller reporting company," meaning that the market value of our stock held by non-affiliates is less than $700.0
million and our annual revenue is less than $100.0 million during the most recently completed fiscal year. We may remain to be a smaller
reporting company after this offering if either (i) the market value of our stock held by non-affiliates is less than $250.0 million,
or (ii) our annual revenue is less than $100.0 million during the most recently completed fiscal year and the market value of our stock
held by non-affiliates is less than $700.0 million. If we are a smaller reporting company at the time we cease to be an emerging growth
company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies.
Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial statements
in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations
regarding executive compensation. This also may cause investors to find our common stock less attractive, there may be a less active
trading market for our common stock, and our stock price may decline or become more volatile.

 The
provision of our amended and restated articles of incorporation requiring exclusive forum in the Eighth Judicial District Court of Clark
County, Nevada for certain types of lawsuits may have the effect of discouraging lawsuits against our directors and officers.

 Our
amended and restated articles of incorporation, as they will be in effect upon the completion of this offering, will require that (i)
any derivative action or proceeding brought on behalf of us; (ii) any action asserting a claim of breach of a fiduciary duty; (iii) any
action arising pursuant to any provision of Nevada law regarding corporations, mergers, conversion or domestications, or our amended
and restated articles of incorporation or amended and restated bylaws (as either may be amended from time to time); (iv) any action to
interpret, apply, enforce or determine the validity of our amended and restated articles of incorporation or our amended and restated
bylaws; or (v) any action asserting a claim against us that is governed by the internal affairs doctrine, will have to be brought only
in the Eighth Judicial District Court of Clark County, Nevada. Our amended and restated articles of incorporation will provide that the
foregoing Nevada exclusive forum provisions do not apply to any action asserting claims under the Securities Act or the Exchange Act.
Although we believe this provision benefits us by providing increased consistency in the application of Nevada law in the types of lawsuits
to which it applies, the provision may have the effect of discouraging lawsuits against our directors and officers.

 The
interests of stockholders may be hurt because we can issue shares to individuals or entities that support existing management with such
issuances serving to enhance existing management's ability to maintain control of our company.

 Our
Board of Directors has the authority, without action or vote of the stockholders, to issue all or part of the authorized but unissued
common shares. Such issuances may be issued to parties or entities committed to supporting existing management and the interests of existing
management which may not be the same as the interests of other stockholders. Our ability to issue shares without stockholder approval
serves to enhance existing management's ability to maintain control of our company.

 In
addition, our common stock is unlikely to be followed by any financial analysts, and there may be few institutions acting as market makers
for our common stock. Either of these factors could adversely affect the liquidity and trading price of our common stock. Until our common
stock is fully distributed and an orderly market develops in our common stock, if ever, the price at which it trades is likely to fluctuate
significantly. Prices for our common stock will be determined in the marketplace and may be influenced by many factors, including the
depth and liquidity of the market for shares of our common stock, developments affecting our business, including the impact of the factors
referred to elsewhere in these Risk Factors, investor perception of our Company and general economic and market conditions. No assurances
can be provided that an orderly or liquid market will ever develop for our common stock.

 Risks
Related to Technology, Privacy, and Intellectual Property Rights

 We
expect to have limited protection of our intellectual property and proprietary rights.

 We
regard the patents, trade secrets, and similar intellectual property acquired via the Scio asset acquisition as critical to our success.
We must rely on patent law, trade secret protection, and confidentiality agreements with our employees, customers, strategic partners,
advisors, and others to protect those proprietary rights. Such measures, however, afford only limited protection, and we may not be able
to maintain the proprietary nature and/or confidentiality of our Diamond Technology. Despite these precautions, unauthorized third parties
might use information that we regard as proprietary to compete or help others to compete against us. There is no assurance that any of
the future patent applications, if made, will be granted, or, if granted, will not be invalidated, or circumvented, or that the rights
granted thereunder will provide us with a competitive advantage. Any misappropriation of our proprietary information by third parties
could materially adversely affect our business. There can be no assurance that any other patents issued will provide us any significant
commercial protection, that we will have sufficient resources to prosecute our patents, or that any patents will be upheld by a court
should we seek to enforce our rights against an infringer.

 There
can be no assurances that:

 any
pending patent application or future patent application will result in issuances of patents;

 the
scope of any patent protection will be effective to exclude competitors or provide competitive advantages to us;

 we
will be able to commercially exploit any issued patents before they expire;

 any
of our patents will be held valid if subsequently challenged;

 others
will not claim rights in or ownership of our patents and other proprietary rights;

 our
diamonds will not infringe, or be alleged to infringe, the proprietary rights of others; or

 we
will be able to protect meaningful rights in proprietary technology over which we do not hold patents.

 Furthermore,
there can be no assurances that others have not developed or will not develop diamonds which may duplicate any of the diamonds produced
using our Diamond Technology or our expected manufacturing processes, or that others will not design around any of our patents. The existence
of valid patents does not provide absolute prevention from other companies independently developing competing technologies. Existing
producers of lab-grown diamonds may refine existing processes for growing diamonds or develop new technologies for growing diamonds in
a manner that does not infringe any of our intellectual property rights.

 Other
parties may independently develop or otherwise acquire substantially equivalent techniques, gain access to our acquired proprietary technology,
or disclose such technology to competitors. In addition, whether we obtain additional patents, others may hold or receive patents covering
components of our technology that we independently develop in the future. There can be no assurances that third parties will not claim
infringement by us, and seek substantial damages, with respect to current or future diamond-related activities. If we were to become
involved in a dispute regarding intellectual property, whether ours or that of another company, we may become involved in material legal
proceedings. Any such claims, with or without merit, could be time-consuming, result in costly litigation, cause production and/or product
shipment delays, and require us to:

 cease
manufacturing and selling the product in question, which could seriously harm us;

 enter
into royalty or licensing agreements; or

 design
commercially acceptable non-infringing alternative diamonds.

 There
can be no assurance that we would be able to obtain royalty or licensing agreements, if required, on terms acceptable to us or at all,
or that we would be able to develop commercially acceptable non-infringing alternative diamonds. The failure to do so could have a material
adverse effect upon our business, results of operations, financial condition, and prospects. We cannot be absolutely certain that our
Diamond Technology does not infringe on issued patents or other intellectual property rights of others. In addition, because patent applications
in the United States are not publicly disclosed until the patent is issued, applications by third parties may have been filed that relate
to our Diamond Technology of which we are presently unaware.

 There
can be no assurance that our business and ability to produce diamonds will not be impaired by claims that we are infringing upon the
intellectual property of others. We may be subject to future legal proceedings and claims from time to time in the ordinary course of
our business, including claims of alleged infringement of the trademarks and other intellectual property rights of third parties. Intellectual
property litigation is expensive and time- consuming and could divert our management's attention from diamond production and operating
our business. As a result of the foregoing, the limited protection of our acquired intellectual property rights and proprietary information
could have a material adverse effect on our business, results of operations, financial condition, and prospects.

 Our
intellectual property rights, and the intellectual property rights of our vendors, are valuable, and the failure to protect those rights
could adversely affect our business.

 Our
intellectual property rights, including existing and future trademarks, trade secrets, and copyrights, are and will continue to be valuable
and important assets of our business. We believe that our proprietary technology, as well as our other technologies and business practices,
are competitive advantages and that any duplication by competitors would harm our business. The measures we have taken to protect our
intellectual property may not be sufficient or effective. Additionally, intellectual property laws and contractual restrictions may not
prevent misappropriation of our intellectual property. Finally, even if we can successfully protect our intellectual property, others
may develop technologies that are similar or superior to our technology.

 ITEM
1B. UNRESOLVED STAFF COMMENTS

 None.

 ITEM
2. PROPERTIES

 The Company executive offices are located
in Scottsdale, Arizona, where we lease approximately 3,414 square feet for office space under a lease that expires in September 2024.
In Greenville, South Carolina, we lease approximately 6,475 square feet for our factory under a lease that expires in August 31, 2028
as well as, an additional 23,485 square feet in Greenville, South Carolina which lease expires in July 2031.

 ITEM
3. LEGAL PROCEEDINGS

 From
time to time, we may become involved in lawsuits, claims, investigations, and proceedings, including those relating to product liability,
intellectual property, commercial relationships, employment issues, and governmental matters. Litigation, regardless of the merits, can
be expensive, time consuming, and divert the time and attention of management personnel, and unfavorable outcomes and prolonged litigation
can harm our business. We actively monitor the status of litigation as it arises, and depending on the circumstances, intend to vigorously
defend claims and assert all appropriate defenses to litigation against us.

 On January 10, 2023, the
Company was joined as a defendant to an existing lawsuit in the United States District Court for the District of Nevada (case no. 2:22-cv-00256)
between Theodorus Strous, a shareholder of Scio Diamond Technology Corp. ("Scio"), and Scio executives, brought as a proposed
derivative shareholder class action. The second amended complaint added the Company and John G. Grdina as defendants, expanding the claim
to assert a proposed derivative shareholder class action against the Company as well as Scio.

 The Company retained outside
counsel and filed a motion to dismiss and joined in Scio's motion to dismiss on February 17, 2023. Specifically, the Company believes
it was mis-joined to the lawsuit and that no claims are adequately pled against it. The Company further contends that the court lacks
subject matter jurisdiction. The case was re-assigned to Hon. Cristina D. Silva. Judge Silva's on July 5, 2023. After a long period
of delay, on June 14, 2024, the court ordered additional briefing on the argument based on the Company's motion to dismiss for
lack of subject matter jurisdiction, signaling we believe the court was inclined to dismiss the entire case for lack of subject matter
jurisdiction. The briefing was to commence on June 28, 2024. Largely, as a result of the court's inclination to dismiss, on June
28, 2024, the Plaintiff stipulated to dismiss the claims against the Company, Mr. Grdina, and Scio's management and filed a voluntary
dismissal of all of the claims.

 Please reference the
Contingencies section of Note 7 of our Financial Statements for additional disclosure.

 ITEM
4. MINE SAFETY DISCLOSURE

 None.

 PART
II

 ITEM
5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 Market
Information

 Our
Common Stock has been listed on Nasdaq since December 9, 2022, and is trading on Nasdaq under the symbol "JEWL".

 Holders
of Common Equity

 As
of September 30, 2023, a total of 27,215,966 shares of our Common Stock were outstanding and there were approximately 591 holders
of record.

 Dividend
Information

 We
have never paid or declared any cash dividends on our common stock. We currently intend to retain any future earnings to finance the
growth and development of our business, and we do not expect to pay any cash dividends on our common stock in the foreseeable future.
Payment of future dividends, if any, will be at the discretion of our Board of Directors and will depend on our financial condition,
results of operations, capital requirements, preferential rights of any preferred stock, restrictions contained in future financing instruments,
and other factors our Board of Directors deems relevant.

 Securities
Authorized for Issuance under Equity Compensation Plans

 As
of September 30, 2023, we have no current employee plan with respect to our compensation plans under which equity securities may be issued.

 Transfer
Agent

 The
transfer agent for our common stock is ClearTrust Transfer, LLC, 16540 Pointe Village Drive, Suite 210, Lutz, FL 33558, (813)
235-4490. Their website is

 Recent
Sales of Unregistered Securities

 None.

 ITEM
6. RESERVED

 Not
required.

 ITEM
7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 This
document contains certain "forward-looking statements". All statements other than statements of historical fact are "forward-looking
statements" for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue
or other financial items; any statements of the plans, strategies, goals and objectives of management for future operations; any statements
concerning proposed new products and services or developments thereof; any statements regarding future economic conditions or performance;
any statements or belief; and any statements of assumptions underlying any of the foregoing.

 Forward
looking statements may include the words "may," "could," "estimate," "intend," "continue,"
"believe," "expect," or "anticipate," or other similar words, or the negative thereof. These forward-looking
statements present our estimates and assumptions only as of the date of this report. Accordingly, readers are cautioned not to place
undue reliance on forward-looking statements, which speak only as of the dates on which they are made. We do not undertake to update
forward-looking statements to reflect the impact of circumstances or events that arise after the dates they are made. You should, however,
consult further disclosures and risk factors we included in the section titled Risk Factors contained herein.

 Overview

 We
are a high-tech diamond company that uses our proprietary technology to produce high-quality, single crystal diamonds and diamond materials
through a CVD process, which we refer to as our Diamond Technology. Lab-grown diamonds have the exact physical, chemical, and optical
properties of the best mined diamonds. Lab-grown diamonds are composed of a pure carbon lattice, just like mined diamonds, and are not
considered synthetic or simulant diamonds like cubic zirconia and moissanite. Simulants are other chemical compounds that resemble diamonds
but do not possess the same hardness, thermal characteristics, band gap energy, and light reflectivity as diamond, whether mined or lab-grown.

 We
use our Diamond Technology to produce finished diamonds that we intend to sell wholesale and retail for jewelry and rough unfinished
diamond materials that we intend to sell wholesale and retail for industrial uses. We are in the initial phases of commercializing diamonds
and diamond materials, and our primary mission is the development of a profitable and sustainable commercial production model for the
manufacture and sale of diamonds and diamond materials, which are suitable for known, emerging, and anticipated industrial, technology,
and consumer applications.

 Since
acquiring the Scio assets over four years ago, we have focused our efforts on research and development of improvements to the fundamental
CVD process. Like most high-tech manufacturers, the philosophy of continuous improvement is at our core. Our development efforts have
focused on commercialization of the diamonds and diamond materials we produce, improvements in our white diamond process, improvements
in our diamond seed processes, automation in our machine operation, expansion of our capacity with our existing machines, and improvements
in our laser cutting procedures. The guiding principle of these efforts is to provide the highest quality diamonds and diamond materials
in a consistent and high-yield manner.

 We
currently have limited available commercial products and have to date sold minimal diamonds or diamond materials to consumers or commercial
buyers. Our current operations, until just recently, have been dedicated to the research and development of our Diamond Technology and
the exploration of markets that we may exploit in the future. While we are unable to predict the timing of our entry into any market
in the future, we will strive to produce on a large scale high-quality finished and raw diamond materials and to pursue related commercial
opportunities.

 Impact
of the War in Ukraine on Our Operations

 The
short- and long-term implications of Russia's invasion of Ukraine are difficult to predict at this time. The imposition of sanctions
and counter sanctions may have an adverse effect on the economic markets generally and could impact our business, financial condition,
and results of operations. The sanctions against Russia include its ability to participate in the international diamond trade. As such,
there are fewer Russian diamonds in the marketplace today, which poses an opportunity for our product as a replacement. However, there
are also disruptions in the supply chain in Russia and Eastern Europe (e.g., Belarus) where diamond cutting services have been slowed
or are no longer available to us. To mitigate such disruptions, we have voluntarily replaced the services of one of our diamond cutters
that is based in Belarus with diamond cutters from other regions. The only negative impact we have identified to date has been the time
it has taken us to switch to another vendor. None of our critical raw materials are sourced from that region. We have no operations or
other projects in that region.

 Inflationary
Pressures

 We
are currently experiencing inflationary pressures in our manufacturing processes. Costs for our industrial equipment, raw materials,
services, and shipping have increased and continue to trend upward. Over the year our average electricity cost has increased approximately
6%. Raw materials used in our manufacturing processes, such as refractory metals, lab-grade gases, and their associated gas delivery
systems, have all shown increases between 6% and 10%; chemical solvents, adhesives, and other consumables have shown annual increases
from approximately 7%. To date, we believe these inflationary increases have had a minimal impact on our business overall. However, to
mitigate such inflationary pressures, we continue to evaluate price increases for our products, negotiate volume discounts, seek alternative
products and suppliers, and explore opportunities to bring several non-critical services inside our company.

 Results
of Operations

 The
following table presents summarized financial information taken from our statements of operations for the years ended September 30, 2023
compared with the year ended September 30, 2022:

 For
 the Year Ended

 September 30,

 2023

 2022

 Net
 Sales

 $

 1,007,705

 $

 1,788,642

 Cost
 of Revenues

 (253,108

)

 603,276

 Gross
 Profit

 754,597

 1,185,366

 Total
 operating expenses

 20,822,220

 10,121,817

 Loss
 from Operations

 (20,067,623

)

 (8,936,451

)

 Other
 expenses

 —

 —

 Warrant
 issuance expense

 (2,038,000

)

 —

 Interest
 expense

 (438,317

)

 (2,131,407

)

 Loss
 before income taxes

 (22,543,940

)

 (11,067,858

)

 Provision
 for income taxes

 —

 —

 Net
 loss

 $

 (22,543,940

)

 $

 (11,067,858

)

the fiscal year ended September 30, 2023, we had net sales of $1.0 million compared to $1.8 for the year ended September 30, 2022. We
anticipate deriving continuing future revenue from the following business lines:

 Direct
Sales of Diamonds: The sale of diamond gemstones direct to the consumer through our website and the sale of industrial grade diamonds
direct to industrial manufacturing companies.

 Wholesale
 of Diamonds: The sale of diamonds to wholesalers, distributors, and jewelers.

 Cost
of Revenues

 Cost
of revenues include direct costs (parts, material, and labor), indirect manufacturing costs (manufacturing overhead, depreciation,
plant operating lease expense, and rent), shipping, lab services, and logistics costs.

 Costs
of revenues for the year ended September 30, 2023, was $0.3 million compared to $0.6 million for the year ended September 30,
2022.

 Gross
profit for the year ended September 30, 2023, was $0.8 million or a gross profit margin on diamond sales of 74.8%
for the year ended September 30, 2023 compared to $1.2 or a gross profit margin on diamond sales of 66.3% for the year ended September
30, 2022.

and Development Expense

 We
conduct research and development activities to enhance existing processes and products and develop new processes and products at our
facilities in Greenville, South Carolina, utilizing our personnel and strategic relationships. We expense all costs associated with our
research and development efforts through either our cost of goods sold, as they are performed by the same employees who produce our finished
product, or through our general and administrative expenses if the product has not been brought to market.

 We
expect our research and development expenses to increase for the foreseeable future as we continue to invest in research and development
activities to achieve our operational and commercial goals.

 Operating
Expense

 Operating
expenses include selling, general and administrative expenses, employee salaries and related expense and depreciation and amortization
expense. Selling, general, and administrative expenses consist primarily of legal and professional, consulting services and all non-personnel-related
expenses or depreciation and amortization. Personnel-related expenses consist of salaries, payroll taxes, benefits, and stock-based compensation.
Depreciation and amortization expenses are related to the Company's fixed assets and intangible assets.

 Operating
expenses for the year ended September 30, 2023, included in the statement of operations was $20.8 million compared to $10.1 million
in the comparison to the comparable prior year.

 We
expect our operating expense to increase for the foreseeable future as we scale headcount and expenses with the growth of our business,
build out our manufacturing facilities, refine our production processes, drive for productivity improvements, acquire new and retain
existing customers, and incur additional costs as a result of being a public company.

 Other
Expenses

 Interest
Expense

 Interest
expense consists of interest paid and accrued on our notes payable, promissory notes and the amortization of debt issue costs.

 Interest
expense was $0.4 million for the year ended September 30, 2023, compared to $2.1 million for the year ended September 30, 2022.
This decrease in interest expense of $1.7 million in interest expense was due to lower net borrowings and outstanding indebtedness
for the year ended September 30, 2023, versus the year ended September 30, 2022 and also a cost of lower debt discounts.

 Net
Loss

 Primarily
as a result of the above factors we had a net loss of $22.5 million compared to a net loss of $11.1 million for the years ended
September 30, 2023, and September 30, 2022, respectively.

 Liquidity
and Capital Resources

 As
of September 30, 2023, we had $26,088 of cash and cash equivalents, a decrease of $62,147 from September 30, 2022.

 Changes
in cash flows are summarized as follows:

 Operating
Activities

 For
the year ended September 30, 2023, net cash used in operating activities totaled approximately $6.8 million. This was primarily the result
of net loss of approximately $22.5 million, increases to our period end inventory of $1.5 million, decrease in accounts receivable of
$0.3 million, a decrease in accrued payroll of $1.5 million, an increase in accrued interest of $0.2 million, which was offset primarily
by increases in accrued liabilities of $0.3 million along with an offset by the benefit of non-cash expenses for depreciation and amortization
of approximately $0.4 million and stock based compensation and expenditures of $11.4 million. The stock-based compensation
and expenditures consist of: stock issued to employees $5.9 million, stock issued to board members $0.3 million, stock issued to consultants
$4.9 million and stock used for loan inducement $0.3 million for the year ended September 30, 2023.

 Investing
Activities

the year ended September 30, 2022, we used no cash in investing activities. During the year ended September 30, 2023, we used
$1.5 million in net cash for investing activities to purchase property and equipment.

 Financing
Activities

the year ended September 30, 2023, net cash provided by financing activities was approximately $8.2 million. This was the net
effect of $0.8 million in increase of net notes payable, $0.6 million decrease related party activity, purchase of treasury stock
$1.2 million and $9.1 million in cash proceeds received from the sale of our common stock.

 These
conditions raise substantial doubt about our ability to continue as a going concern for the ensuing year. Our independent auditors have
added an explanatory paragraph in their audit opinion in regard to this uncertainty.

 Satisfaction
of our Cash Obligations for the Next 12 Months

 Our
recent IPO which closed on December 14, 2022 gave us gross proceeds of $11.0 million before direct IPO expenses and fees associated with
underwriting, These funds along with the ability to obtain additional capital through additional equity and/or debt financing are anticipated
to meet our operating needs. We are not currently generating sufficient revenue to meet operating needs. In the event we cannot obtain
additional capital to pursue our strategic plan, however, this would materially impact our ability to continue as a going concern.

 Since
inception, we have financed cash flow requirements through debt financing and the private issuance of common stock for cash and services
along with advances from our CEO as well as our CEO and CFO deferring significant compensation and benefits that were earned under their
respective employment contracts. If we continue to experience cash flow deficiencies, we would be required to obtain additional financing
to fund operations through private common stock offerings and debt borrowings to the extent necessary to provide working capital. However,
there is no assurance we would be able to obtain such financing on commercially reasonable terms, if at all.

 We
intend to implement and successfully execute our business and marketing strategy, continue to develop, and upgrade technology and products,
respond to competitive developments, and attract, retain, and motivate qualified personnel. There can be no assurance that we will be
successful in addressing such risks, and the failure to do so can have a material adverse effect on our business prospects, financial
condition, and results of operations.

 Summary
of Product Research and Development

 Since
acquiring the Scio assets over four years ago, we have primarily focused our efforts on research and development of improvements to
the fundamental CVD process. Our development efforts have focused on commercialization of the diamonds and diamond materials we
produce, improvements in our white diamond process, improvements in our diamond seed processes, automation in our machine operation,
expansion of our capacity with our existing machines, and improvements in our laser cutting procedures. In the future, our research
and development projects will include further improvements in the CVD process, primarily in capacity expansion per diamond growing
machine. We are planning to invest in other parts of the manufacturing chain as well to develop our own diamond seeds, which are
thin slices of diamond upon which our diamonds are grown; add color enhancement; and add additional laser capabilities.

 Expected
Purchase or Sale of Significant Equipment

 We
anticipate that we will purchase the necessary equipment required to ramp up our production of lab-grown diamonds and increase our capabilities
during the next 12 months. Specifically, we anticipate expenditures on additional proprietary diamond growing machines to increase our
overall capacity, expenditures to double the capacity of each existing and new diamond growing machine, expenditures in lasering equipment
to better prepare diamonds for gemstone cutting and industrial applications, and expenditures to synthesize seeds.

 Significant
Changes in the Number of Employees

 As
of September 30, 2023, we had 12 full-time employees and four independent consultants. We expect a significant increase in the number
of full-time employees over the next 12 months. We are using and will continue to use the services of independent consultants and contractors
to perform various professional services. We believe that this use of third-party service providers may enhance our ability to contain
general and administrative expenses.

 Off-Balance
Sheet Arrangements

 We
do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial
condition, changes in financial condition, revenue or expenses, results of operations, liquidity, capital expenditures, or capital resources
that is material to investors.

 Critical
Accounting Policies and Estimates

 Our
discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been
prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect
the reported amount of assets, liabilities, revenue, and expenses. We have identified several accounting principles that we believe are
key to the understanding of our financial statements. These important accounting policies require our most difficult subjective judgements.

 Use
of Estimates

 The
preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affected the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the
reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates
made in preparing the financial statements include, but are not limited to, the following: collectability of accounts receivable, the
potential impairment of goodwill; the valuation of deferred tax assets; inventories; carrying value of inventory; useful lives and recovery
of equipment and other intangible asset; debt discounts and valuations; and valuation of stock-based compensation.

 Goodwill

 We
evaluate goodwill for impairment annually or more frequently when an event occurs or circumstances change that indicate the carrying
value may not be recoverable. In testing for goodwill impairment, we may elect to utilize a qualitative assessment to evaluate whether
it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If our qualitative assessment indicates
that goodwill impairment is more likely than not, we perform a two-step impairment test. We test goodwill for impairment under the two-step
impairment test by first comparing the book value of net assets to the fair value of the reporting units. If the fair value is determined
to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step
is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value.
We estimate the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate
of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general
economic conditions. The measurement date of our annual goodwill impairment test is September 30. No impairment was recorded for the
year ended September 30, 2023 or the year ended September 30, 2022.

 Accounts
Receivable and Allowance for Doubtful Accounts

 Our
accounts receivable represents amounts due from customers for products sold and include an allowance for uncollectible accounts which
is estimated based on the aging of the accounts receivable and specific identification of uncollectible accounts. As of September 30,
2023 we reserved $1,681,500 on allowance for doubtful accounts and reserved $283,250 for the year ended September 30,
2022.

 Inventory

 We
state inventories at the lower of cost and net realizable value. We determine cost using the average cost method on all inventory generated
by our manufacturing operations upon our transition from research and development in our manufacturing facilities to the full production
of our products for sale. We only produce diamonds and not other precious gemstones such as rubies or sapphires. Therefore, any time
we refer to our inventory, it will consist solely of diamonds as raw materials, work in progress, and finished goods. When we use the
words "stones" or "precious stones" when describing our inventory, we are also talking solely of diamonds. As of
September 30, 2023, our inventory consisted of finished and nearly finished precious stones in various carat sizes, shapes, and colors.
Some of these stones were originally included as part of the assets purchased by our company as part of the Scio asset purchase agreement.
These stones were independently valued as part of the purchase price allocation. Additional stones added to inventory since the Scio
asset purchase are a byproduct of our continuing research and development efforts as well as the beginning phase of our manufacturing
process.

and Development

 To
date, we have expensed all costs associated with developing our product specifications, manufacturing procedures, and products through
our cost of goods sold, as this work was done by the same employees who produced the finished product. We anticipate that it may become
necessary to reclassify research and development costs into our operating expenditures for reporting purposes as we begin to develop
new technologies and lines of diamonds.

 Revenue
Recognition

 We
generate revenue from the sale of diamonds and diamond materials. We recognize revenue according to Accounting Standards Codification,
or ASC, 606. When the customer obtains control over the promised goods or services, we record revenue in the amount of consideration
that we can expect to receive in exchange for those goods and services. We apply the following five-step model to determine revenue recognition:

 identification
of a contract with a customer;

 identification
of the performance obligations in the contact;

 determination
of the transaction price;

 allocation
of the transaction price to the separate performance obligations; and

 recognition
of revenue when performance obligations are satisfied.

 We
only apply the five-step model when it is probable that we will collect the consideration we are entitled to in exchange for the goods
or services we transfer to the customer. At contract inception and once the contract is determined to be within the scope of ASC 606,
we assess the goods or services promised within each contract, and determine those that are performance obligations, and assesses whether
each promised good or service is distinct. If a contract contains a single performance obligation, the entire transaction price is allocated
to the single performance obligation. We anticipate that our contracts will contain a single performance obligation, and the entire transaction
price is allocated to the single performance obligation. We recognize as revenue the amount of the transaction price that is allocated
to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Accordingly, we recognize
revenue (net) when the customer obtains control of our product, which will typically occur upon shipment of the product.

 Fair
Value of Financial Instruments

 Fair
value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of September
30, 2023 and September 30, 2022. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair
value. These financial instruments include cash, accounts receivable, accounts payable, accrued expenses, amounts due to related parties,
and notes payable. Fair values were assumed to approximate carrying values because they are short term in nature and their carrying amounts
approximate fair values or they are payable on demand, or for notes payable, based on borrowing rates currently available to us for loans
with similar terms and maturities.

 Income
Taxes

 We
follow ASC subtopic 740 - Income Taxes, or ASC 740, for recording the provision for income taxes. ASC 740-10 requires the use of the
asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities
are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted
marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses
or benefits are based on the changes in the asset or liability each period. If available evidence suggests that is more likely than not
that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax
assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision
for deferred income taxes in the period of change.

 Stock-Based

 We
grant stock-based compensation to key employees and directors as a means of attracting and retaining highly qualified personnel. We also
grant stock in lieu of cash compensation for key consultants and service providers. We recognize expenses related to stock-based payment
transactions in which we receive employee or non-employee services in exchange for equity. We measure stock-based compensation based
on sales of our common stock near the date of the grant.

 In
addition to our base of employees, we also use the services of several contract personnel and other professionals on an "as needed
basis." We plan to continue to use consultants, legal and patent attorneys, engineers, and accountants, as necessary. We may also
expand our staff to support the market roll-out of our products to both commercial and government-related organizations. A portion of
any key employee compensation likely would include direct stock grants, which would dilute the ownership interest of holders of existing
shares of our common stock and our new investors.

 Severance
Expense

 We
account for severance expenses in accordance with ASC 710, Compensation-General. The severance program provides for benefits
to certain key executive employees, to be paid upon their termination, whether initiated by us or at the employee's direction. These
benefits are fully vested and have an annual escalation provision and are expensed as they are incurred. Certain key executives entitled
to severance compensation have waived these payments prior to the Company's IPO.

 ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 Not
required.

 ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 The
financials are submitted as a separate section of this Annual Report on Form 10-K beginning on page F-1.

 ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 Not
applicable.

 ITEM
9A. CONTROLS AND PROCEDURES

 As
of September 30, 2023, our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of the design
and operation of our disclosure controls and procedures, as required by Exchange Act Rule 13a-15. Based on that evaluation, our Chief
Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of the end
of the period covered by this report. Disclosure controls and procedures are controls and other procedures that are designed to ensure
that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized,
and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without
limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange
Act is accumulated and communicated to management, including our Chief Executive Officer and our Chief Financial Officer, to allow timely
decisions regarding required disclosure.

 a)
Evaluation of Disclosure Controls and Procedures

 Our
management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f)
and 15d-15(f) under the Securities Exchange Act of 1934. Our internal control over financial reporting is a process designed by, or under
the supervision of, our chief executive officer and chief financial officer, or persons performing similar functions, and effected by
our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the
United States of America (GAAP). Our internal control over financial reporting includes those policies and procedures that: (i) pertain
to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and disposition of the assets
of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements
in accordance with GAAP and that receipts and expenditures of the Company are being made only in accordance with authorization of management
and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition,
use, or disposition of the Company's assets that could have a material effect on the financial statements.

 Management
assessed the effectiveness of the Company's internal control over financial reporting as of September 30, 2023. In making this assessment,
management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the 2013 Internal Control-
Integrated Framework. Based on its evaluation, management has concluded that the Company's internal control over financial reporting
was not effective as of September 30, 2023.

the year ended September 30, 2023, management identified the following weaknesses, which were deemed to be material weaknesses in internal
control over financial reporting. Due to the size of the Company and available resources, there are limited personnel to assist with
the accounting and financial reporting function, which results in: (i) a lack of segregation of duties and (ii) controls that may not
be adequately designed or operating effectively.

 Pursuant
to Regulation S-K Item 308(b), this Annual Report on Form 10-K does not include an attestation report of our company's registered
public accounting firm regarding internal control over financial reporting.

 Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of
any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions
or that the degree of compliance with the policies or procedures may deteriorate. A control system, no matter how well designed and operated,
can provide only reasonable, but not absolute, assurance that the control system's objectives will be met. The design of a control
system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their cost.

 b)
Changes in Internal Control over Financial Reporting

the year ended September 30, 2023, there were no changes in our internal controls over financial reporting, which were identified in
connection with our management's evaluation required by paragraph (d) of rules 13a-15 and 15d-15 under the Exchange Act, that materially
affected, or is reasonably likely to have a materially affect, on our internal control over financial reporting.

 ITEM
9B. OTHER INFORMATION

 Not
applicable.

 ITEM
9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 Not
applicable.

 PART
III

 ITEM
10. DIRECTORS AND EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 Identification
of Directors and Executive Officers and Term of Office

 The
following table sets forth the names and ages of our current directors and executive officers. Our Board of Directors appoints our executive
officers. Each director of the Company serves for a term of one year or until the successor is elected at the Company's annual shareholders'
meeting and is qualified, subject to removal by the Company's shareholders. Each officer serves, at the pleasure of the Board of
Directors.

 Name

 Age

 Position

 John
 "Jay" G. Grdina

 President,
 Chief Executive Officer, and Chairman of the Board

 R. Staehr

 Chief
 Financial Officer

 Gerald
 A. McGuire

 Chief
 Operating Officer

 J. Chaunu

 C. Chien

 Alan
 B. Menkes

 Paul
 N. Vassilakos

 John
"Jay" G. Grdina is the founder of our company and has served as President, Chief Executive Officer, and Chairman of
the Board since September 2018. Prior to founding our company, Mr. Grdina was a founder of AMMO, Inc. (OTCQB: POWW), a publicly traded
ammunition company, where he served as Chief Marketing Officer from 2016 to 2019. From 2012 through 2015, Mr. Grdina served as a director
and Chief Executive Officer of NOHO, Inc., a former publicly traded lifestyle beverage company. In 2008, Mr. Grdina helped to create
and co-owns the celebrity blogs, TheDirty.com and Kikster.com. Mr. Grdina was the founder and former Chief Executive Officer of Club
Jenna, Inc., which was sold to Playboy Enterprises in 2006. While at Playboy Enterprises from 2006 to 2009, Mr. Grdina was a Senior Vice
President and the President of Production. We believe Mr. Grdina's experience and extensive knowledge in a multitude of categories
and the public sectors makes him well qualified to serve on our Board of Directors.

R. Staehr has served as our Chief Financial Officer since September 2019. Mr. Staehr served as Chief Financial Officer for Mix
1 Life, Inc., a former publicly traded nutritional supplement company, from October 2016 to August 2018 and served as the sole officer
and director from February 2017 to August 2018. Mr. Staehr served as Chief Financial Officer of NOHO, Inc., a former publicly traded
beverage company, from October 2013 to May 2015. Mr. Staehr served as sole officer and director of Monarchy Resources, Inc., a former
publicly traded company, from June 2013 to August 2013. From 2007 to 2014, Mr. Staehr also served as Corporate Controller of Cash Systems,
Inc., a publicly traded provider of cash access products and related services to the gaming industry until its merger with a subsidiary
of Global Cash Access Holdings, Inc. in August 2008. Mr. Staehr served as Chief Financial Officer of Western Capital Resources, Inc.,
a publicly traded company operating in the cellular retail and consumer finance industries, from November 2007 to December 2008. Mr.
Staehr served as a Senior Vice President of Encore Productions, a Las Vegas-based event planning and production entertainment and convention
provider, from 1998 to 2007. From 1990 to 1998, Mr. Staehr served in various chief financial officer and principal accounting officer
roles with several Las Vegas gaming companies, including MGM Mirage Resorts, Boyd Gaming, and Caesars World. Mr. Staehr worked with the
public accounting firm Deloitte Touche Tohmatsu Limited until 1998 after attending the University of Nevada, Las Vegas, where he received
a BSBA degree. Mr. Staehr is currently a licensed Certified Public Accountant in the state of Nevada.

 Gerald
A. McGuire has served as our Chief Operating Officer since September 2019. From June 2014 until its acquisition by our company
in September 2019, Mr. McGuire served as President and Chief Executive Officer of Scio Diamond Technology Corporation, a former publicly
traded company. Mr. McGuire served as Senior Vice President and General Manager of the Low-Voltage and Mid Power Analog Business at Fairchild
Semiconductor, now On Semiconductor, from 2010 to 2014. Prior to Fairchild Semiconductor, from 1987 to 2010, Mr. McGuire served in various
engineering, marketing, and business roles with Analog Devices, most recently serving as Vice President/General Manager of the Digital
Signal Processing business. Mr. McGuire holds a Master of Science in Electrical Engineering and a Bachelor of Arts in biology from the
University of Vermont.

J. Chaunu has served as a director of our company since October 2021. In 2015, Mr. Chaunu founded BeauGeste Luxury Brands, the
exclusive agent in North America for several watch and jewelry European luxury brands. In 2010, Mr. Chaunu founded Brands Consulting
LLC, a luxury brands consulting company, and has served as its President since inception. From 2005 to 2010, Mr. Chaunu served as President
and Chief Operating Officer of Leviev Diamonds (KLG Jewelry Inc.). Prior to Leviev, Mr. Chaunu served as President North America of Chopard
USA from 1999 to 2005. Mr. Chaunu served as President North America of Christofle Silver USA from 1991 to 1999. Mr. Chaunu started his
career in 1985 with Cartier as Senior Product Manager in Paris before being promoted and transferred to New York as Vice President of
Marketing. Mr. Chaunu is a graduate of Sciences Po' Paris (economics) and the Institut national des langues et civilisations orientales
Paris (Chinese studies) and holds a baccalaureate in sciences and mathematics. Mr. Chaunu currently serves on the board of directors
of Maison Luxe, Inc. We believe Mr. Chaunu's years of significant executive leadership experience in the jewelry industry make him
well qualified to serve on our Board of Directors.

C. Chien has served as a director of our company since October 2021. From January 2001 to September 2017, Mr. Chien served in
various roles with Sony Pictures Entertainment, most recently serving as Executive Vice President. Prior to Sony, Mr. Chien served as
Finance Director at The Walt Disney Company from May 1999 to January 2001. From October 1997 to November 1998, Mr. Chien served as Talent
Agent Assistant at United Talent Agent. Mr. Chien also served as Senior Auditor for media and entertainment companies at Ernst &
Young LLP from September 1994 to July 1997. Mr. Chien holds a Bachelor of Arts from the University of Miami. We believe Mr. Chien's
experience serving on various international joint venture boards as well as audit and compensation committees makes him well qualified
to serve on our Board of Directors.

 Alan
B. Menkes has served as a director of our company since October 2021. Mr. Menkes currently serves as the Managing Partner of
Empeiria Capital Partners, a New York-based private equity firm that he co-founded in 2003. Prior to founding Empeiria, from December
1998 through February 2002, Mr. Menkes was Co-Director of Private Equity and a member of the Executive Committee of Thomas Weisel Partners.
Prior to joining Thomas Weisel Partners, Mr. Menkes was a Partner of Hicks, Muse, Tate & Furst, where he was employed for almost
seven years. Prior to Hicks Muse, Mr. Menkes was with The Carlyle Group from its founding in 1987 to 1992. Mr. Menkes currently serves
on the board of directors of B&B Roadway Security Solutions and Ironwood Power Services LLC (transactions sponsored by Empeiria).
Mr. Menkes also serves on the board of directors of PLH Group and Key Energy Services. Mr. Menkes holds a Bachelor of Arts in Economics
with Highest Distinction from the University of Virginia, where he graduated Phi Beta Kappa, and a Master of Business Administration
with Distinction from the Wharton School at the University of Pennsylvania. We believe Mr. Menkes' extensive experience in private
equity makes him well qualified to serve on our Board of Directors.

 Paul
N. Vassilakos has served as a director of our company since October 2021. Mr. Vassilakos founded, and since July 2020 has been
a partner of Forever 8 Fund, LLC, a privately held consumer products inventory capital provider. In July 2007, Mr. Vassilakos founded
Petrina Advisors, Inc., a privately held advisory firm formed to provide investment banking services for public and privately held companies
and has served as its President since its formation. Mr. Vassilakos previously served as a member of the Board of Directors of Long Island
Iced Tea Corp., a former publicly traded company, from its inception in May 2015 until October 2017, and also served as its Chief Executive
Officer from its inception until the consummation of its business combination with Cullen Agricultural Holding Corp. in May 2015. From
November 2011 to February 2012, Mr. Vassilakos served as Chief Executive Officer, Chief Financial Officer, and director of Soton Holdings
Group, Inc., a former publicly held company now known as Rio Bravo Oil, Inc. Mr. Vassilakos also previously served as interim President
and Chief Executive Officer of Red Mountain Resources, Inc. from February 2011 to March 2011. Mr. Vassilakos also served on the Boards
of Directors of Cross Border Resources, Inc. (since April 2012) and Red Mountain Resources, Inc. (since October 2011), both oil and natural
gas exploration former public companies, until February 2016. Mr. Vassilakos has served as Chief Executive Officer and a director of
Cullen Agricultural Holding Corp., a former publicly traded company, or CAH, since November 2013 and as CAH's Assistant Treasurer
since October 2009. CAH is a development stage agricultural company which was formed in connection with the business combination between
Triplecrown Acquisition Corp. and Cullen Agricultural Technologies, Inc., or Cullen Agritech, in October 2009. Mr. Vassilakos also founded
and has served as the President of Petrina Properties Ltd., a privately held real estate holding company, since December 2006. In July
2007, Mr. Vassilakos was engaged as a consultant to assist Endeavor Acquisition Corp. with its business combination with American Apparel
Inc., a California based retail apparel company, which was completed in December 2007. From February 2002 to June 2007, Mr. Vassilakos
served as vice president of Elmsford Furniture Corp., a privately held furniture retailer. From July 2000 to January 2002, Mr. Vassilakos
was an Associate within the Greek Coverage Group of Citigroup Inc.'s UK Investment Banking Division. From July 1998 to July 2000,
Mr. Vassilakos was an Analyst within the Industrial Group of Salomon Smith Barney's New York Investment Banking Division. From February
1996 through June 1998, Mr. Vassilakos was a Registered Securities Representative at Paine Webber CSC - DJS Securities Ltd., during which
time he provided securities brokerage services to private clients. Mr. Vassilakos holds a Bachelor of Science in finance from the Leonard
N. Stern Undergraduate School of Business and was a licensed Registered Securities Representative (Series 7 and 63) from February 1996
to February 2002. We believe Mr. Vassilakos' experience in corporate finance and the public markets makes him well qualified to
serve on our Board of Directors.

 Each
of our executive officers serves at the discretion of our Board of Directors and holds office until his or her successor is duly elected
and qualified or until his or her earlier resignation or removal.

 Family
Relationships

 There
are no family relationships among any of our directors or executive officers.

 Board
Composition

 Our
business and affairs are managed under the direction of our Board of Directors, which currently consists of five members. Our amended
and restated articles of incorporation and amended and restated bylaws provide that our directors will be elected at each annual meeting
of our stockholders for a term of one year and will hold office until their successors are elected and qualified or until their death,
retirement, or removal.

Independence

 Our
Board of Directors has undertaken a review of its composition, the composition of its committees, and the independence of each director.
Based upon information requested from and provided by each director concerning his or her background, employment, and affiliates, including
family relationships, our Board of Directors has determined that Messrs. Chaunu, Chien, Menkes, and Vassilakos are independent directors,
as "independence" is defined by the listing standards of the Nasdaq Stock Market and by the SEC, because they have no relationship
with us that would interfere with their exercise of independent judgment in carrying out their responsibilities as a director. In making
this determination, our Board of Directors considered the current and prior relationships that each non-employee director has with our
company and our affiliates and all other facts and circumstances our Board of Directors deemed relevant in determining their independence,
including the beneficial ownership of our capital stock by each non-employee director. Mr. Grdina is an employee director.

 Board
Leadership Structure

 We
believe that effective board leadership structure can depend on the experience, skills, and personal interaction between persons in leadership
roles and the needs of our company at any point in time. Our Corporate Governance Guidelines support flexibility in the structure of
our Board of Directors by not requiring the separation of the roles of Chairman of the Board and Chief Executive Officer.

 Our
Board of Directors currently believes that it is in the best interests of our company to have our Chief Executive Officer also serve
as the Chairman of the Board. We believe that our Chairman and Chief Executive Officer provides strong, clear, and unified leadership
that is critical in our relationships with our stockholders, employees, customers, suppliers, and other stakeholders. The knowledge of
our Chief Executive Officer regarding our business and our day- to-day operations uniquely positions him to identify strategies and prioritize
matters for review and deliberation by our Board of Directors. Additionally, we believe the combined role of Chairman and Chief Executive
Officer facilitates centralized board leadership in one person, so there is no ambiguity about accountability. The Chief Executive Officer
serves as a bridge between management and our Board of Directors, ensuring that both groups act with a common purpose. This structure
also eliminates conflict between two leaders and minimizes the possibility of two spokespersons sending difference messages.

 Our
Board of Directors does not believe that combining the position creates significant risks. We believe we have effective and active oversight
by experienced independent directors and independent committee chairs, and our independent directors will regularly meet together in
executive session at Board meetings.

 Our
Chairman of the Board provides guidance to our Board of Directors; facilitates an appropriate schedule for board meetings; sets the agenda
for board meetings; presides over board meetings; and facilitates the quality, quantity, and timeliness of the flow of information from
management that is necessary for our Board of Directors to perform its duties effectively and responsibly.

 Our
Chief Executive Officer is responsible for the day-to-day leadership of our company and setting our company's strategic direction.

 Committees
of the Board of Directors

 Our
Board of Directors has the authority to appoint committees to perform certain management and administrative functions. Upon the closing
of this offering, our Board of Directors will have an audit committee, a compensation committee, and a nominating and corporate governance
committee, each consisting entirely of independent directors as "independence" is defined by the listing standards of Nasdaq
and by the SEC. The composition and responsibilities of each committee are described below. Members will serve on these committees until
their resignation or until otherwise determined by our Board of Directors. Following the closing of this offering, the charters for each
of these committees will be available on our website at www.adamasone.com.

 Audit
Committee

 The
Audit Committee will consist of Messrs. Chien, Menkes, and Vassilakos. Our Board of Directors has determined that each of Messrs. Chien,
Menkes, and Vassilakos, whose backgrounds are described above, qualifies as an "audit committee financial expert" in accordance
with applicable rules and regulations of the SEC. Mr. Menkes will chair the Audit Committee.

 The
purpose of the Audit Committee will include overseeing the financial and reporting processes of our company and the audits of the financial
statements of our company and providing assistance to our Board of Directors with respect to its oversight of the integrity of the financial
statements of our company, our company's compliance with legal and regulatory matters, the independent registered public accountant's
qualifications and independence, and the performance of our company's independent registered public accountant. The primary responsibilities
of the Audit Committee will be set forth in its charter and include various matters with respect to the oversight of our company's
accounting and financial reporting process and audits of the financial statements of our company on behalf of our Board of Directors.
Our Board of Directors also expects that the Audit Committee will select the independent registered public accountant to conduct the
annual audit of the financial statements of our company; review the proposed scope of such audit; review accounting and financial controls
of our company with the independent registered public accountant and our financial accounting staff; and review and approve any transactions
between us and our directors, officers, and its affiliates, also referred to as related-person transactions.

Committee

 The
Compensation Committee will consist of Messrs. Chien, Menkes, and Vassilakos. Mr. Vassilakos will chair the Compensation Committee. The
purpose of the Compensation Committee includes determining, or, when appropriate, recommending to our Board of Directors for determination,
the compensation of the Chief Executive Officer and other executive officers of our company and discharging the responsibilities of our
Board of Directors relating to compensation programs of our company. The Compensation Committee will make all decisions with respect
to executive compensation.

 Nominations
and Corporate Governance Committee

 The
Nominations and Corporate Governance Committee will consist of Messrs. Chien, Menkes, and Vassilakos. Mr. Menkes will chair the Nominations
and Corporate Governance Committee. The purpose of the Nominations and Corporate Governance Committee includes the selection or recommendation
to our Board of Directors of nominees to stand for election as directors at each election of directors, the oversight of the selection
and composition of committees of our Board of Directors, the oversight of the evaluations of our Board of Directors and management, and
the development and recommendation to our Board of Directors of corporate governance principles applicable to our company.

 The
Nominations and Corporate Governance Committee will consider persons recommended by stockholders for inclusion as nominees for election
to our Board of Directors if the information required by our bylaws is submitted in writing in a timely manner addressed and delivered
to our Secretary at the address of our executive offices set forth in this proxy statement. The Nominations and Corporate Governance
Committee identifies and evaluates nominees for our Board of Directors, including nominees recommended by stockholders, based on numerous
factors it considers appropriate, some of which may include strength of character, mature judgment, career specialization, relevant technical
skills, diversity, and the extent to which the nominee would fill a present need on our Board of Directors.

 Executive
Sessions

 We
expect to regularly schedule executive sessions in which independent directors meet without the presence or participation of management.
We expect the chairs of various committees of our Board of Directors to serve as the presiding director of such executive sessions on
a rotating basis.

 Board's
Role in Risk Oversight

 Risk
is inherent in every business. As is the case in virtually all businesses, we face a number of risks, including operational, economic,
financial, legal, regulatory, and competitive risks. Our management is responsible for the day-to-day management of the risks we face.
Our Board of Directors, as a whole and through its committees, has responsibility for the oversight of risk management.

 In
its oversight role, our Board of Directors' involvement in our business strategy and strategic plans plays a key role in its oversight
of risk management, its assessment of management's risk appetite, and its determination of the appropriate level of enterprise risk.
Our Board of Directors receives updates at least quarterly from senior management and periodically from outside advisors regarding the
various risks we face, including operational, economic, financial, cybersecurity, legal, regulatory, and competitive risks. Our Board
of Directors also reviews the various risks we identify in our filings with the SEC as well as risks relating to various specific developments,
such as acquisitions, debt and equity placements, and product development. In addition, our Board of Directors regularly receives reports
from our management.

 The
role that our Board of Directors plays in risk oversight more recently includes its assessment of the ongoing conflict between Russia
and Ukraine. This assessment by our Board of Directors includes consideration of the financial impact of the conflict from both a revenue
recognition and asset impairment perspective and also includes consideration of the operational impact of the conflict, including risks
related to cybersecurity, sanctions, and supply chain. Currently, we have no employees in affected areas; our suppliers in Eastern Europe,
specifically diamond cutters, have been replaced with suppliers in other regions; and we have no investments or operations in the affected
regions.

 Our
board committees assist our Board of Directors in fulfilling its oversight role in certain areas of risk. Pursuant to its charter, the
Audit Committee oversees our financial and reporting processes and the audit of our financial statements and provides assistance to our
Board of Directors with respect to the oversight and integrity of our financial statements, our compliance with legal and regulatory
matters, our policies and practices related to information security, our independent registered public accountant's qualification
and independence, and the performance of our independent registered public accountant. The Compensation Committee considers the risk
that our compensation policies and practices may have in attracting, retaining, and motivating valued employees and endeavors to assure
that it is not reasonably likely that our compensation plans and policies would have a material adverse effect on our company. Our Nominations
and Corporate Governance Committee oversees governance related risk, such as board independence, conflicts of interest of members of
the Board of Directors and executive officers, and management and succession planning.

and Officer Derivative Trading and Hedging and Pledging

 Our
policy on inside information and insider trading, which will become effective upon the closing of this offering, prohibits our directors
and officers, and any family member residing in the same household, from engaging in derivatives trading and hedging (including prepaid
forward contracts, equity swaps, collars, and exchange funds) involving our equity securities directly or indirectly held by them. Additionally,
this policy prohibits our directors and officers from pledging or margining our common stock.

 Stock
Ownership Guidelines

 In
connection with the closing of this offering, it is anticipated that we will adopt stock ownership guidelines for our non-employee directors
and executive officers. Our non-employee directors and executive officers are required to own shares of our common stock or share equivalents
with a value equal to at least the lesser of the following:

 Non-Employee Directors

 Three times cash retainer or 20,000 shares or share equivalents

 Chief Executive Officer

 Three times base salary or 1,000,000 shares or share equivalents

 Chief Financial Officer

 Two times base salary or 100,000 shares or share equivalents

 Other
 Executive Officers

 Two times base salary or 75,000 shares or share equivalents

 Each
individual will have five years, from the later of: the date of adoption of these guidelines, or the date of appointment of the individual
as a director or an executive officer, to achieve the required ownership levels. We believe that these guidelines promote the alignment
of the long-term interests of our executive officers and members of our Board of Directors with our stockholders.

 Stock
ownership generally includes the shares directly owned by the individual (including any shares over which the individual has sole ownership,
voting, or investment power); the number of shares owned by the individual's minor children and spouse and by other related individuals
and entities over whose shares the individual has custody, voting control, or power of disposition; shares underlying stock options that
have vested or will vest within 60 days; and shares held in trust for the benefit of the individual or the individual's immediate
family members.

 If
an individual achieves the required ownership level on the first day of any fiscal year, the value of the individual's stock ownership
on that date will be converted into a number of shares to be maintained in the future by dividing the value of such stock ownership by
the price of our common stock on the prior day, which is the last day of the preceding fiscal year.

 The
failure to satisfy the required ownership level may result in the ineligibility of the individual to receive stock-based compensation
in the case of an executive officer or director or the inability to be a nominee for election to our Board of Directors in the case of
a director.

 Clawback
Policy

 We
intend to adopt a clawback policy. In the event we are required to prepare an accounting restatement of our financial results as a result
of a material noncompliance by us with any financial reporting requirement under the federal securities laws, we will have the right
to use reasonable efforts to recover from any current or former executive officers who received incentive compensation (whether cash
or equity) from us during the three-year period preceding the date on which we were required to prepare the accounting restatement, any
excess incentive compensation awarded as a result of the misstatement. This policy will be administered by the Compensation Committee
of our Board of Directors. Once final rules are adopted by the SEC regarding the clawback requirements under the Dodd-Frank Wall Street
Reform and Consumer Protection Act of 2010, we will review this policy and make any amendments necessary to comply with the new rules.

 Code
of Business Conduct and Ethics

 Upon
the closing of this offering, we will adopt a code of business conduct and ethics that applies to all of our employees, officers, and
directors, including those officers responsible for financial reporting. Following the closing of this offering, the code of business
conduct and ethics will be available on our website at www.adamasone.com. We intend to disclose any amendments to the code, or
any waivers of its requirements, on our website to the extent required by the applicable rules and exchange requirements. The inclusion
of our website address in this prospectus does not include or incorporate by reference the information on or accessible through our website
into this prospectus.

 Board
and Committee Meetings

 Our
Board of Directors held nine formal board meetings and four formal Audit Committee meetings during the year ended September 30, 2023.
Our Board of Directors held six formal board meetings and three formal Audit Committee meetings during the year ended September 30, 2022.

 Annual
Meeting Attendance

 We
encourage each of our directors to attend annual meetings of stockholders. To that end, and to the extent reasonably practicable, we
will schedule a meeting of our Board of Directors on the same day as our annual meeting of stockholders.

 Communications
with Directors

 Stockholders
and other interested parties may communicate with our Board of Directors or specific members of our Board of Directors, including our
independent directors and the members of our various board committees, by submitting a letter addressed to the Board of Directors of
our company in care of any specified individual director or directors at the address of our executive offices. Any such letters are sent
to the indicated directors.

 Delinquent
with Section 16(a) Reports

 Section
16(a) of the Exchange Act requires the Company's directors, executive officers and persons who beneficially own 10% or more of a
class of securities registered under Section 12 of the Exchange Act to file reports of beneficial ownership and changes in beneficial
ownership with the SEC. Directors, executive officers and greater than 10% stockholders are required by the rules and regulations of
the SEC to furnish the Company with copies of all reports filed by them in compliance with Section 16(a). To the Company's knowledge,
based solely on a review of reports furnished to it, for the year ended September 30, 2023, all of the Company's officers, directors
and ten percent holders have made the required filings.

 Legal
Proceedings

the past ten years, none of our current directors or executive officers has been:

 the
subject of any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either
at the time of the bankruptcy or within two years prior to that time;

 convicted
in a criminal proceeding or is subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);

 subject
to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently
or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities;

 found
by a court of competent jurisdiction (in a civil action), the SEC or the Commodity Futures Trading Commission to have violated a federal
or state securities or commodities law, that has not been reversed, suspended, or vacated;

 subject
of, or a party to, any order, judgment, decree or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation
of a federal or state securities or commodities law or regulation, law or regulation respecting financial institutions or insurance companies,
law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

 subject
of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization, any registered
entity or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated
with a member.

 None
of our directors, officers or affiliates, or any beneficial owner of 5% or more of our Common Stock, or any associate of such persons,
is an adverse party in any material proceeding to, or has a material interest adverse to, us or any of our subsidiaries.

 ITEM
11. EXECUTIVE COMPENSATION

 Summary
Compensation Table

 The
following table sets forth, for the fiscal years ended September 30, 2023, and 2022. Information with respect to compensation for services
in all capacities to us earned by our principal executive officer and our two other most highly compensated executive officers as of
the end of our last completed fiscal year. We refer to these persons as our named executive officers.

 Name
 and

 Principal Position

 Year

 Salary

 Bonus

 Stock
 Awards

 (1)

 All
 Other

 (3)

 Total
 (2)

 John
 "Jay" G. Grdina (4)

 2023

 $

 282,500

 —

 $

 3,400,000

 $

 104,400

 $

 3,786,900

 President
 and Chief Executive Officer

 2022

 $

 275,000

 —

 $

 2,300,000

 $

 171,790

 $

 2,746,790

 R. Staehr (4)

 2023

 $

 232,715

 —

 $

 448,395

 $

 37,200

 $

 718,310

 Chief
 Financial Officer

 2022

 $

 213,500

 —

 $

 600,000

 $

 46,606

 $

 860,106

 Gerald
 A. McGuire

 2023

 $

 180,000

 —

 $

 194,000

 —

 $

 374,000

 Chief
 Operating Officer

 2022

 $

 180,000

 —

 $

 800,000

 —

 $

 980,000

 (1)

 The
 amounts shown in this column represent the grant date fair value ($4.00) for shares of common stock granted to
 the named executive officers pursuant to their employment agreements during the covered period calculated prior to the Company's
 IPO after such time the closing price of the Company's common stock listed on the NASDAQ was used for the covered period in
 accordance with ASC Topic 718 excluding the effect of forfeitures. The assumptions used in determining the grant date fair value
 of these awards are set forth in Note 2 to our financial statements, included elsewhere in this document.

 (2)

 The dollar value in this column for each named executive officer represents the sum of all compensation reflected in the previous columns.

 (3)
 All
Other Compensation consisted of the following for fiscal 2023:

 Name

 Auto

Allowance

 Phone

Allowance

 Diamond

Allowance

(1)

 Total (2)

 John "Jay" G. Grdina

 $
 18,000

 $
 2,400

 $
 84,000

 $
 104,400

 Steven R. Staehr

 $
 5,400

 $
 1,800

 $
 30,000

 $
 37,200

 Gerald A. McGuire

 —

 —

 —

 —

 1.
 Represents
the annual monthly carat allowance for each named executive officer valued at $1,000 per carat. As of September 30, 2023, neither Mr.
Grdina nor Mr. Staehr had received any of the finished diamonds to which they were entitled under their respective employment agreements.
These amounts have been accrued, and the diamonds will be given by us in the future.

 2.
 The
dollar value in this column for each named executive officer represents the sum of all compensation reflected in the previous columns.

 Consulting
Agreements, Employment Agreements and Other Arrangements Outstanding Equity Awards as of September 30, 2023

the fiscal year ended September 30, 2023, our named executed officers received grants of common stock, which were fully vested upon the
date of grant and not subject to any other vesting or forfeiture. As a result, there were no outstanding equity awards held by our named
executive officers that remained unvested as of September 30, 2023.

 Retirement
Plans

 We
do not offer any 401(k) or defined benefit pension plans to any of our executive officers.

 Employment
Agreements with our Named Executive Officers

 We
have existing employment agreements with three officers, John "Jay" G. Grdina, our President, Chief Executive Officer, and
Chairman of the Board, Steven R. Staehr, our Chief Financial Officer and Gerald A. McGuire, our Chief Operating Officer.

 The
following table sets forth, for the year ended September 30, 2023, information with respect to compensation for services in all capacities
to us and our subsidiaries earned by our directors, who are not officers, who served during the years ended September 30, 2023 and 2022.

 Name
 and Principal Position

 Fees

 Earned

 or Paid

 In

 Cash (1)

 Stock

 Awards

 (2)

 Option

 Awards

 (2)

 Nonequity

 incentive plan

 compensation

 Nonqualified

 deferred

 compensation

 earnings

 All
 other

 compensation

 (3)

 Total

 Paul
 Vassilakos

 $

 20,000

 $

 64,400

 $

 -

 $

 -

 $

 -

 $

 -

 $

 84,400

 Alan
 Menkes

 $

 20,000

 $

 64,400

 $

 -

 $

 -

 $

 -

 $

 -

 $

 84,400

 C. Chien

 $

 20,000

 $

 64,400

 $

 -

 $

 -

 $

 -

 $

 -

 $

 84,400

 Chaunu

 $

 20,000

 $

 64,400

 $

 -

 $

 -

 $

 -

 $

 -

 $

 84,400

 (1)
 The
amounts in this column reflect the amounts earned during the fiscal year, whether or not actually paid during such year.

 (2)
 The
amounts in this column reflect the aggregate grant date fair value of options awards granted to our directors during the transition period
or fiscal year, as applicable, calculated in accordance with FASB ASC Topic 718. Stock Compensation. The valuation assumptions
used in determining such amounts are described in the footnotes to our audited financial statements included in our Annual Report on
Form 10-K for year ended September 30, 2023. The amounts reported in this column reflect our accounting expense for these awards and
do not correspond to the actual economic value that may be received by our named executive officers from their option awards.

 (3)
 We
make an annual grant to each director of 20,000 shares of our Common Stock in allotments of 5,000 shares to each director on a quarterly
basis. We reimburse all officers and directors for reasonable and necessary expenses incurred in their capacities as such. The named
directors do not participate in certain group life, health, disability insurance, and medical reimbursement plans not disclosed in the
Summary Compensation Table that are generally available to salaried employees and do not discriminate in scope, terms, and operation.

 Outstanding
Equity Awards at Fiscal Year-end

 As
of September 30, 2023 and September 30, 2022 there were no outstanding stock options or restricted stock units. During the years ended
September 30, 2023 and September 30, 2022 we did not grant any restricted stock units or stock options but granted restricted stock to
directors, officers, and others who provided services to our company.

 ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 The
following table presents information regarding the beneficial ownership of our common stock as of December 31, 2023 by the following:

 each
of our directors and named executive officers;

 all
of our directors and executive officers as a group; and

 each
person, or group of affiliated persons, who is known by us to beneficially own more than 5% of our common stock.

 Beneficial
ownership is determined according to the rules of the SEC and generally means that a person has beneficial ownership of a security if
he, she, or it possesses sole or shared voting or investment power of that security, including notes that are currently convertible or
convertible within 60 days of and warrants that are currently exercisable or exercisable within 60 days of Shares issuable pursuant to
convertible notes and warrants are deemed outstanding for computing the percentage of the person holding such convertible notes and warrants
but are not deemed outstanding for computing the percentage of any other person. Except as indicated by the footnotes below, we believe,
based on the information furnished to us, that the persons named in the table below have sole voting and investment power with respect
to all shares of common stock shown that they beneficially own, subject to community property laws where applicable. The information
does not necessarily indicate beneficial ownership for any other purpose.

 The percentages below are calculated based on 27,215,966 shares of our
common stock issued and outstanding as of September 30, 2023.

 Unless
otherwise indicated, the address of each beneficial owner listed in the table below is c/o Adamas One Corp., 17767 N. Perimeter Drive,
Suite B115, Scottsdale, Arizona 85255.

 Name
 of Beneficial Owner

 Number

 Percent

 Named
 Executive Officers and Directors:

 John
 "Jay" G. Grdina (1)

 7,630,126

 28.0%

 R. Staehr

 841,715

 3.1%

 Gerald
 A. McGuire

 1,010,253

 3.7%

 J. Chaunu

 50,000

 *

 C. Chien

 65,000

 *

 Alan
 B. Menkes

 65,000

 *

 Paul
 N. Vassilakos

 65,000

 *

 All
 directors and executive officers as a group (7 persons)

 9,727,094

 35.7%

 5%
 Stockholders:

 Diamond
 Technologies, LLC (2)

 2,556,222

 9.4%

 *
 Less
than 1% of the outstanding shares of common stock.

 (1)
 Consists
 of (a) 10,000 shares of common stock held directly by Mr. Grdina, (b) 2,556,222 shares of common stock held in the name of
 Diamond Technologies, LLC, for which Mr. Grdina holds voting and dispositive power, (c) an aggregate of 1,800,000 shares held equally
 by three of Mr. Grdina's children, over which Mr. Grdina exercises voting and dispositive power, (d) 526,904 shares of common
 stock held in the name of Pubco, LLC, for which Mr. Grdina holds voting and dispositive power, and (e) 1,400,000 shares of
 common stock held in the name of PrivateCo, LLC, for which Mr. Grdina holds voting and dispositive power, and (f) 1,337,000
 shares of common stock held in the name of Lucid Technologies, LLC, for which Mr. Grdina holds voting and dispositive power.

 (2)
 See
 footnote (1) above. The address for Diamond Technologies, LLC is 10015 E Adele Court, Scottsdale, AZ 85255.

 Changes
in Control

 Based
on our common stock outstanding as of our executive officers and directors, in the aggregate, beneficially own approximately 35.7%
of our outstanding common stock. Mr. Grdina, our President, Chief Executive Officer, and Chairman of the Board, who beneficially owns
approximately 28.0% of our outstanding common stock, will be able to significantly influence all matters requiring stockholder
approval, including the election and removal of directors and any merger or other significant corporate transactions. The interests of
Mr. Grdina may not coincide with the interests of other stockholders, and he may vote in a way with which you disagree and that may be
adverse to your interests.

 In
addition, Mr. Grdina's concentration of ownership could have the effect of delaying or preventing a change in control or otherwise
discouraging a potential acquirer from attempting to obtain control of us, which could cause the market price of our common stock to
decline or prevent our other stockholders from realizing a premium over the market price for their common stock. In addition, because
our principal stockholders acquired their shares at prices substantially below the price at which shares are being sold in this offering
and have held their shares for a longer period, they may want us to pursue strategies that deviate from the interests of other stockholders.

 Equity
Incentive Plan

 As
of September 30, 2023, there is no equity incentive plan that has been adopted by the Company.

 ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 Other
than compensation arrangements, we describe below transactions and series of similar transactions that have occurred since October 1,
2021, to which we were a party or will be a party in which:

 the
 amounts involved exceeds the lesser of $120,000 or one percent of the average of our total
 assets at year end for the last two completed fiscal years; and

 any
 director, executive officer, holder of more than 5% of our common stock, or any member of
 their immediate family had or wil1 have a direct or indirect material interest.

 Promissory
Notes

 From
time to time since inception, we have borrowed funds and/or entered into revolving promissory notes with various entities controlled
by Mr. Grdina, our President, Chief Executive Officer, and Chairman of the Board.

 We
had an arrangement with each of Lucid Technologies, LLC, PrivateCo, LLC, Mix 1, LLC, Dolce B. Investments, Inc., PubCo, LLC, and Diamond
Technologies, LLC, each of which is an entity controlled by Mr. Grdina, whereby we could make revolving borrowings from such entities
with no interest and no specific due date. There were no written revolving promissory notes supporting these arrangements. In September
2021, we entered into promissory notes with each of Lucid Technologies, LLC, PrivateCo, LLC, and Mix 1, LLC to document the aggregate
amounts outstanding to each entity as of the date of the note. In April and May 2022, we entered into promissory notes with each of PubCo,
LLC and Dolce B. Investments, Inc. to document the aggregate amounts outstanding to each entity as of the date of the note. Subsequently,
on September 1, 2022, we entered into a revolving promissory note with each of these entities to amend and restate all prior promissory
notes and/or arrangements in their entirety to reflect the revolving terms of the borrowings more accurately from each of these entities.
Following is a description of the various promissory notes and arrangements with each entity:

 From
time to time, we made revolving borrowings from Lucid Technologies, LLC. On September 29, 2021, we entered into a promissory note for
the benefit of Lucid Technologies, LLC in the original principal amount of $438,450, which note had no stated interest and was payable
on September 30, 2022. On September 1, 2022, we subsequently amended and restated the promissory note and any and all other non-written
arrangements with Lucid Technologies, LLC as set forth in a revolving promissory note. The revolving promissory note has a limit of $600,000,
is payable on September 30, 2023, and is interest-free. As of September 30, 2023, an aggregate of $0 was owed to Lucid Technologies,
LLC.

 From
time to time, we made revolving borrowings from PrivateCo, LLC. On September 29, 2021, we entered into a promissory note for the benefit
of PrivateCo, LLC in the original principal amount of $5,100, which note had no stated interest and was payable on September 30, 2022.
On September 1, 2022, we subsequently amended and restated the promissory note and any and all other non-1 written arrangements with
PrivateCo, LLC as set forth in a revolving promissory note. The revolving promissory note has a limit of $310,000, is payable on September
30, 2023, and is interest-free. As of September 30, 2023, an aggregate of $0 was owed to PrivateCo, LLC.

 From
time to time, we made revolving borrowings from Mix 1, LLC. On September 29, 2021, we entered into a promissory note for the benefit
of Mix 1, LLC in the original principal amount of $3,500, which note had no stated interest and was payable on September 30, 2022. On
September 1, 2022, we subsequently amended and restated the promissory note and any and all other non-written arrangements with Mix 1,
LLC as set forth in a revolving promissory note. The revolving promissory note has a limit of $50,000, is payable on September 30, 2023,
and is interest-free. As of September 30, 2023, an aggregate of $0 was owed to Mix 1, LLC.

 From
time to time, we made revolving borrowings from Dolce B. Investments, Inc. On April 30, 2022, we entered into a promissory note for the
benefit of Dolce B. Investments, Inc. in the original principal amount of $18,500, which note had no stated interest and was payable
on December 31, 2022. On September 1, 2022, we subsequently amended and restated the promissory note and any and all other non-written
arrangements with Dolce B. Investments, Inc. as set forth in a revolving promissory note. The revolving promissory note has a limit of
$100,000, is payable on September 30, 2023, and is interest-free. As of September 30, 2023, an aggregate of $0 was owed to Dolce B. Investments,
Inc.

 From
time to time, we made revolving borrowings from PubCo, LLC. On May 6, 2022, we entered into a promissory note for the benefit of PubCo,
LLC in the original principal amount of $24,000, which note had no stated interest and was payable on September 30, 2022. On September
1, 2022, we subsequently amended and restated the promissory note and any and all other non-written arrangements with PubCo, LLC as set
forth in a revolving promissory note. The revolving promissory note has a limit of $100,000, is payable on September 30, 2023, and is
interest-free. As of September 30, 2023, an aggregate of $0 was owed to PubCo, LLC.

 From
time to time, we made revolving borrowings from Diamond Technologies, LLC. On September 1, 2022, we entered into a revolving promissory
note for the benefit of Diamond Technologies, LLC. The revolving promissory note has a limit of $100,000, is payable on September 30,
2023, and is interest-free. As of September 30, 2023, an aggregate of $0 was owed by Diamond Technologies, LLC.

 Other
than the foregoing, none of the directors or executive officers of the Company, nor any person who owned of record or was known to own
beneficially more than 5% of the Company's outstanding shares of its Common Stock, nor any associate or affiliate of such persons
or companies, has any material interest, direct or indirect, in any transaction that has occurred during the past fiscal year, or in
any proposed transaction, which has materially affected or will affect the Company.

 With
regard to any future related party transaction, we plan to fully disclose any and all related party transactions in the following manner:

 Disclosing
such transactions in reports where required;

 Disclosing
in any and all filings with the SEC, where required;

 Obtaining
disinterested director consent; and

 Obtaining
shareholder consent where required.

 ITEM
14. PRINCIPAL ACCOUNTING FEES AND SERVICES

 Turner,
Stone & Company, LLP, independent registered public accounting firm, has audited our financial statements for the fiscal year ended
September 30, 2023 and Semple, Marchal & Cooper, LLP, independent registered public accounting firm, has audited our financial statements
for the fiscal year ended September 30, 2022, as set forth in their report (which contains an explanatory paragraph describing conditions
that raise substantial doubt about our ability to continue as a going concern as described in Note 2 to the financial statements) appearing
elsewhere herein. We have included our financial statements in the prospectus and elsewhere in the registration statement in reliance
on their report, given on their authority as experts in accounting and auditing.

 The
 following is the breakdown of aggregate fees for the last two fiscal years.

 2023

 2022

 Audit
 Fees

 $

 225,000

 $

 225,341

 Audit
 Related Fees

 125,000

 68,199

 Tax
 Fees

 —

 —

 $

 350,000

 $

 293,540

 It
is our policy to engage the principal accounting firm to conduct the financial audit for our company and to confirm prior to such engagement
that such principal accounting firm is independent of our company when required by SEC rules and regulations. All services of the principal
accounting firm reflected above were approved by the Board of Directors.

 -
"Audit Fees" are fees paid for professional services for the audit of our financial statements.

 - "Audit-Related
fees" are fees paid for professional services not included in the first category, specifically, SAS 100 reviews, SEC filings and
consents, and accounting consultations on matters addressed during the audit or interim reviews, and review work related to quarterly
filings.

 -
"Tax Fees" are fees primarily for tax compliance in connection with filing US income tax returns.

 Audit
Committee Pre-Approval Policies

 The
charter of our Audit Committee provides that the duties and responsibilities of our Audit Committee include the pre-approval of all audit,
audit- related, tax, and other services permitted by law or applicable SEC regulations (including fee and cost ranges) to be performed
by our independent registered public accountant. Any pre-approved services that will involve fees or costs exceeding pre-approved levels
will also require specific pre-approval by the Audit Committee. Unless otherwise specified by the Audit Committee in pre-approving a
service, the pre-approval will be effective for the 12-month period following pre-approval. The Audit Committee will not approve any
non-audit services prohibited by applicable SEC regulations or any services in connection with a transaction initially recommended by
the independent registered public accountant, the purpose of which may be tax avoidance and the tax treatment of which may not be supported
by the Code and related regulations.

 To
the extent deemed appropriate, the Audit Committee may delegate pre-approval authority to the Chairman of the Audit Committee or any
one or more other members of the Audit Committee provided that any member of the Audit Committee who has exercised any such delegation
must report any such pre-approval decision to the Audit Committee at its next scheduled meeting. The Audit Committee will not delegate
the pre-approval of services to be performed by the independent registered public accountant to management.

 Our
Audit Committee requires that the independent registered public accountant, in conjunction with our Chief Financial Officer, be responsible
for seeking pre-approval for providing services to us and that any request for pre-approval must inform the Audit Committee about each
service to be provided and must provide detail as to the particular service to be provided.

 All
of the services provided above under the caption "Audit-Related Fees" were approved by our Board of Directors or by our Audit
Committee pursuant to our Audit Committee's pre-approval policies.

 PART
IV

 ITEM
15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 (a)
 Financial
Statements and Financial Statement Schedules are set forth under Part II, Item 8 of this report.

 (b)
 Exhibits

 Other
Schedules are committed because they are not applicable, not required, or because the required information is included in the Financial
Statements or notes thereto.

 Reference Filed
or Furnished

 Exhibit

 Number

 Exhibit
 Description

 Form

 Exhibit

 Filing

 Date

 Herewith

 31.1

 Certification
 of Principal Executive Officer Pursuant to Exchange Act Rules 13a- 1 4(a) and 15d-14(a), as Adopted Pursuant to Section 302 of the
 Sarbanes-Oxley Act of 2002

 08/20/2024

 X

 31.2

 Certification
 of Principal Financial Officer Pursuant to Exchange Act Rules 13a- 1 4(a) and 15d-14(a), as Adopted Pursuant to Section 302 of the
 Sarbanes-Oxley Act of 2002

 08/20/2024

 X

 32.1

 Certification
 of Principal Executive Officer Pursuant to 18 U.S.C. 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 08/20/2024

 X

 32.2

 Certification
 of Principal Financial Officer Pursuant to 18 U.S.C. 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 08/20/2024

 X

 SIGNATURES

 Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report
to be signed on its behalf by the undersigned, thereunto duly authorized.

 By:

 /s/
 John G. Grdina

 Dated:
 August 20, 2024

 John
 G. Grdina, Chief Executive Officer

 By:

 /s/
 Steven Staehr

 Dated:
 August 20, 2024

 Staehr, Chief Financial Officer

 Pursuant
to the requirements of the Securities Exchange Act of 1934, the following persons on behalf of the Registrant and in the capacities and
on the dates indicated have signed this report below.

 Name

 Title

 Date

 /s/
 John G. Grdina

 Chief
 Executive Officer and

 John
 G. Grdina

 Chairman of the Board of Directors

 (Principal Executive Officer)

 /s/
 Steven Staehr

 Chief
 Financial Officer (Principal Financial

 Staehr

 Officer and Principal Accounting Officer)

 /s/
 Paul Vassilakos

 August 20, 2024

 Paul
 Vassilakos

 /s/
 Alan Menkes

 Alan
 Menkes

 /s/
 George C. Chien

 C. Chien

 /s/
 Thierry Chaunu

 Chaunu

TO FINANCIAL STATEMENTS

 Report of Semple, Marchal & Cooper, LLC. PCAOB ID: #178

 Report
 of Turner, Stone & Company, LLP.
 PCAOB ID: # 76

 Balance Sheets as of September 30, 2023 and September 30, 2022

 Statements of Operations for the years ended September 30, 2023 and September 30, 2022

 Statements of Stockholders' Equity for the years ended September 30, 2023 and September 30, 2022

 Statements of Cash Flows for the years ended September 30, 2023 and September 30, 2022

 Notes to Financial Statements

 F- 1

 REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 To
the Board of Directors and Stockholders of:

 Adamas
One Corp.

 Opinion
on the Financial Statements

 We
have audited the accompanying balance sheets of Adamas One Corp. (the "Company") as of September 30, 2022 and 2021, the related
statements of operations, stockholders' equity (deficit), and cash flows for the years then ended, and the related notes (collectively
referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects,
the financial position of the Company as of September 30, 2022 and 2021 and the results of its operations and its cash flows for the years
then ended, in conformity with accounting principles generally accepted in the United States of America.

 Going
Concern Uncertainty

 The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note
2 to the financial statements, the Company has suffered recurring losses from operations, has a negative cash flow from operations, and
has only recently commenced sales. Through a recent IPO, which closed on December 14, 2022, the Company received gross proceeds of $11,025,000
before direct IPO expenses and fees associated with the underwriting. These funds, along with the ability to obtain additional capital
through additional equity and/or debt financing, are going to be needed for the Company to pursue its strategic plan to acquire additional
production equipment and expand capacity. Currently, the Company needs to be able to generate positive cash flow from operations to alleviate
the going concern. These factors raise substantial doubt about the Company's ability to continue as a going concern. Management's
plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result
from the outcome of this uncertainty.

 Basis
for Opinion

 These
financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion
on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

 Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide
a reasonable basis for our opinion.

 /s/
Semple, Marchal & Cooper, LLP

 Certified
Public Accountants

 We
have served as the Company's auditor since 2021.

 Phoenix,
Arizona

 January
13, 2023

 F- 2

 Report
of Independent Registered Public Accounting Firm

 Board of Directors

 Adamas One Corp.

 Opinion on the Financial Statements

 We have audited the accompanying balance sheet of
Adamas One Corp. ("Company") as of September 30, 2023, and the related statements of operations, changes in stockholders'
equity, and cash flows for the year ended September 30, 2023, and the related notes (collectively referred to as the "financial
statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of Adamas
One Corp. as of September 30, 2023, and the results of its operations and its cash flows for the year then ended in conformity with accounting
principles generally accepted in the United States of America.

 Going Concern

 The accompanying financial statements have been prepared
assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has suffered
recurring losses from operations, net working capital deficiency that raise substantial doubt about its ability to continue as a going
concern. Management's plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.

 Basis for Opinion

 These financial statements are the responsibility
of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits. We are
a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required
to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations
of the Securities and Exchange Commission and the PCAOB.

 We conducted our audits in accordance with the standards
of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform,
an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal
control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the entity's internal
control over financial reporting. Accordingly, we express no such opinion.

 Our audits included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 /s/ Turner, Stone & Company, L.L.P

 We have served as Adamas One Corp.'s auditor since 2023.

 Dallas, Texas

 August 20, 2024

 F- 3

 BALANCE SHEETS

 At

September 30,

 At

September 30,

 2023

 2022

 ASSETS

 Current Assets:

 Cash

 $
 26,088

 $
 88,235

 Accounts receivable, net of allowance

 80,347

 1,277,368

 Inventory

 1,555,222

 58,690

 Total Current Assets

 1,661,657

 1,424,293

 Property and Equipment, net

 1,785,753

 640,002

 Non-current Assets:

 Goodwill

 5,413,000

 5,413,000

 Intangible assets, net

 426,000

 498,000

 Right of use assets - operating leases

 1,677,628

 -

 Investment

 1,917,673

 -

 Other non-current assets

 12,800

 12,800

 Total non-current assets

 11,232,854

 5,923,800

 TOTAL ASSETS

 $
 12,894,511

 $
 7,988,095

 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

 Current Liabilities:

 Accrued liabilities

 $
 1,015,050

 $
 686,910

 Accrued interest

 95,197

 509,620

 Due to related party - payroll and related

 1,130,074

 2,679,907

 Due to related party - notes payable

 -

 558,658

 Assumed liability - asset purchase

 457,912

 457,912

 Warrant liability

 298,839

 -

 Notes payable and convertible term notes, net

 2,195,708

 7,882,500

 Current portion of operating lease liability

 157,286

 -

 Contingent consideration for debt compliance related to notes payable

 2,922,280

 -

 Total Current Liabilities

 8,272,346

 12,775,507

 Non-current Liabilities:

 Operating lease liability, net of current portion

 1,498,674

 -

 Total Non-current Liabilities

 1,498,674

 -

 TOTAL LIABILITIES

 9,771,020

 12,775,507

 Commitments and Contingencies (Note 7)

 Stockholders' Equity (Deficit)

 Preferred stock, $ 0.001
 par value, 10,000,000 shares authorized
 with zero issued and outstanding at
 September 30, 2023 and 2022.

 Common stock, $ 0.001
 par value, 100,000,000 shares authorized
with 27,215,966 shares issued and outstanding
at September 30, 2023 and 16,369,423 shares
issued and outstanding at September 30, 2022.

 27,564

 16,369

 Treasury stock 350,000 shares, at cost

)

 -

 Shares to be issued - strategic entity

 1,527,312

 -

 Additional paid-in capital

 66,372,882

 36,511,950

 Accumulated deficit

 ( 63,604,267
)

 ( 41,315,731
)

 Total Stockholders' Equity (Deficit)

 3,123,491

 ( 4,787,412
)

 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

 $
 12,894,511

 $
 7,988,095

 The
accompanying notes are an integral part of these financial statements.

 F- 4

 STATEMENTS OF OPERATIONS

 For
 the Years Ended September 30, 2023 and 2022

 2023

 2022

 Net Revenues

 Diamond sales

 $
 1,007,705

 $
 1,788,642

 Cost of revenues

 253,108

 603,276

 Gross Profit

 754,597

 1,185,366

 Operating Expenses

 Selling, general and administrative

 11,017,046

 4,718,751

 Employee salaries and related expenses

 6,453,045

 5,012,862

 Depreciation and amortization expense

 429,849

 390,204

 Contingent consideration for debt compliance

 2,922,280

 -

 Total operating expenses

 20,822,220

 10,121,817

 Loss from Operations

 ( 20,067,623
)

 ( 8,936,451
)

 Other Expenses

 Warrant issuance expense

 ( 2,038,000
)

 -

 Interest expense

 ( 438,317
)

 ( 2,131,407
)

 Total Other Expenses

 ( 2,476,317
)

 ( 2,131,407
)

 Loss before income taxes

)

)

 Provision for income taxes

 -

 -

 Net Loss

 $
)

 $
)

 Net Loss Per Share

 Basic and diluted

 Weighted average number of shares outstanding

 22,269,981

 18,463,010

 Loss per share-basic and diluted

 $
 ( 1.01
)

 $
 ( 0.60
)

 The
accompanying notes are an integral part of these financial statements.

 F- 5

 STATEMENTS OF STOCKHOLDERS ' EQUITY (DEFICIT)

 Additional

 Stock

 Paid-In

 Shares

 Treasury

 Accumulated

 Shares
 Outstanding

 Par
 Value

 Capital

 To
 Be Issued

 Stock

 (Deficit)

 Total

 Balance
 at September 30, 2021

 18,651,750

 $
 18,652

 $
 23,870,976

 -

 -

 $
 ( 30,247,873
)

 $
 ( 6,358,245
)

 stock issued to board members

 80,000

 319,920

 -

 -

 -

 320,000

 stock issued for cash at $4.00

 25,000

 99,975

 -

 -

 -

 100,000

 stock issued for incentive to lender

 14,667

 58,653

 -

 -

 -

 58,667

 stock issued to employees

 850,000

 3,399,150

 -

 -

 -

 3,400,000

 shares issued from converted interest

 25,708

 102,806

 -

 -

 -

 102,832

 stock issued to consultant

 370,000

 1,479,630

 -

 -

 -

 1,480,000

 stock issued for loan modifications

 352,298

 1,408,840

 -

 -

 -

 1,409,192

 shares returned from CEO

 ( 4,000,000
)

 -

 16,000,000

 -

 ( 16,000,000
)

 -

 -

 Retirement
 of Treasury Stock

 -

 ( 4,000
)

 ( 15,996,000
)

 -

 16,000,000

 -

 -

 CEO
 and CFO waiver of severance liability

 -

 -

 5,768,000

 -

 -

 -

 5,768,000

 Net
loss

 -

 -

 -

 -

 -

)

)

 Balance
 at September 30, 2022

 16,369,423

 $
 16,369

 $
 36,511,950

 $
 -

 $
 -

 $
 ( 41,315,731
)

 $
 ( 4,787,412
)

 Adjustment
 to opening balance

 -

 -

 -

 -

 -

 255,403

 255,403

 -

 -

 Balance
 at October 01, 2022

 16,369,423

 $
 16,369

 $
 36,511,950

 $
 -

 $
 -

 $
 ( 41,060,328
)

 $
 ( 4,532,009
)

 -

 -

 stock issued to employees

 1,933,500

 1,933

 5,992,134

 -

 -

 -

 5,994,067

 stock issued to board members

 85,000

 252,065

 -

 -

 -

 252,150

 stock issued for consultants

 3,963,700

 3,964

 4,885,899

 -

 -

 -

 4,889,863

 stock issued for conversion of note and accrued interest

 2,061,103

 2,060

 6,868,430

 -

 -

 -

 6,870,490

 stock issued for IPO, net of costs of $1,892,250

 2,450,000

 2,450

 9,130,300

 -

 -

 -

 9,132,750

 Warrants
 issued

 -

 -

 2,038,000

 -

 -

 -

 2,038,000

 Repurchase
 stock

 ( 350,000
)

 -

 -

 -

)

 -

)

 stock issued for ownership in strategic entity

 400,000

 389,962

 -

 -

 -

 390,362

 stock issued as inducement to lenders

 303,240

 304,142

 -

 -

 -

 304,445

 Shares
 to be Issued- strategic entity

 -

 -

 -

 1,527,312

 -

 -

 1,527,312

 Net
 loss

 -

 -

 -

 -

 -

)

)

 Balance
 at September 30, 2023

 27,215,966

 $
 27,564

 $
 66,372,882

 $
 1,527,312

 $
)

 $
 ( 63,604,267
)

 $
 3,123,491

 The
accompanying notes are an integral part of these financial statements.

 F- 6

 STATEMENTS OF CASH FLOWS

 For
 the Years Ended September 30, 2023 and 2022

 2023

 2022

 OPERATING ACTIVITIES

 Net loss

)

 $
)

 Adjustments to reconcile net loss to net cash used in operations:

 Common Stock issued to employees for stock-based compensation

 5,994,067

 3,400,000

 Common stock issued to board members

 252,150

 320,000

 Common stock issued to consultants

 4,889,863

 1,480,000

 Common stock issued for loan modifications

 -

 1,409,192

 Common stock issued for interest

 -

 102,832

 Incentive warrants issued

 2,038,000

 -

 Stock issued for loan inducement

 304,445

 58,668

 Depreciation and amortization

 429,849

 390,204

 Debt discount amortization

 67,825

 36,836

 Allowance for doubtful accounts

 1,477,200

 283,250

 Contingent consideration for debt compliance

 2,922,280

 -

 Changes in assets and liabilities:

 Accounts receivable

 ( 280,179
)

 ( 1,560,618
)

 Inventory

 ( 1,496,531
)

 26,310

 Other current assets

 -

 11,306

 Accrued liabilities

 289,139

 411,997

 Accrued interest

 161,470

 237,538

 Due to related party – payroll and related

 ( 1,549,832
)

 1,267,152

 Severance obligation

 -

 43,000

 Warrant liability

 298,839

 -

 Right of use assets - operating leases, net

 ( 21,668
)

 -

 Net cash used in operating activities

 ( 6,767,023
)

 ( 3,150,192
)

 INVESTING ACTIVITIES

 Property and equipment

 ( 1,464,600
)

 -

 Net cash used in investing activities

 ( 1,464,600
)

 -

 FINANCING ACTIVITIES

 Notes Payable Proceeds

 795,384

 2,765,000

 Due to related party

 ( 558,658
)

 111,608

 Purchase of treasury stock

)

 -

 Cash from stock sale, net of costs of $1,892,250 for the year ended September 30, 2023

 9,132,750

 100,000

 Net cash provided by financing activities

 8,169,476

 2,976,608

 Net cash increase (decrease) for the period

 ( 62,147
)

 $
 ( 173,584
)

 Cash, beginning of period

 88,235

 261,819

 Cash, end of the period

 26,088

 $
 88,235

 Non-cash investing and financing activities are as follows:

 Stock issued for debt and interest

 $
 6,870,490

 $
 102,831

 Waiver of severance liability

 $
 -

 $
 5,768,000

 Stock issued for investment

 $
 390,362

 $
 -

 The
accompanying notes are an integral part of these financial statements.

 F- 7

 Adamas
One Corp.

 Notes
to Financial Statements

 NOTE
1 – ORGANIZATION AND BUSINESS ACTIVITY

 We were incorporated on September 6, 2018, in the
state of Nevada for the purpose of acquiring existing technology that would efficiently and effectively produce lab-grown, environmentally
friendly, ethically sourced diamonds. On January 31, 2019, we entered into an Amended Asset Purchase Agreement with Scio Diamond Technology
Corporation, or Scio, which was subsequently amended February 3, 2020, pursuant to which we acquired substantially all of the assets
of Scio, which assets consisted primarily of proprietary diamond growing chemical reactors, which we refer to as diamond growing machines,
patents, and all intellectual property related thereto, for an aggregate of 1,500,000
shares of our common stock and payment to certain lenders
of Scio of an aggregate of $ 2.1
million in cash. In addition, we agreed to pay
one-half of certain other unsecured operational liabilities of Scio. The transaction was approved by a majority of the Scio stockholders
voting in person or by proxy at a special meeting of stockholders held commencing on July 12, 2019, and reconvening on August 6, 2019.
The transaction closed on October 17, 2019. We recorded the fair value of the assets purchased and liabilities assumed at $ 8.65
million.

 The
assets and liabilities were valued using ASC 805, the fair value of assets acquired and liabilities assumed in a business combination,
which requires the measurement of assets acquired and liabilities assumed to be recognized at their acquisition-date fair values.

 Since
acquiring the assets of Scio, we have continued to further develop the technologies acquired from Scio, and we have begun producing diamonds
for fine jewelry and diamond material for industrial uses.

 NOTE
2 – GOING CONCERN

 The
accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction
of liabilities in the normal course of business. We incurred a net loss of $22.5 million and used approximately $6.8 million of cash
in operations for the year ended September 30, 2023. We incurred a net loss of $11.1 million and used approximately $3.2 million of cash
in operations for the year ended September 30, 2022. In addition, we have only recently commenced commercial sales of our product. These
conditions raise substantial doubt about our ability to continue as a going concern for the ensuing year.

 The
ability to obtain additional capital through additional equity and/or debt financing, are anticipated to meet our short-term operating
needs. However, we are not currently generating sufficient revenue to meet operating needs and to pursue our strategic plan. The pursuit
of our strategic plan without higher revenues from operations would materially impact our ability to continue as a going concern.

 We
will need additional financing to implement our full business plan and to service our ongoing operations. There can be no assurance that
we will be able to secure any needed funding, or that if such funding is available, the terms or conditions would be acceptable to us.
If we are unable to obtain additional financing when it is needed, we will need to restructure our operations and possibly divest all
or a portion of our business. We may seek additional capital through a combination of equity offerings and debt financing. Debt financing,
if obtained, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring
additional debt, and could increase our expenses and require that our assets secure such debt. Equity financing, if obtained, could result
in dilution to our then-existing stockholders and/or require such stockholders to waive certain rights and preferences. The financial
statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amount and
classification of liabilities or any other adjustment that might be necessary should we be unable to continue as a going concern.

 See
Note 14 for additional equity and debt proceeds received subsequent to September 30, 2023.

 NOTE
3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 Basis of Presentation and Preparation

 The accompanying financial statements of the Company have been prepared
in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for financial information
and with the instructions to Form 10-K as promulgated by the Securities and Exchange Commission (the "SEC"). Accordingly,
these financial statements include all of the disclosures required by generally accepted accounting principles for complete financial
statements.

 The
Company's fiscal year begins on October 1 and ends on September 30. Unless otherwise stated, references to particular years, quarters,
months and periods refer to the Company's fiscal years ended in September and the associated quarters, months and periods of those
fiscal years.

 Reclassification

 Certain
prior period amounts in the balance sheet, statement of cash flows and accompanying notes have been reclassified to conform to the
current period's presentation.

 Use
of Estimates

 The
preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and reported
amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates
made in preparing the financial statements include, but are not limited to, the following: collectability of accounts receivable,
the potential impairment of goodwill, valuation of deferred tax assets, carrying value of inventories, useful lives and recovery of
equipment and other intangible assets, debt discounts and valuations, and valuation of stock-based compensation.

 Cash
and Cash Equivalents

 For
purposes of the statements of cash flows, we consider highly liquid financial instruments purchased with a maturity of three months or
less at the time of purchase to be cash equivalents.

 F- 8

 Accounts
Receivable

 We
follow the allowance method of recognizing uncollectible accounts receivable, which recognizes bad debt expense based on a review of
the individual accounts outstanding and our prior history of uncollectible accounts receivable. We extend credit based on an evaluation
of each customer's financial condition, and our receivables are generally unsecured. Accounts receivable are stated net of an allowance
for doubtful accounts in the balance sheet. We consider accounts past due if outstanding longer than contractual payment terms. We record
an allowance based on consideration of a number of factors, including the length of time trade accounts are past due, our previous loss
history, the creditworthiness of individual customers, economic conditions affecting specific customer industries, and economic conditions
in general. We charge-off accounts receivable after all reasonable collection efforts have been exhausted. We credit payments subsequently
received on such receivables to bad debt expense in the period we receive the payment.

 As of September 30, 2023, we
had established an allowance of $1.7 million for potentially uncollectible accounts receivable. As of September 30, 2022, we had established
an allowance of $0.3 million for potentially uncollectible accounts receivable. We record delinquent finance charges on outstanding accounts
receivable only if they are collected.

 Property
and Equipment

 We
recorded property and equipment purchased at cost. Depreciation of property, plant and equipment is on a straight-line basis
beginning at the time it is placed in service and based on the estimated useful lives.

 Schedule of Estimated useful lives

 Years

 Machinery
 and equipment

 – 10

 Furniture
 and fixtures

 – 5

 Engineering
 equipment

 – 12

 Leasehold
improvements which are included in the fixed
assets on the balance sheet are depreciated over the lesser of the remaining term of the lease or the life of the asset (generally
3 – 5 years).

 Upon retirement or sale of property and
equipment, we will remove the cost of the disposed assets and related accumulated depreciation from the accounts and any resulting gain
or loss is credited or charged to other income and expense. We charge expenditures for normal repairs and maintenance to
expense as incurred. We capitalize additions and expenditures for improving or rebuilding existing assets that extend the useful life.
Leasehold improvements made either at the inception of the lease or during the lease term will be amortized over the shorter of their
economic lives or the lease term including any renewals that are reasonably assured.

 Intangible
Assets

 As
of September 30, 2023, and 2022, we held the following number of patents:

 Schedule of Number of Patents held

 Jurisdiction

 No. of Patents

 United States

 Foreign

 Total

 Our
patents were filed during the period of 1999 to 2012, with the expiration of such patents occurring between 2019 and 2032. Our patents
contain an aggregate of over 750 claims, including methods for forming single crystal diamond using a CVD technique, methods for forming
synthetic diamond (a term which is no longer used in the industry and has been replaced with lab-grown diamond), techniques for seed
removal, methods of seed removal, applications of diamond for semiconductors, forming structures in diamond, using diamond as wave guides,
techniques for cutting diamonds, methods for forming boron doped Schottky diode devices, and methods for detection of lab-grown diamonds.
In addition to patents, we have also developed proprietary recipes, techniques, workflows, and other know-how.

 Of
our 36 patents, 15 of them have expired, and we are working to restore 12 of such patents. One of our patents, System and Method for
Producing Synthetic Diamond, has run its full course of 20 years and has expired. There are several follow-on system and method patents
that are still in effect. Our patent portfolio spans the method of producing lab-grown diamond to many application patents where lab-grown
diamond can be used. Our portfolio includes patents that should expire from as early as 2023 to as late as 2032. While all of the patents
are important, we consider the method patents the most material of our portfolio. We have method patents with filing dates of 2003, 2004,
2006, 2008, 2011, and 2012, which will begin to expire from as early as April 2023 to as late as 2032. The expiration of our patents
should not have a material effect on our ability to market or sell our diamonds in the future.

 While
patents are important, other intellectual property, most notably, know-how is also critical. We continue to improve, evolve, and update
our processes, recipes, procedures, and proprietary equipment on a continuous basis. All our employees are under strict non-disclosure,
non-compete, and non-solicitation restrictions as part of their employment agreements.

 Our
research and development staff will continue efforts to develop proprietary manufacturing processes and equipment designed to enhance
our manufacturing facilities, improve yield, and reduce manufacturing costs. All our employees have executed intellectual property and
proprietary rights agreements. These agreements also include confidentiality, non-compete, and non-solicitation provisions.

of Intangible Assets

 Intangible
 assets – Research and Development (fully depreciated)

 $
 1,700,000

 Intangible
 assets – Technology (10 year amortization)

 720,000

 Total
 intangible assets

 2,420,000

 Less
 accumulated amortization as of September 30, 2021

 ( 1,850,000
)

 Net
 intangible assets as of September 30, 2021

 570,000

 Less
 amortization for September 30, 2022

 ( 72,000
)

 Net
 intangible assets as of September 30, 2022

 498,000

 Less
 amortization for September 30, 2023

 ( 72,000
)

 Net
 intangible assets as of September 30, 2023

 $
 426,000

 We
recorded amortization expense for intangible assets in the amounts of $72,000 for each of the fiscal years ended September 30, 2023 and
2022. Future amortization will be $72,000 per year for the following five years and $66,000 for the sixth year.

and development was fully amortized as of September 30, 2023. Intangible assets – technology is being amortized over 10 years.

 F- 9

 Goodwill

 We evaluate goodwill for impairment annually or more
frequently when an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below
its carrying amount. In testing for goodwill impairment, we may elect to utilize a qualitative assessment to evaluate whether it is more
likely than not that the fair value of a reporting unit is less than its carrying amount. If our qualitative assessment indicates that
goodwill impairment is more likely than not, we perform a two-step impairment test. We test goodwill for impairment under the two-step
impairment test by first comparing the book value of net assets to the fair value of the reporting unit. If the fair value is determined
to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step
is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value.
We estimate the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate
of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general
economic conditions.

 The Company's g oodwill
represents the excess of fair value over identifiable tangible and intangible net assets acquired in the Scio business combination.
Goodwill is not amortized, instead goodwill is reviewed for impairment at least annually, or on an interim basis between annual
tests when events or circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than
it's carrying value. The goodwill from the Scio asset purchase was valued at $ 5,413,000. The Company completed the annual goodwill impairment test in the fourth
quarter and determined the fair value of the reporting unit exceeded the carrying value. No impairment expense was recognized for the
years ended September 30, 2023 or 2022.

 Impairment
of Long-Lived Assets

 We
continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable.
When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the
carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows
is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the
fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.
No impairment expense was recognized for the years ended September 30, 2023 or 2022.

 Revenue
Recognition

 We
generate revenue from the production and sale of diamonds. We recognize revenue according to Accounting Standards Codification 606 –
Revenue from Contracts with Customers ("ASC 606"). When the customer obtains control over the promised goods or services, we
record revenue in the amount of consideration that we can expect to receive in exchange for those goods. We apply the following five-step
model to determine revenue recognition:

 identification
of a contract with a customer;

 identification
of the performance obligations in the contact;

 determination
of the transaction price;

 allocation
of the transaction price to the separate performance obligations; and

 recognition
of revenue when performance obligations are satisfied.

 At contract inception and once the contract is determined to be within the scope of ASC 606,
we assess the goods or services promised within each contract and determine those that are performance obligations and assess whether
each promised good or service is distinct. Our contracts contain a single performance obligation (delivery of diamonds), and the entire
transaction price is allocated to the single performance obligation. We recognize as revenue the amount of the transaction price that
is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Accordingly,
we recognize revenue when the customer obtains control of our product, which typically occurs upon delivery of the product. Our credit
terms are currently that payment is due within 90 days.

 Shipping costs consists of fees charged to customers
for shipping of sold items by the Company. The performance obligation is to ship the item sold as initiated by the customer. The price
is set based on the third-party service provider selected to be used by the customer as well as the speed and location of shipment. Revenue
is recognized at a point in time when the shipping label is printed.

 Disaggregated
Revenue Information

 We
have no disaggregated revenue to report for the years ended September 30, 2023 or 2022.

 F- 10

 Advertising
Costs

 We
plan to expense advertising costs as they are incurred. We have incurred no advertising costs to date.

and Development

 We
conduct research and development activities to enhance existing processes and products and develop new processes and products at our
facilities in Greenville, South Carolina, utilizing our personnel and strategic relationships. We expense all costs associated with our
research and development efforts through either our cost of goods sold, as they are performed by the same employees who produce our finished
product, or through our general and administrative expenses if the product has not been brought to market. We anticipate that it may become necessary to reclassify research and development costs into our operating expenditures
for reporting purposes as we begin to develop new lines of jewelry and extend into the semiconductor industry.

and Development costs are accounted for in accordance with ASC 730, Research and Development. All of our R&D for the years ended
September 30, 2023 and September 30, 2022 is recognized as an expense and incurred in accordance with ASC 730-10-25. The expenses
related to research and development for the years ended September 30, 2023 and 2022 included in the Statement of Operations were
approximately $ 200,000 and
$ 220,000, respectively.

 Fair
Value of Financial Instruments

 Accounting Standards Codification ("ASC")
requires disclosure of the fair value of financial statements held by the Company. ASC 820 specifies a valuation hierarchy based on
whether the inputs to those valuation techniques are observable or unobservable.

 Observable
inputs reflect market data obtained from independent sources, while unobservable inputs reflect our own assumptions. These two types
of inputs have created the following fair value hierarchy:

 Level
1 – Quoted prices for identical instruments in active markets;

 Level
2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that
are not active, and model- derived valuations in which all significant inputs and significant value drivers are observable in active
markets; and

 Level
3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 This
hierarchy requires the use of observable market data, if available, when estimating fair
value. These financial instruments include cash, accounts receivable, accounts payable, accrued expenses, amounts due to related parties,
and notes payable. The fair values of these financial instruments approximate their carrying values using Level 3 inputs, based on their
short maturities or, for notes payable, based on borrowing rates currently available to us for loans with similar terms and maturities.

 Inventories

 Inventories are stated at the lower of cost or net realizable value, and consist of various diamond pieces, jewelry pieces, and work in process.
Work-in-process and finished goods included the cost of materials, direct labor and overhead. At the closing of each reporting period,
the Company evaluates its inventory in order to adjust the inventory balance for obsolete and slow-moving items. We also purchase lab-grown
diamonds from a vendor who cuts and polishes the majority of our manufactured diamonds as the vendor has access to other lab-grown diamonds
that may supplement the inventory needed by the Company or which may be unique in nature which may appeal to our customers or be used
in design of our proprietary jewelry line which is under development. We carry the value of these purchased diamonds at the lower of
cost or net realizable value. Included in inventory is work in process which states the average cost method of these items at their state
of completion at the balance sheet date. At September 30, 2023 and September 30, 2022 our inventory consisted of finished precious stones
in various carat sizes, shapes, and colors that we produced or purchased and work in process.

 Stock-Based

 We account for stock-based compensation at fair
value in accordance with Accounting Standards Codification 718 – Compensation – Stock Compensation ("ASC 718"),
which requires the measurement and recognition of compensation expense for all share-based payment awards to employees and directors.
On October 01, 2022, we adopted ASU 2022-03, "Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions."
Accordingly, stock-based compensation is valued using market value of our Common Stock. Stock-based compensation is recognized on a straight-line
basis over the vesting periods and forfeitures are recognized in the periods they occur. We account for common stock purchase option awards
by estimating the fair value of each option award on the grant date using the Black-Scholes option pricing model that uses assumption
and estimates that we believe are reasonable.

 We
account for stock-based compensation at estimated fair value on the date of grant. There were 1,933,500
shares of common stock granted and issued to employees for services during the fiscal year ended September 30, 2023. These were
valued at an average price per share of $3.10, for an aggregate of $ 5,994,067.
There were 850,000
shares of common stock granted and issued to five employees for services during the fiscal year ended September 30, 2022. These were
valued at $4.00 per share, or an aggregate of $ 3,400,000.

 The
price per share is $4.00 for all shares granted prior to the first day of public trading December 9, 2022, and the closing price of the
day of the grant for all grants after December 9, 2022. The grants are fully vested and are recognized upon the date of grant.

 Severance
Expense

 We
account for severance expenses in accordance with ASC 710-10-25-1, Compensation-General. The severance program, prior to being
waived by the CEO and CFO, provided for benefits to those two key executive employees, to be paid upon their termination, whether initiated
by us or at the employee's discretion. These benefits were fully vested and had an annual escalation provision and were expensed
as they were incurred. As part of the Company's IPO, the CEO and CFO waived their contractual severance related amounts previously
recorded to help meet various formal and informal valuation analysis and the NASDAQ listing guidelines requirement at the initial listing
date. The effect of this waiver was to reduce the liability and record an increase in paid-in capital in the amount of $5,768,000 as
of September 30, 2022. As a result of the above-mentioned waivers there was no severance expense during the year ended September 30,
2023.

 F- 11

 Concentrations
of Credit Risk

 Accounts
at banks are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to $250,000. As of September 30, 2023, and September
30, 2022 our bank account balances did not exceed the federally insured limit.

 Income
Taxes

 We
filed federal and state income tax returns in accordance with the applicable rules of each jurisdiction. We account for income taxes
under the asset and liability method in accordance with Accounting Standards Codification 740 – Income Taxes, or ASC 740. The provision
for income taxes includes federal, state, and local income taxes currently payable, and deferred taxes. We recognize deferred tax assets
and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax basis. We measure deferred tax assets and liabilities using enacted tax rates expected
to apply to taxable amounts in years in which those temporary differences are expected to be recovered or settled. If it is more likely
than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized. In accordance with
ASC 740, we recognize the effect of income tax positions only if those positions are more likely than not of being sustained. We measure
recognized income tax positions at the largest amount that is greater than 50% likely of being realized. We reflect changes in recognition
or measurement in the period in which the change in judgment occurs.

 Contingencies

 Certain
conditions may exist as of the date the financial statements are issued that may result in a loss to us but will only be resolved when
one or more future events occur or fail to occur. We assess such contingent liabilities, and such assessment inherently involves an exercise
of judgment. In assessing loss contingencies related to potential unasserted claims that may result in legal proceedings against us,
we evaluate the perceived merits of any claims and the perceived merits of the amount of relief sought or expected to be sought therein
and determine if any loss is likely.

 If the assessment of a contingency indicates that
it is probable that a material loss has been incurred and the amount of the liability is reasonably estimated, the estimated liability
would be accrued in our financial statements. If the assessment indicates that a potentially material loss contingency is not probable
but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate
of range of possible loss if determinable and material, would be disclosed. There was a contingency consideration identified as of September
30, 2023 Refer to Note 7 for commitments and contingencies.

 The
Company retained outside counsel and filed a motion to dismiss and joined in Scio's motion to dismiss on February 17, 2023. Specifically,
the Company believes it was mis-joined to the lawsuit and that no claims are adequately pled against it. The Company further contended
the court lacked subject matter jurisdiction. The case was re-assigned to Hon. Cristina D. Silva. Judge Silva's on July 5, 2023.
On June 14, 2024, the court ordered additional briefing based on the Company's motion to dismiss for lack of subject matter jurisdiction.
The briefing was to commence on June 28, 2024, however, as a result of the court's inclination to grant the Company's motion
to dismiss, the Plaintiff stipulated to dismiss the claims against the Company, Mr. Grdina, and Scio's management and filed a voluntary
dismissal of all of the claims as of June 28, 2024.

 We
have accrued for contingencies totaling approximately $2.9 million year ended September 30, 2023, respectively. There were no other known
contingencies as of September 30, 2023.

 Recent
Accounting Pronouncements Adopted

 In
February 2016, the FASB issued Accounting Standards Update ("ASC") 2016-02, Leases (Topic 842). The update improves
financial reporting about leasing transactions by requiring a lessee to record on the balance sheet the assets and liabilities for
the rights and obligations created by lease terms of more than 12 months. We adopted ASU 2016-02 effective October 1, 2022 as
required for private companies, given the Company went public in December 2022. We have applied the modified retrospective approach
to adopt the new leasing standard. This approach typically applies the new standard to all existing leases existing at the date of
initial application and does not require a restatement of comparative periods. We completed the process of aggregating and
evaluating lease arrangements and implementing new processes during the fiscal year ended at September 30, 2023. As a result of
evaluating the impact of adoption of the ASC on our financial statements we recognized a right-of-use asset and lease liability on
our balance sheet for our real estate operating leases. At October 1, 2022 we recognized a right of use asset of $1.4 million, and a
lease liability of $1.4 million.

 Recent
Accounting Pronouncements

 In August 2020, the FASB issued Accounting Standards
Update ("ASU") 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging
– Contracts in Entity's Own Equity (Subtopic 815 – 40) ("ASU 2020-06"). ASU 2020-06 simplifies the accounting
for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on
an entity's own equity. The ASU is part of the FASB's simplification initiative, which aims to reduce unnecessary complexity
in US GAAP. The ASU's amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those
fiscal years. The Company is currently evaluating the impact of ASU 2020-06 on its financial statements.

 F- 12

 In
June 2016, the FASB issued ASU No. 2016-13, "Financial Instruments-Credit Losses (Topic 326)," which replaces the current incurred
loss impairment methodology for most financial assets with the current expected credit loss, or CECL, methodology. The series of new
guidance amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred
losses to estimate credit losses on certain types of financial instruments, including trade receivables. The guidance should be applied
on either a prospective transition or modified-retrospective approach depending on the subtopic. The guidance is effective for annual
periods beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted. We are
currently evaluating the impact that the new guidance will have on our financial statements, but since we have yet to recognize revenue,
adoption is not anticipated to have a material effect.

 In December 2023, the Financial Accounting Standards
Board ("FASB") issued Accounting Standards Update 2023-09 ("ASU 2023-09"), Income Taxes, which enhances the transparency
of income tax disclosures by expanding annual disclosure requirements related to the rate reconciliation and income taxes paid. The amendments
are effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied on a prospective
basis. Retrospective application is permitted. The Company is currently evaluating this ASU to determine its impact on the Company's disclosures.

 We
do not believe that any other recently issued, but not yet effective, accounting standards would have a material effect on the accompanying
financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

 Loss
Per Common Share

 We
calculate basic loss per share using the weighted average number of shares of common stock outstanding during each reporting period.
Diluted loss per share includes potentially dilutive financial instruments, such as convertible term notes and related interest. We
excluded 1,712,088
and 1,994,979
shares from the weighted average diluted common shares outstanding for September 30, 2023 and 2022, respectively, because their
inclusion would have been antidilutive. These shares are what would have been issued if the convertible debt, plus accrued interest
had been converted for each of the years ended September 30, 2023 and 2022. In addition, we have excluded 1,200,000 shares from the weighted average diluted common shares outstanding for the
years ended September 30, 2023. These shares would have been issued had both the Chief Executive Officer and the
Chief Financial Officer elected to terminate their employment with us prior to waiving their respective contractual rights to these shares.

 NOTE
4 – INVENTORIES

 As
of September 30, 2023 and September 30, 2022, the inventory balances were composed of purchased products carried at the lower of cost
or net realizable value, finished products and work in process carried at the value of the costs associated with the manufacturing of
the goods. As of September 30, 2023, finished products and work in process were $ 903,409 and $ 651,813, respectively. As of September
30, 2022, finished products and work in process were $ 26,833 and $ 31,857 respectively. There was no inventory obsolescence in the years
ended September 30, 2023 or September 30, 2022.

 NOTE
5 – PROPERTY AND EQUIPMENT

 Property
and equipment consisted of the following at September 30, 2023 and 2022:

 Schedule of Property and Equipment

 2023

 2022

 Property and equipment- in use

 $
 1,722,850

 $
 1,304,039

 Less accumulated depreciation

 ( 1,328,136
)

 ( 970,287
)

 Net property and equipment- in use

 394,714

 333,752

 Property and equipment- in process

 1,391,039

 306,250

 Total property and equipment, net

 $
 1,785,753

 $
 640,002

 Depreciation
expense for the years ended September 30, 2023 and 2022 totaled $ 357,849 and $ 318,204, respectively.

 NOTE
6 – DUE TO RELATED PARTY – PAYROLL AND RELATED

 Due to related party - payroll
and related liabilities are comprised of the following as of September 30, 2023 and 2022. Also see Note 11:

of Payroll and Related Liabilities

 2023

 2022

 CEO- Payroll and related

 $
 440,254

 $
 1,117,575

 CFO- Payroll and related

 675,974

 748,485

 COO- Payroll and related

 13,846

 813,846

 Total Due to related Party - payroll and related

 $
 1,130,074

 $
 2,679,907

 F- 13

 NOTE
7 – COMMITMENTS AND CONTINGENCIES

 Indemnifications

the normal course of business, we make certain indemnities and commitments under which we may be required to make payments in relation
to certain transactions. These may include (i) indemnities to vendors and service providers pertaining to claims based on negligence
or willful misconduct; and (ii) indemnities involving the representations and warranties in certain contracts. In addition, under our
bylaws we are committed to our directors and officers for providing for payments upon the occurrence of certain prescribed events. The
majority of these indemnities and commitments do not provide for any limitation on the maximum potential for future payments that we
could be obligated to make. We have not incurred costs to defend lawsuits or settle claims related to these indemnification agreements.
As a result, we believe the estimated fair value of these agreements is minimal. Accordingly, we had no liabilities recorded for these
agreements as of September 30, 2023 and 2022.

 Contingent Consideration

 At
September 30, 2023, the Company determined that it was probable the Company would default on its obligations under the June 9, 2023,
and September 14, 2023, note agreements. Upon the occurrence of any default under the note agreements, the Company is obligated to pay
the holders an amount equal to the outstanding principal and accrued interest through the date of full repayment multiplied by 150%.
As a result, the Company recorded a default penalty totaling $2.92 million as a contingent liability at September 30, 2023.

 Subsequent
to September 30, 2023, the Company failed to remit periodic payments under the June 9, 2023, and September 14, 2023, note agreements.
As a result, each outstanding periodic payment may be converted into shares of the Company's common stock at 80% of the lowest
VWAP on any trading day during the five (5) trading days prior to the respective conversion date until the periodic payments are made
or settled.

 Leases

 As the Company's leases generally do not provide
an implicit discount rate, the Company uses the estimated collateralized incremental borrowing rate based on information available at
the lease commencement date in determining the present value of lease payments for use in the calculation of the operating lease liabilities
and right-of-use assets. This rate is determined using a portfolio approach based on the risk-adjusted rate of interest and requires estimates
and assumptions including credit rating, credit spread, and adjustments for the impact of collateral. The Company believes that this is
the rate it would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar lease term. Operating
lease liabilities and corresponding right-of-use assets include options to extend lease terms that are reasonably certain of being exercised.
The Company does not record a lease liability and corresponding right-of-use asset for leases with terms of 12 months or less, and accounts
for lease and non-lease components as a single lease component. The Company's lease portfolio is comprised of operating leases with the
lease cost recorded on a straight-line basis over the lease term.

 We
are obligated under a triple-net operating lease for our 6,475 square foot manufacturing facility located in Greenville, South Carolina,
which is classified as an operating lease. The terms of the lease require a payment of approximately $10,000 per month, which includes
an estimate for utilities, taxes, and repairs. This lease expired in August 2023 and was subsequently renewed and has
a new expiration date of August 2028.

 We
believe this facility will be adequate to meet our current needs based on the property and equipment currently owned. However, our business
plan will require additional space, and we will be making plans to expand our building footprint at possible new or additional locations
to accommodate additional manufacturing equipment. As part of the initial expansion discussed above, we have entered into a lease for
23,485 square feet of additional manufacturing space in Greenville, South Carolina, expiring in July 2036. The lease amount
per month is $9,785 per month through September 2024. In addition, we have a lease for 3,414 square feet of office space in Scottsdale,
Arizona for $6,259 per month, which expires in September 2024. There are no options to extend this lease, however, the Company intends
on continuing to lease this space and will negotiate terms and conditions at the going market rate. The office is to facilitate the administration
and marketing of expanding the manufacturing aspect of our Company as well as to administer increased management anticipated in areas
of human resources, finance, accounting, and financial analysis as well as sales and marketing to manage the growth in the production
output as a result of the second facility in Greenville, South Carolina. We intend to pay for these improvements using a combination
of working capital, new debt financing, and equity offerings.

 The
weighted average remaining lease term and weighted average discount rate for operating leases were 3.8 years and 8.0 %,
respectively. The operating lease cost for the twelve months ended at September 30, 2023 was approximately $ 56,000. The operating lease
cost for the twelve months ended at September 30, 2022 was approximately $ 43,000.

 The
future minimum lease payment required under our leases as of September 30, 2023 are as follows:

of future minimum lease payment

 2024

 $

 285,735

 2025

 296,032

 2026

 299,323

 2027

 302,696

 2028

 295,714

 Thereafter

 788,787

 Total
 undiscounted cash flows

 2,268,287

 Less:
 present value discount (8% per annum)

 612,328

 Total
 lease liabilities

 $

 1,655,959

 Employment
Agreements

 We
have entered into three separate employment agreements that provide for stock to be issued annually in varying amounts through fiscal
2025. Future commitments through the expiration of these three agreements, if each were to be fully earned, would total 1,772,469
shares of our common stock earned as follows:

of Employment Agreement

 Fiscal Year

 Total Shares

 2024

 1,578,215

 2025

 194,254

 1,772,469

 The
price per share will be based upon the fair market value of the stock on the date of grant. The grants are fully vested,
pending the service requirement of continued employment.

 We
also have salary commitments contained in our various employment agreements. These commitments for the next three fiscal years are
as follows:

of Salary Commitments

 2024

 $
 984,000

 2025

 577,000

 2026

 407,380

 $
 1,968,380

 After
2025, one salary continues to increase at 9% per year from its approximately $280,000 base salary.

 F- 14

 Additional

 In
addition to the above stock commitments, we have agreed to provide certain executive officers with compensation paid in diamonds.
These commitments amount to issuing 9.5 carats of diamonds per month through September 2022 and 7 carats of diamonds per month
through December 2023. Through the years ended September 30, 2023 and 2022 this obligation has been accrued at a valuation of $1,000
per carat, which is based on management's estimate of the market value of the diamonds and is included as part of accrued
executive payroll and related expenses, see Note 6.

 NOTE
8 – NOTES PAYABLE AND CONVERTIBLE TERM NOTES

 Notes payable at September 30, 2023 and 2022 consisted
of the following:

 We
have a note with a private lender, dated May 14, 2019, with an original principal balance of $100,000 and an original maturity date of
September 5, 2019. The note has been re-negotiated on several occasions with the most recent extension executed December
1, 2022 with a maturity date of December 31, 2024. Accrued interest was capped at 46,500 shares of the Company's common stock which
were issued to the private lender on November 29, 2023. The principal balance outstanding on the note at September 30, 2023 and 2022,
respectively was $72,500. The note is unsecured.

 On May 18, 2023, we entered into a note with a private
lender with an original principal balance of $200,000 and an original maturity date 30 days after the effective date. The note contains
an interest rate of 10% which is payable at maturity along with the outstanding principal balance. As an inducement to enter into the
note 10,000 shares of the Company's common stock was issued upon the acceptance of this note by the private lender. This note and
accrued interest was paid in full in July 2023.

 On June 2, 2023, we entered into a note with a private
lender with an original principal balance of $50,000 and an original maturity date 30 days after the effective date. The note has been
re-negotiated and has a current maturity date of December 31, 2025. The note contains an interest rate of 15% which is payable at maturity
along with the outstanding principal balance. As an inducement to enter into the note 20,000 shares of the Company's common stock
was issued upon the acceptance of this note by the private lender. The principal balance outstanding as of September 30, 2023 was $50,000.

 On
July 31, 2023, we entered into a note with a private lender with an original principal balance of $250,000 and an original maturity date
45 days after the effective date. The note contains a fixed interest rate of 5,000 shares of common stock which is payable at maturity
along with the outstanding principal balance. As an inducement to enter into the note 25,000 shares of the Company's common stock
was issued upon the acceptance of this note by the private lender. On March 22, 2024, an extension was granted effective as of September
30, 2023, with an extension until December 31, 2024 in return for an interest rate of 5,000 shares of common stock per week. The
principal balance outstanding on the note at September 30, 2023 was $250,000, and as of September 30, 2023, all interest shares have
been issued. Convertible term notes with a discount as of September 30, 2023 and 2022 consisted of the following:

 On September 14, 2023, the Company entered into an
8% note agreement with a face value of $271,739 and proceeds totaling $250,000. The convertible note requires periodic principal and interest
payments until maturity on September 14, 2024, and is convertible at $2.00 per share of common stock. In connection with the note agreements,
the Company issued a total of 16,620 warrants exercisable at $2.50 per share which expire five years from issuance and 2,500,000 warrants
exercisable at $0.01 per share which expire five years from issuance. The warrants, 16,620 of which were immediately vested and 2,500,000
vested upon a missed filing deadline in October 2023, were valued at $2,017,428 and resulted in an additional discount on the note totaling
$222,436 pursuant to ASC 470-20-30. Under the terms of the note, the Company is obligated to make periodic payments from March 2024 to
September 2024. For any periodic payments not made under the payment schedule, the payment amount may be converted into shares of the
Company's common stock at 80% of the lowest VWAP on any trading day during the five (5) trading days prior to the respective conversion
date. Further, the note and warrants contain provisions whereby the conversion rate and exercise price, respectively, are to be adjusted
to any more favorable subsequent issuance.

 On June 9, 2023, the Company entered into a 16% note
agreement with a face value of $1,635,000 and proceeds totaling $1,504,200. The convertible note requires periodic principal and interest
payments until maturity on June 9, 2024, and is convertible at $2.00 per share of common stock. In connection with the note agreements,
the Company issued a total of 100,000 warrants exercisable at $2.50 per share which expire five years from issuance. The warrants, which
were immediately vested, were valued at $80,491 and resulted in an additional discount on the note totaling $76,403 pursuant to ASC 470-20-30.
Under the terms of the note, the Company is obligated to make periodic payments from December 2023 to June 2024. For any periodic payments
not made under the payment schedule, the payment amount may be converted into shares of the Company's common stock at 80% of the
lowest VWAP on any trading day during the five (5) trading days prior to the respective conversion date. Further, the note and warrants
contain provisions whereby the conversion rate and exercise price, respectively, are to be adjusted to any more favorable subsequent issuance.

 The 2,500,000 warrants issued with the September 14,
2023, note agreement contained a vesting provision whereby the warrants would be returned if the Company issued its Form 10-Q for the
period ended June 30, 2023, prior to October 20, 2023 (the "Trigger Date"). Upon issuance of the September 14, 2023, note
agreement, the Company determined that it would not meet the Trigger Date deadline for the filing of the June 30, 2023, Form 10-Q and
on the Trigger Date the warrants vested and were deemed to be outstanding. As a result, the exercise rate of the June 9, 2023, and September
14, 2023, warrants were amended from $2.50 per share to $0.01 per share and the conversion price of the June 9, 2023, and September 14,
2023, note agreements were amended from $2.00 per share to $0.01 per share.

 Subsequent to September 30, 2023, the Company failed
to remit periodic payments under the June 9, 2023, and September 14, 2023, note agreements. As a result, each outstanding periodic payment
may be converted into shares of the Company's common stock at 80% of the lowest VWAP on any trading day during the five (5) trading
days prior to the respective conversion date until the periodic payments are made or settled.

 From December 15, 2022, through
June 30, 2023, the Company converted five notes of $50,000, $150,000, $100,000, $100,000 and $50,000 out of the seven separate investor
notes totaling an aggregate of $850,000 which had origination dates ranging from May to September 2019, with an interest rate of 7%. Both
principal and interest were convertible at a 20% discount to the IPO price, the discounted price is $3.60. The five notes were converted
into 175,712 shares of common stock shares of common stock for accrued interest. At September 30, 2023, two convertible term notes with
principal balances of $150,000 and $100,000, respectively, remain outstanding. One lender for $150,000 has had interest paid in prior
periods in common shares of stock, and as of September 30, 2023, the principal and accrued interest is $170,970. The second lender for
$100,000 has had interest paid in prior periods in common shares of stock, and as of September 30, 2023, the principal and accrued interest
is $114,115.

 During December 2022, we had
convertible notes with a discount with four separate investors totaling an aggregate of $1.75 million. The notes contain a provision
that the debt will be paid through a conversion to common stock at a discount of 20%. As a result, we have imputed a discount of $350,000
as of the inception of the notes. The notes originated from July to September 2019, with an anticipated due date of December 31, 2022.
The conversion trading price of stock was $4.50 per share, giving an effective conversion price of $3.60 per share after the discount.
During December 2022, all four separate investors converted the aggregate balance outstanding during the time of $1.75 million into 392,131
shares of our common stock.

 F- 15

 On August 23, 2022, we
entered into the 2022 Convertible Note with the 2022 Noteholder for an aggregate original principal amount of $4,100,000. The 2022 Convertible
Note bears interest at a rate of 8% per year with a maturity date of August 23, 2023. The outstanding principal and accrued interest
on the 2022 Convertible Note is convertible, at the discretion of the holder, into shares of our common stock at a price that reflects
a 20% discount from the price paid by investors in any transaction by us that occurs after the date of the 2022 Convertible Note with
the principal purpose of raising equity capital in a private or public sale of our common stock in any amount, provided that in the event
we have not completed an initial public offering within 90 days of the 2022 Convertible Note, then the conversion price will be amended
to a price that reflects a 30% discount from the price paid by investors in any transaction by us. The number of shares issuable upon
conversion of the 2022 Convertible Note and the conversion price are also subject to adjustment in certain circumstances in connection
with future issuances of common stock, stock options, and/or convertible securities and certain corporate transactions. In connection
with the 2022 Convertible Note, we issued to the 2022 Noteholder a five-year warrant (referred to herein as the "2022 Noteholder
Warrant") to purchase shares of our common stock in an amount equal to 33.33% of the number of shares received by the 2022 Noteholder
from the conversion of the 2022 Convertible Note, which number of shares will increase to an amount equal to 50% of the number of shares
received by the 2022 Noteholder from the conversion of the 2022 Convertible Note if within 90 days after the date of the 2022 Convertible
Note either (i) we have not completed an initial public offering, or (ii) the shares of common stock underlying the 2022 Noteholder Warrant
are not registered for resale pursuant to an effective registration statement declared effective by the SEC. The 2022 Noteholder Warrant
is exercisable upon conversion of the 2022 Convertible Note or an event of default under the 2022 Convertible Note, and the exercise
price of the 2022 Noteholder Warrant is equal to 1.25 times the conversion price for the 2022 Convertible Note. For purposes of the 2022
Convertible Note and the 2022 Noteholder Warrant, an initial public offering means an underwritten public offering pursuant to an effective
registration statement under the Securities Act, other than pursuant to a registration statement on Form S-4 or Form S-8, with aggregate
gross proceeds equal to or greater than $15 million and which results in our common stock being listed on any tier of the Nasdaq Stock
Market, the New York Stock Exchange or the NYSE American. Subsequently, on December 6, 2022, the 2022 Noteholder agreed to convert all
of the 2022 Convertible Note into 1,332,825 shares of our common stock concurrently with and conditioned upon the pricing of our initial
public offering. As a result of such conversion of the 2022 Convertible Note, the 2022 Noteholder Warrant will be exercisable for 666,413
shares of our common stock at an exercise price of $3.94 per share. As of September 30, 2023, the note was fully converted with a zero
remaining balance.

 On July 12, 2022, we entered
into a Subordinated Note Purchase Agreement with a private lender. The original principal amount was $750,000 and bears an interest rate
of 20% per year annum. The note was originally due on the earlier to occur of: (i) thirty (30) days from the Original Issue Date of this
Note; or (ii) the date of the Company's initial public offering ("IPO") of its common stock, however, was modified to
the earlier of (i) December 31, 2022; or (ii) the date of the Company's initial public offering ("IPO") of its common
stock. As of September 30, 2023 the outstanding interest and principal amount is zero, having been paid off on December 19, 2022.

 On March 1, 2022, we entered
into a convertible promissory note with a private lender in the original principal amount of $250,000. The note bears interest at a rate
of 8% per year and has a maturity date of July 31, 2022. The note was subsequently amended to extend the maturity date to October 31,
2022. The note is convertible into shares of our common stock at the option of the holder at a conversion price equal to $4.00 per share.
As of September 30, 2022, an aggregate of $255,000 of principal and interest was outstanding under this note. The principal and interest
were converted to shares of Company common shares in December 2022, and as of September 30, 2023 the balance of this note was zero.

 The Company has entered into
various revolving promissory notes with related entities. All these entities are controlled by our Chief Executive Officer. These notes
are non-interest bearing, unsecured, and are payable on September 30, 2023, or earlier at the option of the Company. As of September 30,
2023 and 2022, the outstanding balances were $0 and $558,658, respectively.

 NOTE
9 – SEVERANCE OBLIGATION

 As
of September 30, 2023, we had no severance obligations. As of September 30, 2022, we had a severance obligation of $ 43,000.

 NOTE
10 – CAPITAL STOCK

 Our
authorized capital consists of 100,000,000 shares of common stock with a par value of $ 0.001 per share and 10,000,000 shares of preferred
stock with a par value of $ 0.001 per share.

 At
September 30, 2023 and 2022, we had no shares of preferred stock issued or outstanding.

 As
of September 30, 2023, there were 27,215,966 shares of common stock issued and outstanding. During the fiscal year ended September
30, 2023 we issued 11,196,543 shares of common stock as follows:

 3,963,700
 shares were issued for $142,263 for consulting and other professional services;

 2,061,103
 shares were issued for $ 6,870,490 for conversion of note and accrued interest;

 2,450,000 shares were issued for IPO for
$ 9,132,750 net proceeds;

 400,000 shares were issued for ownership in strategic entity;

 1,933,500
 shares valued at $ 5,994,067 were granted to employees as compensation;

 85,000
 shares valued at $252,065 were granted to our board of directors as fees; and

 303,240
 shares were issued for $ 304,445 for incentive to lenders and for loan modifications with lenders and inducements.

 F- 16

 As
of September 30, 2022, there were 16,369,423 shares of common stock issued and outstanding. During the fiscal year ended September 30,
2022 we issued 1,717,673 shares of common stock and received 4,000,000 shares of common stock as follows:

 25,000
 shares were sold to investors for $ 100,000;

 450,000
 shares were issued for $1,800,000 for consulting and other professional services;

 25,708
 shares were issued for $ 102,832 for interest;

 850,000
 shares valued at $ 3,400,000 were granted to employees as compensation;

 4,000,000
 shares were returned by our CEO and retired as treasury stock for $16,000,000; and

 366,965
 shares were issued for $1,467,860 for incentive to lenders and for loan modifications with lenders.

 NOTE
11 – RELATED PARTY TRANSACTIONS

 Net
amounts due to related parties at September 30, 2023 and 2022 were $ 0 and $ 558,658 respectively, primarily for non-interest bearing,
due on demand advances to our company from our President and Chief Executive Officer or entities controlled by him. Effective September
2021, these obligations were memorialized in written notes. See Note 8 - Notes Payable.

 In
addition, we have various employment contracts and additional compensation agreements with members of the executive team, which are discussed
in Note 7 – Commitments.

 We
also have payroll and related liabilities outstanding as of September 30, 2023, and 2022 that are primarily owed to our principal officers
and are discussed in Note 6 – Payroll and Related Liabilities, and severance obligation discussed in Note 8.

 We
had jewelry sales to one of our directors in the amount of approximately $8500 during the year ending September 30, 2023.

 NOTE
12 – INCOME TAXES

 We compute income taxes using the asset and liability
method in accordance with FASB ASC Topic 740, Income Taxes. Under the asset and liability method, we determine deferred income
tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities and measure
them using currently enacted tax rates and laws. We provide a valuation allowance for deferred tax assets that, based on available evidence,
we are more likely than not to be realized. We currently have substantial net operating loss carryforwards. We have recorded a valuation
allowance equal to the net deferred tax assets due to the uncertainty of the ultimate realization of the deferred tax assets. Realization
of our net operating loss carryforward was not reasonably assured as of September 30, 2023 and 2022 and we have recorded a valuation allowance
of $11.0 million and $6.3 million, respectively, against deferred tax assets in excess of deferred tax liabilities in the accompanying
financial statements.

 The
components of net deferred taxes are as follows:

of Deferred Tax Assets

 As of September 30,

 2023

 2022

 Other
 deferred

 $
 (299,452
)

 $
 (61,803
)

 Net operating loss

 11,294,395

 6,322,519

 Total
 deferred tax assets, net

 10,994,943

 6,260,716

 Valuation
 allowance

 ( 10,994,943
)

 ( 6,260,716
)

 Net deferred taxes

 $
 —

 $
 —

 No
income tax expense was recorded in 2023 or 2022.

 F- 17

 The
reconciliation between the income tax expense calculated by applying statutory federal rates to net loss as follows:

of Effective Reconciliation of Income Tax

 Years Ended September 30,

 2023

 2022

 U.S. federal corporate statutory rate

 21.0 %

 21.0 %

 Valuation allowance

 - 21 %

 - 21.0 %

 Effective tax rate

 0.0%

 0.0%

 The
Company accounts for uncertain tax positions in accordance with ASC No. 740-10-25. ASC No. 740-10-25 addresses the determination of
whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC No.
740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax
position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefit
to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely of being realized upon
ultimate settlement. To the extent that the final tax outcome of these matters is different than the amount recorded, such
differences impact income tax expense in the period in which such determination is made. Interest and penalties, if any, related to
accrued liabilities for potential tax assessments are included in income tax expense. ASC No. 740-10-25 also requires management to
evaluate tax positions taken by the Company and recognize a liability if the Company has taken uncertain tax positions that more
likely than not would not be sustained upon examination by applicable taxing authorities. The Company has evaluated tax positions
taken by the Company and has concluded that as of September 30, 2023 and 2022, there are no uncertain tax positions taken, or
expected to be taken, that would require recognition of a liability that would require disclosure in the financial statements.

 We
file federal income tax returns. The statute of limitations will begin to expire with the use of our net operating losses in a future
year. We do not file state income tax returns due to losses. No state deferred amounts are accounted for.

 As
of September 30, 2023 and 2022, we had federal income tax net operating loss carryforwards of approximately $ 53 million
and $ 29.3 million, respectively. These net operating losses may be carried forward indefinitely. We are
subject to limitations existing under Internal Revenue Code Section 382 (Change of Control) relating to the availability of the
operating loss, therefore utilization of a portion of our net operating loss may be limited in future years. No state NOLs have been claimed due to valuation allowance and Section 382 uncertainty.

 As
of September 30, 2023 and 2022, we did not recognize any assets or liabilities relative to uncertain tax positions, nor do we anticipate
any significant unrecognized tax benefits will be recorded during 2023. It is our policy to classify interest and penalties on income
taxes as interest expense or penalties expense, should any be incurred.

 Tax
positions are positions taken in a previously filed tax return or positions expected to be taken in a future tax return that are reflected
in measuring current or deferred income tax assets and liabilities reported in the financial statements. Tax positions include the following:

 an
 allocation or shift of income between taxing jurisdictions;

 the
 characterization of income or a decision to exclude reportable taxable income in a tax return; or

 a
 decision to classify a transaction, entity, or other position in a tax return as tax exempt.

 As
of September 30, 2023 and 2022, we had no Internal Revenue Service or state tax examinations. Our tax returns for the years 2018 forward are open to examination by the tax authorities.

 NOTE 13 – ADJUSTMENT TO OPENING BALANCE
– STATEMENT OF STOCKHOLDERS EQUITY

 At September 30, 2022, accrued
interest was determined to be overstated by $255,403, resulting in the overstatement of interest expense and net loss for the year ended
September 30, 2022 by the amount of the overstatement. The Statement of Stockholders Equity (Deficit) includes an adjustment to the opening
balance of $255,403 for October 1, 2022.

 Management
determined the prior period financial statements were not materially misstated; therefore, the Company is not required to notify users
that they can no longer rely on the prior period financial statements.

 Schedule of Adjustment
to Prior Period Financial Statement

 Opening Balance, accumulated deficit as
 of October 1, 2022

 $
 41,315,731

 Adjustment

 255,403

 Adjusted opening balance as of October 1, 2022

 $
 41,060,328

 F- 18

 NOTE
14 – SUBSEQUENT EVENTS

 We have analyzed our operations subsequent to the
balance sheet and determined that the following would require recognition or disclosure in the financial statements for the year ended
September 30, 2023. They are as follows:

 On July 01, 2024, we entered into a promissory note
with a private lender with the original balance of $50,000 with a maturity date of June 30, 2025. The Note has an interest rate of 10%
with the principal balance and interest due maturity date. The Note has a stock origination fee of 75,000 shares of common stock.

 On June 27, 2024, we entered into a promissory note
with a private lender with the original balance of $50,000 with a maturity date of June 27, 2025. The Note has an interest rate of 10%
with the principal balance and interest due maturity date. The Note has a stock origination fee of 100,000 shares of common stock.

 On May 17, 2024, we entered into a promissory note
with a private lender with the original balance of $100,000 with a maturity date of September 17, 2024. The Note has an interest rate
of 12% with the principal balance and interest due maturity date. The Note has a stock origination fee of 100,000 shares of common stock.

 As of March 31, 2024, there were 35,052,478 shares of common stock issued
and outstanding. During the three months ended March 31, 2024, we issued 6,483,333 shares of common stock as follows:

 2,450,000 shares valued at $ 1,400,250 were
granted to employees as compensation;

 20,000 shares valued at $ 11,900 were granted
to our board of directors as compensation;

 163,333 shares were issued for $ 87,200 for
incentive to lenders:

 2,010,000 shares valued at $ 821,260 were
issued for consulting services;

 210,000 shares valued at $ 83,110 were issued
for the conversion of notes and accrued interest;

 1,330,000 shares valued at $ 851,200 were
issued for the conversion of Warrants; and

 300,000 shares valued at $ 163,700 were issued
for ownership in a strategic entity.

 On February 15, 2024, we entered into a
securities purchase agreement with a lender with an original principal balance of $272,500 and an original maturity date 6 months after
the effective date. The note contains an interest rate of 8% with final payment and accrued interest due on at maturity along with the
outstanding principal balance due on August 15, 2024. The securities purchase agreement contained an original issue discount of $21,800
which is being amortized as interest expense over the turn of the agreement. As an inducement to enter into the note 33,333 shares of
the Company's common stock was issued upon the effective date of this note to the lender. The note also included a 5 year warrant
to purchase 16,667 shares of the Company's common stock at a price of $2.50 per share. The Company determined that the fair value
of these warrants at the time the agreement was executed to be $76,403 which is being amortized as interest expense over the term of the
agreement. The note does not provide for prepayment or repayment of the principal balance and is required to be repaid according to an
agreed upon amortization schedule. The note is convertible in full or part at a rate of $2.00 per share. The note is also convertible
in part or in total into common shares of the Company at $2.00 per share. The agreement contains an escrow agreement for 458,751 shares
of the Company's common stock to be reserved by the Company's transfer agent as collateral for the security of the note. The
Company has also pledged the majority of its assets as additional security and as part of a security agreement entered into in conjunction
with this securities purchase agreement. The principal balance outstanding on the note at March 31, 2024 was $272,500 and $2,688 in interest.

 The Company retained outside counsel and filed a motion
to dismiss and joined in Scio's motion to dismiss on February 17, 2023. Specifically, the Company believes it was mis-joined to
the lawsuit and that no claims are adequately pled against it. The Company further contended the court lacked subject matter jurisdiction.
The case was re-assigned to Hon. Cristina D. Silva. Judge Silva's on July 5, 2023. On June 14, 2024, the court ordered additional
briefing based on the Company's motion to dismiss for lack of subject matter jurisdiction. The briefing was to commence on June
28, 2024, however, as a result of the court's inclination to grant the Company's motion to dismiss, the Plaintiff stipulated
to dismiss the claims against the Company, Mr. Grdina, and Scio's management and filed a voluntary dismissal of all of the claims
as of June 28, 2024.

 There were unregistered sales of the Company's
equity securities during the quarter ended December 31, 2023 that were not previously reported in a Current Report on Form 8-K as follows:

 178,215 shares valued at $ 106,038 were granted to
employees as compensation;

 180,000 shares were issued for $ 91,200 for incentive
to lenders:

 566,964 shares valued at $ 461,331 were issued for
consulting services;

 30,000 shares valued at $ 16,950 were issued for the
conversion of notes and accrued interest;

 18,000 shares valued at $ 25,020 were issued from
the sale of stock

 80,000 valued at $ 43,700 shares were issued to our
board of directors for compensation; and

 300,000 shares valued at $ 180,000 were issued for
ownership in a strategic entity.

 The previously mentioned securities were issued in
reliance on the exemptions from registration under the Securities Act in Section 4(a)(2) of the Securities Act and/or Regulation D thereunder.

 On December 15, 2023, we entered into a promissory
note with a private lender with the original balance of $750,000 plus a loan origination fee of $50,000 with a maturity date of June 15,
2024. The Note has a fixed interest payment at $9,500 per month with the principal balance due maturity date. The Note has a stock origination
fee of 150,000 shares of common stock.

 On October 18, 2023, we entered into a promissory
note with a private lender for with the original principal balance of $150,000 with a maturity date of January 18, 2024. The Note bears
a fixed interest rate of 30,000 shares of common stock with a default interest rate of 50,000 shares of common stock per month after
January 18, 2024. The principal outstanding balance as of December 31, 2023 was $165,443.48.

 F- 19